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ABSTRACT  
 
Introduction: This program of research targeted the impact of an 8-month weight loss 
intervention induced by physical activity and nutrition on bone health in adolescents with 
obesity. The overall aim of this thesis was to examine the impact of a lifestyle weight loss 
intervention on the bone parameters in adolescents with obesity.  
Method: Sixty-five adolescents were recruited: 31 (6 males) adolescents with obesity in the 
weight loss intervention (age: 13.61 (1.27)), 23 normal weight (NW) adolescents (age: 15.90 
(0.43)) and 11 (4 males) adolescents with obesity in another control group (14.02 (1.39)). 
Primary outcomes targeted bone densitometry (whole body, spine, hip DXA). Secondary 
outcomes included body composition, bone geometry and strength (hip structural analysis) 
and bone biomarkers (procollagen type 1 N-terminal propeptide (P1NP), C telopeptide (CTx) 
estradiol, leptin). Data were collected at baseline, 4 months and 8 months.  Data were adjusted 
for body weight, fat mass and lean mass changes. 
Results: Compared with the NW controls, adolescents with obesity displayed lower unadjusted 
and adjusted bone density. Following successful weight loss (~ -11%) adolescents with obesity 
increased whole body (%Ob ∆ 3.22 (3.58) p<0.001) and lumbar spine (%Ob ∆ 6.27 (12.45) 
p=0.014) BMD. However, values remain lower than their NW peers after adjustment to body 
weight changes. After the weight loss intervention, compromised estimates of fracture risk 
remained especially at the narrow neck (buckling ratio (BR) 8.25 (2.00) p=0.005), despite 
positive adaptations of some geometric properties (i.e. NN CSA, NN Z). Also, bone accretion 
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changes in adolescents with obesity followed an androgen-like adaptation demonstrated by 
periosteal expansion (% NW ∆ 0.69 (3.71); Ob ∆ 1.67 (9.11)) and endocortical resorption (% 
NW ∆ -2.11 (11.79); Ob ∆ 4.42 (10.56)). Among the intervention group, differences in bone 
markers favoured formation during the first 4 months and favoured resorption in the 
remaining months. 
Conclusion: Bone fragility in adolescents with obesity was demonstrated by (1) baseline and 
post intervention lower whole body and regional BMD than NW controls, (2) post-intervention 
higher fracture risk index at the narrow neck, (3) bone biomarkers showing reduced z-scores, 
uncoupling indices and qualitative representations of the distribution of bone remodeling. 
Future investigations of links between bone and obesity during adolescence can be well 
informed by the results of this thesis.   
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SYNTHESE DU TRAVAIL DE 
RECHERCHE 
 
Contexte 
Définie comme une accumulation excessive de graisse corporelle pouvant engendrer des 
problèmes de santé, l’obésité représente un enjeu complexe pour les pays occidentaux depuis 
quelques décennies. Véritable pandémie  ((WHO) 2000) l’obésité infantile est un facteur de 
complications en terme de santé (Daniels 2009) (Ebbeling et al. 2002). De nombreux travaux 
scientifiques se sont intéressés aux conséquences négatives de l’obésité sur les systèmes 
cardio-vasculaires et métaboliques.  
Chez l’enfant comme chez l’adulte, le développement de l’obésité est souvent le résultat d’un 
déséquilibre entre les apports et les dépenses énergétiques engendrant ainsi un bilan 
énergétique positif et une augmentation de la masse corporelle (Rosenbaum et al. 1998). Les 
facteurs environnementaux, les troubles métaboliques, psychologiques et sociaux sont des 
éléments importants dans le développement de cette pathologie. De plus, l’augmentation de 
la proportion de graisses dans le régime alimentaire, la diminution de l’activité physique ainsi 
que l’augmentation des comportements sédentaires sont à prendre en considération. 
 
Bien connu pour induire des troubles graves de santé (diminution / perte motrice et physique, 
complications psychologiques ou métaboliques, maladies cardio-vasculaires), l'obésité fut 
longtemps considérée comme protectrice contre l’apparition de l’ostéoporose. Effectivement, 
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le concept d’os plus résistants dû à une charge mécanique supérieure était considéré. 
Récemment, des études ont cependant mis au défi l’idée d’un effet protecteur de l'obésité sur 
l'os, démontrant que l’accumulation de masse grasse peut nuire à la qualité des os, 
particulièrement lors de la croissance.  
 
Le squelette n’est pas seulement stimulé par une charge mécanique telle que le poids du corps, 
mais également via les effets métaboliques de certaines hormones (adipokines) sécrétées par 
le tissu adipeux. En raison de leur origine commune, les cellules osseuses et adipeuses sont 
intimement liées, suggérant un dialogue entre le tissu adipeux et le tissu osseux. Longtemps 
considéré comme inerte, dédié au stockage de l’énergie, le tissu adipeux est de nos jours 
reconnu comme actif d’un point de vue endocrinien. En effet, le tissu adipeux est impliqué 
dans le contrôle de la satiété, le contrôle homéostatique ainsi que dans le développement 
pubertaire (Karsenty 2006). Le tissu osseux quant à lui est reconnu pour son rôle dans la 
dépense énergétique et l’homéostasie du glucose (Lee et al. 2007). 
Entrainant l’altération hormonale des protéines pro-inflammatoires ainsi qu’un stress oxydatif 
(déséquilibre cellulaire), l’accumulation de masse grasse et la perte de masse osseuse sont dès 
lors favorisées. Les stratégies et programmes de prise en charge de l'obésité s’orientent vers 
une prise en charge pluridisciplinaire (nutrition, activités physiques et soutien psychologique). 
Les effets positifs de la perte de poids sur la santé rencontrent cependant des effets 
indésirables comme entre autre la perte de masse osseuse. Il est probable que cette 
dégradation osseuse générée par la perde de poids lors de l’enfance et l’adolescence, soit liée  
aux facteurs suivants : (1) la diminution de la charge mécanique (Shapses et al. 2012), (2) 
l’altération des sécrétions hormonales impliquées dans le remodelage osseux (Ricci et al. 2001) 
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et / ou (3) la baisse de l’apport calorique (Shapses et al. 2012). De part ces observations, 
l’intérêt de la pratique des activités physiques semble primordial.  L’activité physique induisant 
une contrainte mécanique (ex : activités dites à impact) est anabolisante pour le tissu osseux 
et ce même lors d’une perte de poids.  
 
Contrairement à la population adulte pour laquelle les conséquences et complications de 
l’obésité ont été largement étudiées (Zibellini et al. 2015) (Soltani et al. 2016), peu 
d’informations sont disponibles sur la période de l’adolescence. En effet, la plupart des 
données disponibles dans les études sont limitées par la population incluse puisque celles-ci 
ont mélangé à la fois des adolescents en surpoids et des adolescents en situation d’obésité 
(Van Leeuwen et al. 2017).  
 
Les travaux scientifiques actuels démontrent des résultats contradictoires concernant les 
effets de l’obésité sur le tissu osseux chez les enfants et adolescents. Cette discordance est 
due à plusieurs limitations. 
Tout d’abord, la large hétérogénéité dans les populations recrutées (ex : le genre, l’âge, le 
statut pubertaire, le stade de maturation) peut expliquer l’incapacité à parvenir à un consensus 
concernant les effets de l'obésité sur la santé osseuse chez ces jeunes populations. Le stade de 
maturation revêt une importance particulière. En effet, les adolescents obèses démontrent 
une maturation avancée pour le même âge chronologique que les adolescents normo-
pondérés. De plus, les stades de maturations et le développement osseux sont intimement liés 
indépendamment de la  taille et de l’âge. Les effets de la masse grasse sur le pic de masse 
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osseuse et l’accrétion osseuse dépendent du genre et de la maturité (Shapses et al. 2012) 
(Wang 2002) (Dimitri et al. 2012). Cette relation est modérée en fonction des phases 
spécifiques de croissance (Dimitri et al. 2012). 
 
Puis, le degré de précision des outils de mesure pourrait contribuer à la contradiction des 
résultats observés. Méthode de référence pour évaluer la santé osseuse des enfants et 
adolescents, la DXA a cependant quelques limites en raison d’une surestimation de la densité 
minérale osseuse lors de situation d’obésité (Crabtree et al. 2014). La normalisation des valeurs 
(DMO) est importante particulièrement en période de croissance lorsque plusieurs populations 
de tailles et poids différents sont comparés (Kröger et al. 1995) (Katzman et al. 1991). Il n’est 
pas possible d’obtenir des informations sur l’architecture osseuse, en effet la validité de ces 
mesures quant aux changements structurels liés à la croissance où à la charge mécanique sont 
remis en cause (Khan 2001).  
 
En outre, afin de mieux comprendre les changements structurels osseux, les marqueurs 
sanguins et/ou urinaires sont nécessaires. L’analyse de marqueurs tels que P1NP, CTx, OC 
(unOC, COC, tOC), OPG / RANK / RANKL, sclérostine, vitamine D permettrait d’obtenir 
d’avantages d’informations sur le tissu osseux lors de situations d’obésité. 
 
D’autre part, la précision des outils de mesures permettant d’évaluer la composition corporelle 
doit être considérée. A l’heure actuelle, l’IRM est la technique la plus précise pour différencier 
la graisse sous-cutanée et la graisse viscérale (Karlsson et al. 2013), son coût élevé et sa rareté 
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ne permettent pas, malheureusement, une utilisation fréquente. Contrairement à l’IRM, la 
DXA, l’ultrason et l'impédancemétrie ne mesurent pas la mesure directe de l’adiposité 
viscérale.  
 
Par ailleurs, une autre limitation consiste dans le nombre d’études spécifiquement conçues de 
manière adéquate pour répondre à l’effet de la prise en charge par intervention 
pluridisciplinaire sur la santé osseuse des adolescents obèses. Seule la moitié des travaux de 
recherche a recruté un groupe de références (normo-pondéré et/ou obèse sans intervention). 
De plus, peu d’études se sont intéressées aux effets de programmes comprenant des activités 
physiques sur la santé osseuse. Peu de ces programmes s’intéressaient à la perte de poids. 
 
Enfin, l’absence de report de l’adhérence des adolescents aux programmes de prise en charge  
affaiblie la rigueur des travaux scientifiques. Les informations relatives aux personnes délivrant 
l’intervention ainsi que les ressentis de cette population lors de l’intervention pourraient être 
utiles.  
 
Objectifs 
Le protocole ADIBOX a été pensé afin de déterminer l’influence de la perte de poids induite 
par une prise en charge combinant activités physiques et nutrition sur la santé osseuse des 
adolescents obèses.  
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Quatre objectifs découlent de ce projet : 
(1) étudier les paramètres osseux chez les adolescents obèses et normo-pondérés ayant un 
même niveau de maturation ; 
 
(2) étudier l’influence d’un programme multidisciplinaire de perte de poids combinant 
nutrition et activités physiques sur la santé osseuse des adolescents obèses ; 
 
(3) étudier l’effet d’une perte de poids induite par activités physiques et nutrition sur les 
paramètres osseux comparé aux adolescents normo-pondérés (norme de référence) ; 
 
(4) étudier l’influence du statut pondéral et de la perte de poids sur le remodelage osseux à 
l’adolescence. 
 
Matériel et Méthodes 
Conformément aux lignes directrices de l’éthique pour la recherche clinique, le protocole 
ADIBOX a été approuvé par le comité d’éthique (comité Hôpital Sud Est 1, France).  
L’estimation du nombre de participant a été calculée sur la variabilité attendue de la masse 
grasse corporelle par rapport à la variabilité de la densité osseuse mesurée à la colonne 
vertébrale (lombaire). Un minimum de vingt et un participants (hors arrêt d’étude) par groupe 
est nécessaire afin de mettre en avant les potentielles différences significatives. 
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Soixante-cinq adolescents ont été recrutés : 31 adolescents (dont 6 garçons) atteints d’obésité 
inscrits dans le programme de perte de poids de TZA NOU (âge 13.61 (1.27)), 23 adolescentes 
de poids normaux (âge 15.90 (0.43)) et 11 adolescents (dont 4 garçons) atteints d’obésité 
comme groupe de référence (absence de prise en charge de perte de poids) (âge 14.02 (1.39)). 
Un total de vingt-quatre adolescents a complété l’intervention sur 31 initialement recrutés.  
 
L’IMC des adolescents obèses devait se situer au-dessus du 95e percentile alors que pour les 
normo-pondérés être entre le 5e et le 85e percentile (McCarthy et al. 2006). Afin de réduire les 
biais liés à la maturation, les participants invités à participer à cette étude étaient âgés entre 
12 et 16 ans, avec un stade pubertaire égal ou supérieur au stade 4 de Tanner. Les adolescentes 
incluses dans ce travail de recherche devaient avoir atteint le stade de ménarche au moins un 
an avant le début de l’étude. 
Les participants devaient (1) être exempts de toute histoire récente d’hospitalisation (depuis 
deux ans), (2) ne pas avoir d’antécédents de maladie systémique pendant plus de deux 
semaines au cours des douze derniers mois, (3) ne pas avoir de contre-indication à la pratique 
d’activité physique.  
 
Les mesures primaires : densité minérale osseuse (DMO, g/cm2), contenu minéral osseux 
(CMO, g) et l’aire osseuse (cm2) ont été déterminées par DXA (DXA, QDR-4500A, Hologic, Inc., 
Waltham, MA). En accord avec les recommandations Internationales de l’ISCD (Crabtree et al. 
2014) les mesures suivantes ont été effectuées : corps entier, corps entier moins la tête, rachis 
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lombaire. De plus, les mesures du score trabéculaire au rachis lombaire (TBS iNsight® version 
2.1) ainsi que des mesures au niveau de la hanche ont été réalisées. 
 
Les mesures secondaires correspondent aux mesures anthropométriques (taille, poids), au 
calcul de l’indice de masse corporelle (Kg.m-2), aux stades de Tanner autodéterminés, à l’âge 
de ménarche. De plus, la composition corporelle du corps entier a été mesurée par DXA pour 
la masse musculaire (g), la masse grasse (g, %), la masse grasse androïde (%), la masse grasse 
gynoïd (%) ainsi que l’estimation de la masse grasse viscérale (%, g, cm3). La DXA fournit 
également la possibilité d’une analyse géométrique de la hanche au col étroit du fémur, à la 
zone inter trochantérienne ainsi qu’à la diaphyse fémorale. Dans chaque zone la DMO (g.cm-
2), le diamètre endocortical (cm), l’épaisseur corticale moyenne (cm), la largeur (cm), la coupe 
transversale du moment d’inertie (cm), la section transversale (cm2), le moment de résistance 
(cm3) et le rapport de masse ont été analysés. Des prélèvements sanguins à jeun ont 
également été effectués par une infirmière qualifiée. Le marqueur de formation osseuse P1NP 
(Cloud-Clone Corp, Houston, États-Unis), le marqueur de résorption osseuse CTx (Cloud-Clone 
Corp, Houston, États-Unis), la leptine (BioVendor, République tchèque) et l'œstradiol 
(BioVendor, République tchèque) ont été mesurés.  
 
Pour répondre aux objectifs de l’étude, il est nécessaire de mieux comprendre les changements 
du remodelage osseux entre autre par l’utilisation de l’index de découplage. Les calculs des 
concentrations des marqueurs de formation et résorption sont basés sur le travail de  
Bieglmayer et ses collaborateurs (Bieglmayer et al. 2009) (Grimm et al. 2010). Conformément 
à leurs recommandations, les données ont été logarithmiquement transformées pour la 
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représentation graphique (Microsoft Excel et XLSTATS). Les nuages de points ont été présentés 
avec une ellipse de confiance de 95 %. 
 
La prise en charge institutionnelle de l’obésité offerte par le Centre d’obésité infantile « TZA 
NOU » combine activités physiques, nutrition et soutien psychologique sur une période de 10 
mois.  
Les adolescents ont bénéficiés de quatre séances d'activités physiques supervisées par 
semaine. Deux de ces sessions comprenaient environ 70 minutes de travail aérobie ou de 
résistance. Les séances de travail en aérobie consistent en 10 minutes d'échauffement, 20 
minutes de travail par intervalle, 30 minutes d'exercices continus et 10 minutes de retour au 
calme (étirement, relaxation). Les adolescents ont également bénéficiés de cours de natation 
une fois par semaine (60 min). De plus, 120 à 150 minutes basées sur la découverte de 
nouvelles activités physiques étaient proposées chaque semaine aux adolescents. 
 
Concernant l’aspect nutritionnel, le centre de prise en charge de l’obésité se conforme au 
régime normo-calorique recommandé par rapport au niveau d’activité physique, de l’âge et du 
sexe (Murphy et al. 2002). La prise en charge nutritionnelle comprend également des séances 
d’éducation diététique toutes les deux semaines abordant des sujets tels que la perte de poids, 
la sensation alimentaire, les recommandations de macronutriments, les choix nutritionnels lors 
des repas de fêtes. Des rendez-vous avec les familles sont également organisés toutes les 10 
semaines. 
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Le soutien psychologique a été assuré par des rencontres individuelles mensuelles, ainsi que 
des entretiens avec les familles toutes les 10 semaines. Des sujets comme la motivation, le 
retour à domicile, comment faire face aux émotions (stress, anxiété) ont été abordés lors de 
ces entretiens. 
 
Les analyses statistiques ont été réalisées avec le logiciel Stata (version 13, StataCorp, College 
Station, US). Les données sont présentées sous forme de moyennes ± écart-types ou médianes 
[interquartiles]. Les valeurs ajustées sont présentées en utilisant les moyennes [95% intervalles 
de confiance]. L'hypothèse de normalité a été évaluée à l'aide du test Shapiro-Wilk. 
L’homogénéité des échantillons a été effectuée par le test de chi-carré.  
L’analyse des marqueurs sanguins concernaient les trois groupes. Par conséquent, le test 
ANOVA ou le test de Kruskal-Wallis (KW) ont été utilisés. Les tests de Pearson ou Spearman, 
selon la répartition statistique, ont servi à déterminer les coefficients de corrélation entre les 
paramètres de composition corporelle, les paramètres osseux ainsi que les paramètres 
endocriniens. Les variabilités inter et intra participants lors de l’analyse des effets fixes (groupe, 
temps, temps x groupe) pour les paramètres mesurés longitudinalement ont été analysées par 
modèles mixtes. Les analyses multivariées ajustées au poids corporel, à la masse graisseuse ou 
encore à la masse maigre, en fonction des résultats obtenus lors des tests univariés et de la 
pertinence clinique, ont été effectuées. De plus, les modélisations de régression ont également 
été ajustées aux modifications du poids corporel, de la masse grasse totale pendant 
l'intervention. 
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Résultats principaux 
Etudier les paramètres osseux chez les adolescents obèses et normo-pondérés ayant un même 
niveau de maturation. 
Pour cette analyse, les données de 54 adolescents ont été traitées : 31 adolescents obèses 
(dont 6 garçons) et 23 adolescentes normo-pondérées. Comparés aux normo-pondérées, les 
adolescents obèses ont un IMC (32.30±4.15 vs 20.48±1.32), un poids corporel (86.32±15.21 vs 
55.91±5.90), une masse grasse totale (% 39.49±3.82 vs %20.33±3.82) et spécifique (viscérale 
% 43.33±4.22 vs %19.37±5.06) supérieurs. Les adolescentes normo-pondérées sont plus âgées 
que les adolescents obèses (13.61±1.27 vs 15.90±0.43 ans), cependant tous sont au même 
stade de maturation (estradiol et âge de ménarche similaire). 
 
Concernant les paramètres osseux, les adolescents obèses ont une plus faible densité osseuse 
au corps entier (sans la tête) (p<0.001), à la hanche (p=0.022) et un plus faible contenu minéral 
osseux au corps entier (sans la tête) (p=0.048), au rachis lombaire (p<0.001) ainsi qu’à la 
hanche (p=0.008) comparé au groupe de référence. Lorsque les données ont été ajustées au 
poids corporel (PC), à la masse grasse (MG) ou encore à la masse musculaire (MM), les 
adolescents obèses démontrent une plus grande altération des paramètres osseux à tous les 
sites mesurés.  
L’analyse structurale de la hanche montre que les adolescents obèses ont une densité osseuse 
inférieure (p=0.008), une plus faible épaisseur corticale (p=0.009), un diamètre endocortical 
(p=0.040) et un indice de fracture (p=0.028)  supérieur à la diaphyse fémorale. Après 
ajustement, les adolescents obèses ont une densité osseuse inférieure au niveau inter 
trochantérique (p<0.005 ajusté PC, p=0.012 ajusté MM and p=0.038 ajusté MG) de même qu’à 
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la diaphyse fémorale (p=0.001 ajusté PC et MM, p=0.022 ajusté MG). De plus, les résultats de 
l’analyse géométrique mettent en avant une plus petite largeur périostéale aux trois sites de 
mesures (col étroit, inter trochanter, diaphyse) chez les obèses (p=0.001 ajusté PC, p<0.009 
ajusté MG et p<0.010 ajusté MM pour le col étroit et la diaphyse, p=0.002 pour l’inter 
trochanter). A la région du col étroit, un diamètre endocortical inférieur (p=0.002 ajusté PC,  
p=0.001 ajusté MG) est observé chez les adolescents en situation d’obésité comparé au groupe 
de référence. De plus, les résultats démontrent une altération de l’épaisseur corticale dans la 
région inter trochantérienne ainsi qu’à la diaphyse fémorale (p<0.008 ajusté PC et p<0.005 
ajusté MM).  
Au début de l’étude un indice de fracture plus élevé a également été observé chez les 
adolescents obèses versus normo-pondérés à la diaphyse fémorale (p=0.028).  
 
Etudier l’influence d’un programme multidisciplinaire de perte de poids combinant nutrition 
et activités physiques sur la santé osseuse des adolescents obèses. 
Pour cette analyse, les données des 24 adolescents (dont 3 garçons) ayant complétés les 8 
mois d’intervention de perte de poids ont été traitées. L’analyse longitudinale met en avant 
une diminution significative du poids corporel et de la masse grasse (totale et spécifique) lors 
de l’intervention (p<0.007). Seule la masse musculaire reste inchangée.  
 
Lors des 8 mois de prise en charge de l’obésité, le contenu minéral osseux, la densité minérale 
osseuse au corps entier (sans la tête) (p<0.001) et le contenu minéral osseux (p=0.003), la 
densité minérale osseuse (p=0.014), la densité apparente osseuse (p=0.015) au rachis lombaire 
ont été améliorés. 
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L’analyse structurale de la hanche montre qu’à la fin des 8 mois du programme de perte de 
poids, les adolescents ont une densité osseuse diminuée au col étroit (∆ -4.74 (6.07) % 
p<0.001) ainsi qu’une augmentation du diamètre endocortical (∆ 6.20 (6.77) % p<0.001) et de 
la largeur périostéale (∆ 6.16 (7.69) % p<0.001). Des résultats similaires ont été observés au 
niveau inter trochantérique. L’épaisseur corticale quant à elle, augmente à la diaphyse 
fémorale (∆ 4.49 (5.21) % p=0.002). 
L’analyse des paramètres de résistance osseuse met en avant une augmentation de l’index de 
risque de fractures principalement au col étroit du fémur (∆ 8.24 (2.00) % p=0.005) avec des 
valeurs proches du seuil de fracture. 
 
Etudier l’effet d’une perte de poids induite par activités physiques et nutrition sur les 
paramètres osseux comparés aux adolescents normo-pondérés (norme de référence). 
Pour cette analyse, les données de 47 adolescents ont été traitées : 24 adolescents obèses 
(dont 3 garçons) et 23 adolescentes normo-pondérées.  
 
A l’achèvement du programme de perte de poids une densité osseuse plus faible au corps 
entier (sans la tête) (p<0.001) et à la hanche (p=0.017) a été observée chez les adolescents 
obèses versus normo-pondérés. Par ailleurs, après ajustement (changements poids corporel 
et masse grasse), les adolescents obèses démontrent des valeurs osseuses inférieures aux 
normo-pondérés : DMO corps entier (sans la tête) (p<0.008), col (p<0.001 ajusté PC, p=0.031 
ajusté MG), à la hanche (p<0.008) ainsi qu’une densité minérale apparente inférieur au corps 
entier (p<0.008). 
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Comparés aux changements observés chez les adolescentes normo-pondérées, les 
adolescents obèses ont un diamètre endocortical (p<0.006), une largeur périostéale (p<0.017) 
supérieure aux trois sites du fémur (col étroit, inter trochanter, diaphyse).  
En parallèle, des valeurs plus faibles ont été observées chez les adolescents obèses versus 
normo-pondérés pour la densité osseuse (p<0.009) et l’épaisseur corticale (IT p= 0.031, DF 
p=0.001) aux sites inter trochantérien et diaphysaire. Lorsque les valeurs sont ajustées aux 
changements de poids ou masse grasse, l’épaisseur corticale aux deux sites reste inférieure 
chez les adolescents obèses. De plus, le diamètre endocortical est supérieur chez les obèses 
après ajustement au poids de corps (DF p=0.014) et masse grasse  (IT p<0.05, DF p=0.018). Des 
différences au niveau des paramètres de résistance ont été observées au col étroit (p=0.008), 
à l’inter trochanter (p=0.004) et encore à la diaphyse fémorale (p=0.004) pour l’indice de 
fracture. Après avoir ajusté les données aux changements de poids corporel, l’indice de 
fracture à l’inter trochanter et à la diaphyse fémoral sont supérieur (p<0.004). De même, la 
section transversale inter trochantérienne et diaphysaire est supérieure chez les adolescents 
obèses versus normo-pondérés (p<0.003). 
 
Etudier l’influence du statut pondéral et de la perte de poids sur le remodelage osseux à 
l’adolescence. 
Pour cette analyse, les données de 38 adolescents ont été traitées : 10 adolescents obèses 
(groupe intervention), 11 adolescents obèses (dont 4 garçons - groupe contrôle) et 17 
adolescentes normo-pondérées. Les deux groupes obèses montrent des caractéristiques 
corporelles (IMC, poids corporel, masse musculaire, masse grasse) supérieures au groupe 
normo-pondéré de référence. Les adolescents obèses ont des résultats similaires entre eux en 
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terme de composition corporelle à l’exception d’une masse grasse viscérale supérieure pour 
le groupe obèse contrôle (p=0.034).  
 
Afin de comparer les valeurs dans le temps, celles-ci ont été normalisées à partir des valeurs 
de départ de chaque groupe.  
En ce qui concerne les adolescentes normo-pondérées, l’analyse des marqueurs sanguins 
montre qu’à 4 mois, le remodelage osseux favorise la formation. En effet, lorsque l’on regarde 
la répartition au sein du nuage de point, 76% des points sont dans la zone de formation rapide, 
17% en résorption rapide et 7% en résorption lente. Le calcul de l’index de découplage (p= 
0.028; 0.47 (0.78)) confirme l’observation graphique. De plus, une différence significative est 
mise en avant concernant la médiane de formation/résorption à 4 mois (p=0.044).  
Le groupe contrôle d’adolescents obèses a un remodelage osseux favorisant la formation. 
Cependant, à 4 mois, l’ellipse de confiance se décale vers la zone de résorption rapide. Cet état 
de résorption a été démontré, même si non significatif, lors du calcul de l’index de découplage 
allant de 0.00 (1.20) à -1.32 (1.43)). 
Finalement, la représentation graphique du groupe ayant suivi l’intervention de perte de poids 
démontre un remodelage osseux à la fois en formation et en résorption rapide. Après 4 mois 
d’intervention, un décalage du nuage de poids en faveur de la formation osseuse apparaît. 
Néanmoins, cet effet positif est limité puisqu’à la fin de l’intervention les valeurs sont similaires 
à celle du début de la prise en charge. Ces résultats ont été confirmés par l’analyse des 
médianes du taux de renouvellement osseux et de l’équilibre formation/résorption. A 4 mois, 
la formation osseuse semble être promue par un plus faible taux de renouvellement osseux 
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(p=0.037) et une activité plus forte formation/résorption en faveur de la formation osseuse 
(p=0.037). Le retour aux valeurs de base correspondrait à un équilibre formation/résorption 
stimulant la résorption  (p=0.007) et un taux de renouvellement osseux supérieur (p=0.009). 
 
Les valeurs des trois groupes ont été normalisées par rapport aux données de base du groupe 
normo-pondéré afin de comparer leur évolution. Contrairement à ce qui a pu être observé 
précédemment, les ellipses des deux groupes d’adolescents obèses sont représentées dans la 
zone de résorption osseuse. 
 
Le remodelage osseux a également été mesuré entre les deux groupes atteints d’obésité. Pour 
ce faire, les valeurs ont été normalisées aux valeurs de base du groupe contrôle obèses. Le 
programme de perte de poids semble influencer le remodelage osseux (p=0.037 médiane 
formation/résorption, p=0.066 taux de renouvellement osseux).  
 
Conclusion 
Ce projet de thèse a étudié l'impact d'une intervention multidisciplinaire de perte de poids 
combinant nutrition et activités physiques, sur la santé osseuse des adolescents atteints 
d'obésité. Afin de renforcer la compréhension relative à la santé osseuse des adolescents 
atteints d’obésité, les données ont été recueillies lors d’un programme de perte de poids de 8 
mois combinant les activités physiques et la nutrition. 
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Le projet ADIBOX a dans un premier temps étudié les paramètres osseux chez les adolescents 
ayant une même maturité. Ensuite, les effets d'un programme multidisciplinaire de perte de 
poids combinant nutrition et activités physiques, sur les paramètres osseux chez les 
adolescents obèses, ont été évalués. Une comparaison relative aux différences corporelles 
(obèses versus normo-pondérés) a également été effectuée sur le même intervalle de temps. 
Enfin, ce projet s’est intéressé à l’influence du poids et de la perte de poids sur l'activité de 
remodelage osseux. 
 
Les résultats pour les variables primaires ont montré :  
(1) une altération des paramètres osseux (DMO, CMO) chez les adolescents en situation 
d’obésité par rapport aux adolescents de poids normal, même lorsque les données ont été 
ajustées pour le poids corporel, la masse grasse et de la masse maigre ;  
 
(2) une amélioration de la DMO pendant la prise en charge au corps entier et au rachis 
lombaire. Cependant lorsqu’ajustées au changement de poids corporel, ces valeurs sont 
inférieures à celles de leurs pairs de poids normal. 
 
L’analyse structurale de la hanche (géométrie et résistance) est relativement novatrice au sein 
de cette population. Les principaux résultats secondaires de ce projet de recherche ont mis en 
avant : 
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(1) une altération importante des indices géométriques de la résistance de l’os au col étroit du 
fémur. Malgré les adaptations positives de certains paramètres géométriques suite à la prise 
en charge, l’index d’estimation du risque de fracture est très élevé chez cette population ; 
 
(2) des tendances plus subtiles mais significatives concernant l’accrétion osseuse chez les 
adolescents obèses. Le développement osseux semble suivre une adaptation de type 
androgène, en stimulant l’expansion périostéale et la résorption endocorticale.  
 
(3) une réponse positive du remodelage osseux lors des quatre premiers mois de l’intervention 
avant de retourner aux valeurs observées au début de la prise en charge. 
 
Le travail présenté dans ce manuscrit présente un certain nombre de limites. 
Tout d’abord, il n’était pas possible de mesurer individuellement le volume et l’intensité de la 
pratique sportive du programme de perte de poids. Cet effet dose-réponse de la perte de poids 
aux activités physiques est intéressant du fait du niveau de sédentarité des adolescents à 
l’entrée de ce programme. De même, plus d’informations quant à la nutrition aurait été 
appréciable afin de déterminer l’impact de ces deux composantes (nutrition et activités 
physiques) sur la perte de poids et la réponse du tissu osseux. 
 
Ensuite, le programme d’activité physique proposé par le centre de prise en charge de l’obésité 
est orienté sur la remise en activité des adolescents à la pratique sportive. Il est possible que 
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les activités proposées n’aient pas été suffisamment ostéogéniques afin de promouvoir 
l’accrétion osseuse. 
 
De plus, il n’a pas été possible de mettre en place une visite post-intervention. Le centre de 
prise en charge de l’obésité a un recrutement national, ce qui d’un point de vue logistique 
complique la mise en place d’une visite de suivi. 
 
Par ailleurs, des difficultés telles que des données manquantes, un nombre inférieur à celui 
initialement souhaité ont été rencontrées lors du regroupement des groupes contrôles. De 
plus, le ratio garçon / fille ne permet pas une étude plus approfondie d’un point de vue des 
genres. L’inclusion de garçons dans l’analyse peut également être perçue comme variable de 
confusion, malgré la confirmation statistique du maintien de l’homogénéité dans les groupes.  
Initialement le travail de recherche a été mis en place dans les deux pays. Cependant des 
difficultés en Australie lors du recrutement des participants ont été rencontrées. 
 
D’autre part, les marqueurs osseux sont complexes à analyser lors de la période de croissance. 
En effet, ils peuvent refléter à la fois la croissance, le remodelage ou encore un statut 
nutritionnel.  
 
 En outre, pour raison budgétaire, l’analyse complémentaire de marqueurs sanguins 
(OPG/RANK/RANKL, sclérostine, ostéocalcine, PTH, GH/IGF1, adiponectine) n’a pas pu être 
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effectuée. Idem concernant la mesure de la testostérone et la SHBG. Ces marqueurs peuvent 
fournir d’importantes informations sur l’effet de croissance type androgène. 
 
Finalement, il n’était pas possible de mesurer les différentes phases du cycle menstruel, cycle 
connu pour influencer les marqueurs osseux. 
 
Ce travail présente également un certain nombre de points positifs contribuant à sa force. 
Premièrement, la population recrutée était appariée d’un point de vue de la maturation. De 
plus, ce projet a ciblé la population adolescente en situation d’obésité et non pas un mixte 
entre enfants/adolescents et obésité/surpoids.  
 
Deuxièmement, le challenge lié au recrutement des participants est bien connu, malgré 
l’abandon du projet Australien, en France 42 adolescents obèses ont été recrutés, ce qui 
représente un nombre considérable comparé à certaines études. 
 
Troisièmement, une autre force de ce projet réside dans la durée de celui-ci. En effet, outre le 
fait que le temps alloué permet d’observer une réponse en termes de remodelage osseux, les 
mesures ont été collectées en trois temps : au début, au milieu et à la fin de l’intervention. 
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Quatrièmement, ce travail permet également d’obtenir d’intéressantes informations de par la 
présence d’un groupe contrôle sur la totalité de la prise en charge (8 mois). De plus, peu 
d’études ont, en plus d’un groupe normo-pondéré, recruté un groupe obèse contrôle. 
 
Cinquièmement, bien que les données puissent être considérées comme incomplètes, ce 
projet : 
(1) a abordé l'obésité chez les adolescents avec une intervention prolongée dans un 
programme résidentiel.  
 
(2) a exploré les réponses osseuses à la hanche ; site critique et soumis aux variations de poids ; 
en utilisant l'analyse structurale de la hanche. 
 
(3) a combiné les données obtenues par DXA à celles des marqueurs du remodelage osseux. 
 
Collectivement, les résultats de ce travail de thèse contribuent à l’avancée de la 
compréhension des réponses osseuses à l'obésité et la perte de poids chez les adolescents. 
  
29 
 
ACKNOWLEDGEMENTS 
 
  
30 
 
 
 
 
 
31 
 
 
 
 
 
 
32 
 
 
 
  
33 
 
 
  
34 
 
TABLE OF CONTENTS 
 
Introduction .............................................................................................................................. 57 
Review of literature .................................................................................................................. 61 
Bone and growth ................................................................................................................... 62 
2.1. Bone cells ........................................................................................................................ 63 
2.1.1. The osteoblast lineage cells .................................................................................... 63 
Osteoblasts ............................................................................................................... 63 
Osteocytes ................................................................................................................ 64 
Bone-lining cells ........................................................................................................ 64 
2.1.2. Bone resorbing cells ................................................................................................ 64 
2.2. Bone remodeling cycle ................................................................................................... 65 
2.3. Adolescence and gender differences ............................................................................ 66 
2.4. Bone strength ................................................................................................................. 68 
2.5. Bone remodeling regulation .......................................................................................... 71 
2.5.1. Genetic factors ........................................................................................................ 72 
2.5.2. The osteoblast lineage cells’ hormonal factors ...................................................... 72 
2.5.2.1. Bone derived factors ........................................................................................ 72 
RANK/RANKL/OPG .................................................................................................... 72 
Osteocalcin ............................................................................................................... 73 
Sclerostin ................................................................................................................... 74 
2.5.2.2. Others hormonal factors arising directly or indirectly from adipose tissue ... 74 
Growth Hormone/ Insulin-like Growth Factor 1 ..................................................... 74 
Estrogen synthase .................................................................................................... 75 
Insulin ........................................................................................................................ 75 
Leptin ........................................................................................................................ 76 
Adiponectin ............................................................................................................... 77 
Ghrelin ....................................................................................................................... 78 
35 
 
2.5.3. Lifestyle factors ....................................................................................................... 80 
2.5.3.1. Physical activity ................................................................................................ 80 
2.5.3.2. Nutrition ........................................................................................................... 84 
Calcium ..................................................................................................................... 84 
Vitamin D .................................................................................................................. 85 
2.6. Bone health assessment ................................................................................................ 86 
2.6.1. Bone densitometry devices .................................................................................... 86 
2.6.1.1. Dual-energy X-ray Absorptiometry ................................................................. 87 
Classical measures .................................................................................................... 87 
Trabecular Bone Score ............................................................................................. 88 
Hip Structural Analysis ............................................................................................. 89 
2.6.1.2. Peripheral quantitative computed tomography ............................................. 89 
2.6.1.3. Quantitative UltraSound .................................................................................. 90 
2.6.2. Bone biomarkers of bone turnover ........................................................................ 95 
2.6.2.1. Analysis of bone remodeling activity .............................................................. 96 
The Uncoupling Index ............................................................................................... 97 
The bone marker plot ............................................................................................... 98 
2.7. Summary....................................................................................................................... 100 
Obesity and bone tissue: specificity of adolescence .......................................................... 102 
2.8. Obesity .......................................................................................................................... 102 
2.9. Bone mass in obese youth ........................................................................................... 103 
2.9.1. Analysis via DXA .................................................................................................... 104 
Whole body analysis ............................................................................................... 104 
Regional analysis .................................................................................................... 105 
Meta-analysis of cross sectional data ................................................................... 106 
2.9.2. Analysis via pQCT .................................................................................................. 109 
2.9.3. Analysis via biomarkers of bone formation and resorption................................. 109 
2.10. Factors influencing bone mass .................................................................................. 110 
2.10.1. Puberty and gender ............................................................................................ 110 
Whole body analysis ............................................................................................... 110 
36 
 
Regional analysis .................................................................................................... 111 
2.10.2. Fat tissue ............................................................................................................. 111 
2.10.3. Role of hormones? .............................................................................................. 112 
2.10.3.1. Leptin and adiponectin: potential contributors to BMD? .......................... 113 
Leptin ...................................................................................................................... 113 
Adiponectin ............................................................................................................. 114 
2.10.3.2. Bone hormones: potential actor on energy metabolism? ......................... 115 
Osteocalcin ............................................................................................................. 115 
Sclerostin ................................................................................................................. 116 
2.11. Effects of obesity intervention on bone parameters ................................................ 116 
2.11.1. Effects of physical activity intervention on bone in the absence of reporting 
weight loss ....................................................................................................................... 117 
2.11.2. Effects of intervention directly targeting the impact of weight loss on bone ... 121 
2.11.3. Meta-analysis on the effects of structured intervention on bone parameters 126 
Limitations and gaps of the current literature ................................................................... 130 
Research questions ............................................................................................................. 133 
2.12.1. Do adolescents with obesity have altered bone mass compared with 
maturation-matched lean peers? ................................................................................... 133 
Hypotheses ............................................................................................................. 133 
Aim .......................................................................................................................... 133 
2.12.2. Can the negative effects of weight loss on bone health in adolescents with 
obesity be attenuated with a lifestyle intervention? ..................................................... 134 
Hypotheses ............................................................................................................. 134 
Aim .......................................................................................................................... 134 
2.12.3. Does exposure to an 8-month WL intervention involving physical activity and 
nutrition normalise bone health in adolescents with obesity? ..................................... 135 
Hypotheses ............................................................................................................. 135 
Aim .......................................................................................................................... 135 
2.12.4. Do weight status and weight changes influence bone markers in adolescents 
with obesity? ................................................................................................................... 136 
Hypotheses ............................................................................................................. 136 
37 
 
Aim .......................................................................................................................... 136 
Methodology ........................................................................................................................... 137 
3.1. The ADIBOX study design ............................................................................................. 139 
3.2. Ethics Approval and Clinical Trial registration ............................................................. 139 
3.3. Participants ................................................................................................................... 139 
3.4. Sample size calculation ................................................................................................ 140 
3.5. Inclusion/exclusion criteria .......................................................................................... 141 
Inclusion criteria ..................................................................................................... 141 
Exclusion criteria ..................................................................................................... 143 
3.6. Data collection Overview ............................................................................................. 143 
3.6.1. Primary outcomes ................................................................................................. 144 
Bone density assessed using DXA .......................................................................... 144 
Quality Assurance and Radiation dosage .............................................................. 145 
3.6.2. Secondary outcomes............................................................................................. 146 
Anthropometric characteristics ............................................................................. 146 
Maturation .............................................................................................................. 146 
Body composition ................................................................................................... 146 
Hip Structure Analysis ............................................................................................ 147 
Endocrine markers .................................................................................................. 148 
3.7. Details of analysis involving key endocrine markers ................................................... 149 
Uncoupling index .................................................................................................... 149 
Bone marker plot .................................................................................................... 149 
3.8. Clinical intervention ..................................................................................................... 150 
Physical activity intervention ................................................................................. 150 
Nutrition intervention ............................................................................................. 151 
Psychological support ............................................................................................. 151 
Participant compliance .......................................................................................... 151 
3.9. Statistical treatment of the data .................................................................................. 152 
Results ..................................................................................................................................... 153 
38 
 
4.1. Do adolescents with obesity have altered bone mass compared with maturation-
matched lean peers? ........................................................................................................... 159 
4.2. Does nutrition and physical activity inducing WL can reverse the negative effects of 
WL on bone health? ............................................................................................................ 168 
4.3. Does 8 months WL induced by physical activity and nutrition result in normal bone 
health? ................................................................................................................................. 185 
4.4. Does weight status and weight changes influence bone markers? ............................ 196 
Discussion and conclusion ...................................................................................................... 215 
5.1. Summary of major findings .......................................................................................... 217 
5.2. Discussion of major findings ........................................................................................ 221 
5.3. Limitations .................................................................................................................... 237 
5.4. Strengths ...................................................................................................................... 240 
5.5. Further research considerations .................................................................................. 242 
5.6. Conclusion .................................................................................................................... 244 
References ............................................................................................................................... 245 
Appendices .............................................................................................................................. 277 
 
 
  
39 
 
LIST OF PUBLICATIONS 
 
Journal Publications related to the PhD Thesis: 
Elliptical approach of bone remodelling activity during a structured weight loss program in 
adolescents with obesity: The ADIBOX study. Chaplais E, Naughton G, Julian V, Dutheil F, 
Masurier J, Greene D, Duclos M, Thivel D, Courteix D. 2018. J Clin Densito; under submission 
process 
Geometric and mechanical bone response to a multidisciplinary weight loss intervention in 
adolescents with obesity: The ADIBOX study. Chaplais E, Dutheil F, Naughton G, Masurier J, 
Greene D, Pereira B, Duclos M, Thivel D, Courteix D. 2018. J Clin Densito; under submission 
process 
Effects of physical activity interventions on bone health in obese children and adolescents: a 
systematic review and meta-analysis. Chaplais E, Naughton G, Greene D, Dutheil F, Pereira B, 
Thivel D, Courteix D. 2017. JBMM (IF: 2.31) 
“ADIposity and BOne metabolism: effects of eXercise-induced weight loss in obese adolescents” 
(ADIBOX): a protocol. Chaplais E, Naughton G, Thivel D, Dutheil F, Pereira B, Greene D, Courteix 
D. 2016. BMJ Open (IF: 2.56) 
The bone-adiposity cross-talk: implication in pediatric obesity. A narrative review of literature. 
Chaplais E, Thivel D, Greene D, Dutheil F, Duche P, Naughton G, Courteix D. 2014. JBMM (IF: 
2.46) 
 
Conference Abstracts related to the PhD Thesis: 
Effects of an 8-month physical activity and nutrition-induced weight loss program on bone health 
of obese adolescents. Chaplais E, Naughton G, Greene D, Duclos M, Masurier J, Dutheil F, Thivel 
D, Courteix D. Bone Abstracts  
40 
 
Other Journal Publications: 
Cardiovascular risk of adipokines: a review. Dutheil F, Naughton G, Crendal E, Courteix D, 
Chaplais E, Thivel D, Lac G, Benson AC. 2017. Journal of International Medical Research (IF: 
1.431)  
Soluble milk proteins improve muscle mass recovery after immobilization-induced muscle 
atrophy in old rats but do not improve muscle functional property restoration. Verney J, Martin 
V, Ratel S, Chavanelle V, Bargetto M, Etienne M, Chaplais E, Le Ruyet P, Bonhomme C, 
Combaret L, Guillet C, Boisseau N, Sirvent P, Dardevet D. 2016. J Nutr Health Aging (IF: 2.99) 
Bioelectrical impedance is an accurate method to assess body composition in obese but not 
severely obese adolescents. Verney J, Metz L, Chaplais E, Cardenoux C, Pereira B, Thivel D. 2016. 
Nutrition Research (IF: 2.52) 
Smartphone interventions for weight treatment and behavioural change in childhood obesity: a 
systematic review. Chaplais E, Naughton G, Thivel D, Courteix D, Greene D. 2014. Telemedicine 
& e-Health (IF: 1.67) 
Reproducibility of a pQCT scan protocol to measure bone mineral density of the second 
metatarsal. Chaplais E, Greene D, Hendry GJ, Hood A, Telfer S, du Toit V, Singh-Grewal S, 
Chaitow J, Burns J, Rome K, Schiferl DJ. 2014. BMC Musculoskeletal Disorders (IF: 1.88) 
 
  
41 
 
LIST OF COMMUNICATIONS 
 
Communications related to the PhD Thesis: 
Speaking communication: 
Effects of an 8-month physical activity and nutrition-induced weight loss program on bone health 
of obese adolescents. Chaplais E, Naughton G, Greene D, Duclos M, Masurier J, Dutheil F, Thivel 
D, Courteix D. 8th International Conference on Children’s Bone Health. Allied Health 
Professionals session. June 2017, Wurzburg, Germany. 
ADIBOX – ADIposity and BOne metabolism: effects of eXercice induced weight loss in obese 
youth. The Auvergne Regional Final. « Ma Thèse en 180 secondes », CPU-CNRS France. March 
2016, Clermont-Ferrand, France. 
Big and breakable: Adolescents bone health.  Australian Catholic University, 3 Minutes Thesis 
competition. September 2015 Melbourne, Australia 
ADIBOX – ADIposity and Bone metabolism: effects of eXercise induced weight loss in obese 
youth. Australian Catholic University, Melbourne Higher Degree Research seminar. September 
2015, Melbourne, Australia 
 
Poster communication: 
Effects of an 8-month physical activity and nutrition-induced weight loss program on bone health 
of obese adolescents. Chaplais E, Naughton G, Greene D, Duclos M, Masurier J, Dutheil F, Thivel 
D, Courteix D. 8th International Conference on Children’s Bone Health. June 2017, Wurzburg, 
Germany. 
Effects of physical activity-induced weight loss on bone health in obese adolescents. Chaplais E, 
Masurier J, Dutheil F, Duclos M, Green D, Naughton G, Thivel D, Courteix D. European Congress 
on Obesity. May 2017, Porto, Portugal. 
42 
 
Big and Breakable? Importance of fat mass on bone health in obese adolescents - a retrospective 
analysis. Chaplais E, Thivel D, Greene D, Naughton G, Courteix D. Research Seminar of the 
Doctoral School of Life, Health and Environmental Sciences, June 2016, Clermont-Ferrand, 
France.  
 
Other Communications: 
Speaking communication: 
Neural response to food cues and energy intake following exercise in adolescents: effect of 
weight status. Thivel D, Fearnbach SN, Chaplais E, Silvert L, Duclos M, Keller KL  26th Wingate 
Institute Congress. Juin 2016, Netanya, Isaral,  
 
Poster communication: 
Moderate versus High Intensity Interval Exercise trainings on Energy intake and appetite feelings 
in adolescents with obesity. Miguet M, Masurier J, Julian V, Metz L, Chaplais E, Cardenoux C, 
Boirie Y, Duclos M, Thivel D. European Congress on Obesity. May 2017, Porto, Portugal. 
Reliability of pQCT scan protocol of second metatarsal for children with Juvenile Idiopathic 
Arthritis. Greene D, Chaplais E, Hendry G, Hood A, Schiferl D. 6th International Conference on 
Children’s Bone Health. June 2013, Rotterdam, Netherlands.  
  
43 
 
LIST OF AWARDS 
 
Awards related to the PhD Thesis: 
2nd Runner, Australian Catholic University, 3 Minutes Thesis competition. September 2015 
Melbourne, Australia 
Best presentation, Australian Catholic University, Melbourne Higher Degree Research seminar. 
September 2015, Melbourne, Australia 
  
44 
 
OBTAINED FUNDING 
 
Funding related to the PhD Thesis: 
Conference Travel Grant Scheme, Australian Catholic University, 2017. AUD 2 000 
Blaise Pascal University Cotutelle Grant, Blaise Pascal University, 2015. EUR 900 
Australian Catholic University Postgraduate Award International, Australian Catholic University, 
2014. AUD 27 000 per year for 3 years 
 
 
 
  
45 
 
LIST OF APPENDICES 
 
Appendix 1 - Confirmation of Candidature ............................................................................ 278 
Appendix 2 - Attestation letter of compulsive training module (France) .............................. 279 
Appendix 3 - Ethics approval by the ANSM (National Agency for the Safety of Medicines and 
Health Products) .................................................................................................................... 280 
Appendix 4 - Ethics approval by the University Hospital G.Montpied, Clermont-Ferrand (63)
................................................................................................................................................ 281 
Appendix 5 - Ethics amendment letter to male participants ................................................. 282 
Appendix 6 - Ethics application form ..................................................................................... 283 
Appendix 7 - Clinical trial registration .................................................................................... 353 
Appendix 8 - Article 1 ............................................................................................................. 366 
Appendix 9 - Article 2 ............................................................................................................. 377 
Appendix 10 - Article 3 ........................................................................................................... 386 
Appendix 11 - Article 4 ........................................................................................................... 428 
Appendix 12 - Baseline data of the Ob intervention group ................................................... 448 
Appendix 13 - Baseline and 8 months data of the NW group ............................................... 451 
Appendix 14 - Baseline, 4 months and 8 months data of the adolescents that completed the 
whole WL intervention ........................................................................................................... 457 
Appendix 15 - Baseline and 4 months data of the adolescents with obesity in the control group
................................................................................................................................................ 466 
46 
 
Appendix 16 - Excel file calculation of baseline bone turnover normalised to NW baseline 
median ................................................................................................................................... 469 
Appendix 17 - Excel file calculation of the 4 months bone turnover normalised to NW baseline 
median ................................................................................................................................... 473 
Appendix 18 - Excel file calculation of the 8 months bone turnover normalised to NW baseline 
median ................................................................................................................................... 478 
Appendix 19 - Excel file calculation of baseline Ob bone turnover normalised to Ob baseline 
median ................................................................................................................................... 481 
Appendix 20 - Excel file calculation of 4 months Ob bone turnover normalised to Ob baseline 
median ................................................................................................................................... 483 
Appendix 21 - Excel file calculation of 8 months Ob bone turnover normalised to Ob baseline 
median ................................................................................................................................... 486 
Appendix 22 - Excel file calculation of baseline Ob control bone turnover normalised to Ob 
control baseline median ......................................................................................................... 490 
Appendix 23 - Excel file calculation of 4months Ob control bone turnover normalised to Ob 
control baseline median ......................................................................................................... 493 
Appendix 24 - Excel file calculation of baseline Ob bone turnover normalised to Ob control 
baseline median ..................................................................................................................... 496 
Appendix 25 - Excel file calculation of 4 months Ob bone turnover normalised to Ob control 
baseline median ..................................................................................................................... 498 
Appendix 26 - Excel file calculation of 8 months Ob bone turnover normalised to Ob control 
baseline median ..................................................................................................................... 500 
Appendix 27 - Bone variables of the 24 adolescents with obesity at 4 months adjusted to (A) 
BW changes and (B) fat mass changes .................................................................................. 502 
47 
 
Appendix 28 - Bone variables of the 24 adolescents with obesity at 8 months adjusted to (A) 
BW changes and (B) fat mass changes .................................................................................. 504 
Appendix 29 - Baseline bone variables of the adolescents with obesity in the control group 
compared with the Ob intervention group ............................................................................ 506 
Appendix 30 - Proposed future research question ................................................................. 507 
Appendice 31- Ethics approval by the ACU Human Research Ethics ..................................... 510 
  
48 
 
LIST OF TABLES 
 
Table 1 - Synthesis of hormonal factors influencing bone mass ................................................. 79 
Table 2 - Comparison of bone densitometry techniques (modified from Binkley et al. 2008 
(Binkley et al. 2008)). .................................................................................................................... 93 
Table 3 - Meta-analysis results from cross-sectional studies .................................................... 108 
Table 4 - Aerobic based intervention described by El Hage et al. 2009 (El-Hage et al. 2009) . 118 
Table 5 - Aerobic based intervention described by McGuigan et al. 2009 (McGuigan et al. 
2009) ............................................................................................................................................ 119 
Table 6 - Outlines of weight loss targeted interventions ........................................................... 124 
Table 7 - Meta-analysis results from longitudinal studies ........................................................ 128 
Table 8 - Meta-regression results from longitudinal studies .................................................... 129 
Table 9 - Synthesis of the recruited population ......................................................................... 142 
Table 10 - Outline of the intra, inter-assay coefficient of variation and sensitivity results for 
blood markers .............................................................................................................................. 148 
Table 11 - Outline of the data collection for primary and secondary outcomes ...................... 155 
Table 12 - Outline of the data collection and participants for the first aim ............................. 160 
Table 13 - Descriptive statistics at baseline in the Ob group and NW control group .............. 162 
Table 14 - Bone variables at baseline. A. Unadjusted mean.  B. Body weight adjusted.  C. Fat 
mass adjusted. D. Lean mass adjusted. ..................................................................................... 164 
Table 15 - Outline of the data collection and participants for the second aim ........................ 169 
Table 16 - Unadjusted bone variables at baseline between the adolescents who dropped out 
of the weight loss intervention and the rest of the intervention sample.................................. 173 
49 
 
Table 17 - Biochemical characteristics of the Ob during the weight loss program ................. 179 
Table 18 - Bone remodeling scores and uncoupling index ........................................................ 180 
Table 19 - Correlation analysis.  A. Between hormones and bone parameters. B. Between body 
composition parameters and bone parameters. ....................................................................... 181 
Table 20 - Body composition parameters (A) and bone variables (B) of the 24 adolescents with 
obesity at baseline, 4 and 8 months. .......................................................................................... 182 
Table 21 - Outline of the data collection and participants for the third aim ............................ 186 
Table 22 - Biochemical characteristics of the groups at baseline (T0) and 8 months (T2) ...... 190 
Table 23 - Bone variables at 8 months. A. Unadjusted mean.  B. Body weight adjusted.  C. Fat 
mass adjusted. ............................................................................................................................. 191 
Table 24 - Outline of the data collection and participants for the fourth aim ......................... 197 
Table 25 - Bone markers concentration ..................................................................................... 198 
Table 26 - Descriptive statistics at baseline ............................................................................... 199 
Table 27 - Scores, UI and bone markers plot normalised to groups’ respective median ......... 204 
Table 28 - Balance and turnover normalised to NW baseline median ..................................... 207 
Table 29 - Scores and UI normalised to NW baseline ................................................................ 207 
Table 30 - Outline of the major findings within this thesis ........................................................ 219 
 
  
50 
 
LIST OF FIGURES 
 
Figure 1 - Outline of chapter of this thesis ................................................................................... 60 
Figure 2 - Bone growth adapted from Khan et al (Khan 2001)and Seeley et al (Seeley et al. 
2011) .............................................................................................................................................. 62 
Figure 3 – Bone remodeling cycle ................................................................................................. 65 
Figure 4 - Peak bone mass ............................................................................................................ 67 
Figure 5 – Bone strength influencing factors (adapted from Bouxsein 2005 (Bouxsein 2005)) 68 
Figure 6 - Frost's Mechanostat theory: modeling and remodeling thresholds (adapted from 
Novotec Medical (Novotec Medical GmbH 2008-2013)) ............................................................ 70 
Figure 7 - Biomechanical communication influencing bone development (adapted from 
Isaacson et al. (2014) (Isaacson et al. 2014)) .............................................................................. 71 
Figure 8 - Bone marker plot four-quadrant graph ....................................................................... 99 
Figure 9 - Effect size forest plot for the effects of obesity on lumbar spine bone mineral 
apparent density (a) and whole body BMD (b). ......................................................................... 108 
Figure 10 - Effect size forest plot for the effects of structured physical activity intervention on 
bone mineral density (a) and percentage of fat mass (b) ......................................................... 128 
Figure 11 - Summary of the primary and secondary outcomes measures ............................... 144 
Figure 12 - Whole body, lumbar spine and hip positioning DXA scans ..................................... 145 
Figure 13 - Body composition analysis by Dual energy X-ray Absorptiometry (DXA) .............. 147 
Figure 14 - Hip Structural Analysis by Dual energy X-ray Absorptiometry (DXA) ..................... 148 
Figure 15 - Flow charts of participants of the 3 first aims of this thesis ................................... 157 
51 
 
Figure 16 - Body composition measurement (kg) of the obese interventional group during the 
weight loss intervention .............................................................................................................. 172 
Figure 17 - Unadjusted bone geometric evolution at NN, IT and FS of the obese interventional 
group during the weight loss program ....................................................................................... 177 
Figure 18 - Unadjusted bone strength changes at NN, IT and FS of the obese interventional 
group during the weight loss program ....................................................................................... 178 
Figure 19 - Schematic representation of unadjusted geometric changes at the femoral shaft at 
8-months. Over the 8 months, CSA significantly increased with a similar magnitude in both 
group.  ACT and BMD significantly increased only for the NW group. ..................................... 189 
Figure 20 - Bone turnover changes of the three groups: normal weight (A), Ob (B) and Ob 
control (C), normalised to their respective baseline median ..................................................... 203 
Figure 21 - Bone turnover changes of both obese groups: Ob (A) and Ob control (B), the 
baseline median of NW control was used for normalisation .................................................... 208 
Figure 22 - Bone turnover evolution of both obese groups: Ob (A) and Ob control (B), the 
baseline median of Ob control was used for normalisation ...................................................... 211 
Figure 23 - Bone marker plot of 3 participants (one from each group) normalised to baseline 
NW median (A) and normalised to group’s baseline median (B) .............................................. 213 
Figure 24 - Schema of mechanistic hypothesis of bone metabolism in adolescents with obesity
...................................................................................................................................................... 236 
  
52 
 
ABBREVIATIONS 
 
Android Fat Mass (aFM) Fat tissue in android region, expressed in g or %. 
 
Average Cortical 
Thickness (ACT) 
Estimate of mean cortical thickness calculated as follow: (ROI 
WIDTH - ROI ED) / 2) expressed in cm (Beck 2002). 
 
Body Mass Index (BMI) Index for assessing weight status. BMI is obtained by dividing 
body weight in kilograms by height in m² (Kuczmarski et al. 2000). 
 
Bone Mineral Content 
(BMC) 
The amount of bone mineral per anatomical region expressed in 
grams (g) (Carter et al. 1992). 
 
Bone mineral density 
(BMD) 
The amount of bone mineral content per projected bone scanned 
area expressed in g·cm2 calculated as follow: BMC/projected area 
(Carter et al. 1992). 
 
Bone mineral apparent 
density (BMAD) 
An estimate of volumetric bone mineral density. The mineralised 
tissue mass per total tissue volume (Carter et al. 1992) WB BMAD: 
WB BMC/(WB bone area²/body height); LS BMAD: LS BMC/LS 
bone area1.5 (Katzman et al. 1991). 
 
Body weight (BW) Total mass of the whole body expressed in g. 
 
Buckling ratio (BR) Reflect thickness and cortical instability in bulking ((ROI CSMI / 
ROI Z) / ROI ACT) (Beck 2002). 
 
Center of mass position 
(CMP) 
Distance from center of mass to medial margin (ROI PCD / ROI 
WIDTH) (Beck 2002). 
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Cross-sectional area 
(CSA) 
Estimate of BMC (exclude trabecular bone and soft tissue) 
calculated as follow: (Sum of pixel values in profile) * (pixel 
spacing along profile / 1.05) expressed in cm (Beck 2002). 
 
Cross-sectional 
moment of inertia 
(CSMI) 
Index of structural rigidity; reflect the distribution of the mass 
about a neutral or centroidal axis calculated as follow: (Sum of 
pixel mass at each point in profile times square of its distance 
center of mass) * (pixel spacing along profile / 1.05) expressed in 
cm4 (Beck 2002). 
 
C-telopeptide (CTx) Bone resorption marker comprised of collagen molecules which 
are released when collagen within the bone is broken down (Szulc 
et al. 2007). 
 
Endocortical diameter 
(ED) 
Estimation of the inside diameter of the cortex calculated as 
follow:  (2 * ((ROI WIDTH / 2) * 2 - (0.6 * ROI CSA / pi)) * 0.5) 
expressed in cm (Beck 2002). 
 
Dual energy x-ray 
absorptiometry (DXA) 
A scanner that provides two-dimensional images of regional areas 
or the whole body, using two x-ray beams of differing energy 
levels to measure the absorption of each beam in order to 
calculate bone mineral (An et al. 1999). 
 
Fat mass (FM) Fat tissue in the whole body, expressed in g or %. 
Femoral shaft (FS) - HSA Region located 2 cm distally to the midpoint of the lesser 
trochanter (Beck 2002). 
Gynoid fat mass (gFM) Fat tissue in gynoid region, expressed in g or %. 
 
Grams (g) Metric unit of measure equal to 1/1000 kilogram. 
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Hip structural analysis 
(HSA)  
DXA program measuring BMD and structural geometry of cross-
sections traversing the proximal femur (Beck 2002). 
 
Intertrochanteric (IT) - 
HSA 
Region located along the bisector of the neck-shaft angle (Beck 
2002). 
 
Lean mass (LM) Lean tissue in the whole body, expressed in g or %. 
 
Lumbar spine (LS) Portion of the spine comprising the lumbar vertebrae. 
 
Narrow neck (NN) - HSA The narrowest diameter of the femoral neck (Beck 2002). 
  
Normal weight (NW) Based on BMI, population classified as “normal” (Cole et al. 2005). 
 
MoM MoM=markeri/median (marker) Measure of how far an 
individual result deviates from the median (Bieglmayer et al. 
2009) 
 
Peak bone mass (PBM) The amount of bony tissue present at the end of the skeletal 
maturation (Bonjour et al. 1994). 
 
Peripheral quantitative 
computed tomography 
(pQCT) 
Scanner that provides high-resolution three-dimensional images 
of the peripheral skeleton and uses absorptiometry techniques to 
measure the attenuation of radiation passing through the 
scanned site in order to provide measures of volumetric bone 
density (An et al. 1999). 
 
Procollagen type 1 N-
terminal propeptide 
(P1NP) 
Bone formation marker cleaved from type 1 collagen molecules 
during the process of incorporating collagen into the bone matrix 
(Szulc et al. 2007). 
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Profile center distance 
(PCD) 
Distance from profile center of mass to medial margin of cortex, 
expressed in cm (Beck 2002). 
 
Quantitative 
Ultrasounds (QUS) 
Radiation free device for assessing bone mineral density by 
ultrasound especially to the calcaneus (An et al. 1999).  
 
Region of interest (ROI) Area on a digital image that circumscribes a desired anatomical 
location. 
 
Section modulus (Z) Indicator of bending strength calculated as follow:  (If (ROI CMP  
0.5) then (ROI CSMI / ROI PCD) else (ROI CSMI / (ROI WIDTH - ROI 
PCD))) expressed in cm3 (Beck 2002). 
 
Standard deviation (SD) Measure the dispersion in a distribution.  
 
Tanner Stage (TS) Scale of physical development in children, adolescents and adults 
(Tanner 1962). 
 
Total area Total surface of a two-dimensional figure or shape, expressed in 
m². 
 
Total body less head 
(TBLH) 
 
Whole body measure by DXA excluding the head region. 
Trabecular area Cross-sectional area of trabecular bone in mm2. 
 
Trabecular density The amount of trabecular bone in a certain volume of bone 
(McGraw-Hill 2002). 
 
Tumor necrosis factor 
alpha (TNF- α) 
A pleiotropic cytokine synthesised widely throughout the female 
reproductive tract.  
 
Uncoupling Index (UI) Index representing the balance between bone formation and 
resorption during bone remodeling (Eastell et al. 1993). 
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Visceral fat (VFAT) Fat tissue in largest visceral fat region, expressed in g or %. 
 
Visceral fat mass (VFAT) Mass of fat inside abdominal cavity, expressed in cm3. 
 
Width (WIDTH) Subperiosteal width, outer diameter of the bone. Blur-corrected 
width of the mass profile expressed in cm (Beck 2002). 
 
Whole body (WB) Relates to the entire body. 
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CHAPTER ONE 
 
 
 
 
 
 
 
Introduction 
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The complex consequences of child and adolescent obesity represent major concerns in most 
developed countries ((WHO) 2000), largely contributing to metabolic complications with costly 
repercussions for the burden of disease (Daniels 2009) (Ebbeling et al. 2002). This burden is 
exemplified by high prevalence rates of overweight or obesity. Well known to lead to serious 
health-related disorders (compromised movement capacity, psychological or metabolic 
complications such as type 2 diabetes and cardiovascular disease), obesity was thought to be 
protective against osteoporosis. Until recently, the concept of stronger bones due to extra 
mechanical load had widespread acceptance. However, recent studies have challenged the 
concept of a protective effect of obesity on bone, indicating that fat accumulation may be 
detrimental to bone quality during the growing years. Even less is known about the impact of 
fat loss on bone quality among adolescents.  
 
The skeletal system is not only stressed from mechanical loading such as weight bearing 
movements but also through the metabolic effect of some of the adipokines secreted by fat 
(adipose) tissue. Due to their common origin, bone cells and hormones released by fat tissue 
(adipocytes) are intimately connected; suggesting a cross-talk between adipose tissue and 
bone tissue. Adipose tissue has long been considered an inert tissue dedicated for energy 
storage. Recent advances have established that both adipose tissue and bone tissue are 
dynamic endocrine organs. Adipose tissue is involved in satiety, energy balance and pubertal 
development (Karsenty 2006), while bone tissue acts on energy expenditure and glucose 
homeostasis (Lee et al. 2007). Indeed, obesity leads to hormonal alterations associated with 
increased pro-inflammatory proteins released by immune cells (cytokines) and cellular 
imbalance known as oxidative stress. Under some conditions, inflammatory and oxidative 
stress can favour the accumulation of fat mass and loss of bone mass. It is possible that bone 
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breakdown generated by weight loss during childhood and adolescence is related to a number 
of factors that includes: (1) decreased mechanical loading on the skeleton (Shapses et al. 2012), 
(2) altered hormonal secretion involved in bone regulation (Ricci et al. 2001) and/or (3) 
decreased caloric intake (Shapses et al. 2012). However, weight bearing physical activity may 
be anabolic for bone, even during periods of weight loss during the years surrounding 
adolescent growth. To date, most studies have not considered adding sex-hormone status and 
other components of pubertal development to bone investigations among adolescents 
aspiring to use physical activity as part of weight loss strategies. 
 
The overall purpose of this work was to determine the impact of weight loss induced by 
physical activity and nutrition on bone health among adolescents with obesity. Figure 1 
provides an outline of chapters in this thesis. After a brief review on bone and growth, the 
existing literature on the adipocyte-osteocyte cross-talk, the impact of obesity on bone health 
as well as the effects of structured intervention on bone health were considered among 
adolescents with obesity. Finally, the methodology and results of this thesis are detailed and 
discussed. 
 
 
 
 
 
 
Figure 1 - Outline of chapter of this thesis
Introduction
Review of literature
Methodology
03
01
04
02 05
06
• Bone and growth
• Obesity and bone tissue: 
specificity of adolescence
Results
• Bone parameters among adolescents of various weight
• Nutrition & physical activity induced WL on bone health
• Bone parameters after WL vs normal development
• Various weight & weight changes on bone biomarkers
Appendices
Discussion & Conclusion
• Limitations
• Strengths
• Further research considerations
• Conclusion
• Study design 
• Primary & secondary outcomes
• Intervention
• Statistical treatment
CHAPTER TWO 
 
 
 
 
 
 
 
 
Review of literature 
 
 
 
 
 
 
  
62 
 
Bone and growth 
Bone development (length, mass and breadth) results from complex interactions between 
genetics, hormonal and modifiable lifestyle factors such as nutrition and physical activity. The 
basic morphology of bone is genetic (50-90%), but final mass and architecture can respond to 
mechanical environments (10-50%) (Health et al. 2004). Investigating growth during 
adolescence remains critical as the skeleton, under endocrinal control, undergoes rapid 
changes through modelling and remodeling processes. Growth in stature during the first two 
decades of life is the result of multiple contribution of appendicular and axial growth.  
 
 
 
Figure 2 - Bone growth adapted from Khan et al (Khan 2001)and Seeley et al (Seeley et al. 2011) 
 
 
Bones tissue in the human skeletal comprises cortical (80%) and trabecular (20%) bone (Zebaze 
et al. 2010). As such, the external surface of long bones comprises cortical bone, surrounding 
bone marrow space, while trabecular bone is principally found at the metaphysis and epiphysis 
of long bones (Figure 2). Trabecular and cortical bone are composed of osteons; concentric 
layers of compact bone tissue that are fundamental to the function of bone. Dense and solid, 
with less than 5% porosity (Clarke 2008), endosteum and periosteum comprise the two 
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surfaces of cortical bone. The endosteum surface is the inner surface of long bones and has a 
thin layer of cells lining the medullary cavity. With higher remodeling activity than the 
periosteum surface, it is postulated that endosteum experiences greater biomechanical strain 
or increased cytokine exposure (Clarke 2008). The periosteum forms the outside surface of the 
bone and consists of two shapes: an outer shape (rich in blood vessels and nerves) and an inner 
shape (helping to build stability in the layers of bone during growth) (Khan 2001). Therefore, 
the periosteum surface activity is important for growth and fracture repair.  
 
2.1. Bone cells 
Throughout life, the skeleton continuously remodels. Changes can be observed in shape, mass 
and intrinsic properties as well as a self-repair capacity (Frost 1987) (Macdonald et al. 2005) 
(Rantalainen et al. 2010). The osteoblasts, osteocytes and bone-lining cells (osteoblast lineage) 
and osteoclasts (bone resorbing cells) are the two bone lineage cells involved in bone 
remodeling. 
 
2.1.1. The osteoblast lineage cells 
Osteoblasts 
Mature osteoblasts continuously add new bone between the epiphyseal plate and metaphysis 
(Aubin 2001). Osteoblasts are derived from chondrocytes, adipocytes, fibroblasts and bone 
marrow mesenchymal stem cells. They reside along the bone surface at which bone formation 
is active. Osteoblast differentiation has four stages: the preosteoblast, osteoblast, osteocyte 
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and bone-lining cells. Fifty to seventy per cent of mature osteoblasts undergo apoptosis; the 
remaining osteoblasts differentiate into osteocyte or quiescent lining cells (Lynch et al. 1998). 
 
Osteocytes 
Residing in newly formed osteoid and the mineralised matrix of bone, osteocytes are thought 
to send resorption or formation signals in response to mechanical strain (Parra-Torres et al. 
2013). The fundamental roles of osteocytes are to determine and maintain bone structure. 
Osteocytes can undergo apoptosis when located near to the bone matrix and micro-damage 
when bone remodeling increases (Tatsumi et al. 2007).  
 
Bone-lining cells 
The last members of the osteoblast family are the bone-lining cells. Their suggested role is to 
prevent inappropriate interaction between bone surface and osteoclast precursors. Signals 
stimulating osteoclast formation may initiate bone-lining cells to prepare the bone for a 
resorption phase (Chambers et al. 1985).  
 
2.1.2. Bone resorbing cells 
Located on endosteal or periosteal surface of bone, osteoclasts are the bone cells capable of 
resorbing mineralised bone matrix. Osteoclast differentiation is mediated by the ratio between 
the expressing receptor activator (RANK) of RANKL and osteoprotegerin (OPG); an osteoclast 
formation paracrine inhibitor (Boyce et al. 2007). 
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2.2. Bone remodeling cycle 
Bone remodeling phases are well established (Hadjidakis et al. 2006) and are shown in Figure 
3. The activation of bone remodeling depends on acidity levels in cells (Boyle et al. 2003).  
Resorbing osteoclasts secrete ions that lower the pH to 4.5 within the bone-resorbing 
compartment. The lowered pH facilitates the mobilisation of bone mineral (Silver et al. 1988). 
Bone formation takes approximately 4 to 6 months (Khan 2001). Bone formation has the 
purpose of maintaining mineral homeostasis and bone strength by repairing micro fractured 
bone. During this period, about 80% of new bone is trabecular, with the remaining 20% being 
cortical. Indeed, less metabolically active than trabecular bone, cortical bone has a slower bone 
turnover. An increase in cortical remodeling causes an increase in cortical porosity and a 
decrease cortical bone mass.  
 
 
 
Figure 3 – Bone remodeling cycle 
 
Reprinted from Servier Medical Art, Copyright by Servier, Creative Commons Attribution 3.0 
Unported License 
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2.3. Adolescence and gender differences 
Unlike any other phase of development, adolescence provides optimal opportunities to boost 
BMD.  The majority of musculoskeletal mass and bone structure are accrued during childhood 
and peri-pubertal development (Parfitt 1994) (Baxter-Jones et al. 2011). Indeed, 26% of adult 
bone mass accumulates during pubertal growth (Bailey et al. 1999). Both maturation timing 
and sexual dimorphism have an effect on bone mass. Late maturation has been shown to have 
deleterious effects on whole body BMC especially in female (Jackowski et al. 2011). Although 
the peri-pubertal period emerges as the most suitable time to boost bone structure, elongation 
of long bones continues into late adolescence (Figure 4). It is also during the peri-pubertal stage 
of development that adolescents can optimise bone strength (Parfitt 1994) (Ducher et al. 
2006).  Negative or positive influences during this period can subsequently modify the peak 
bone mass (Dimitri et al. 2012). Peak bone mass is defined as the amount of bone tissue 
present at the end of the skeletal maturation (Bonjour et al. 1994). However, peak bone mass, 
as previously mentioned is strongly influenced by dimorphism. 
 
Wider in males than females, bones do not differ in length between sexes before puberty (Clark 
et al. 2007). Dimorphism in bone emerges largely during puberty (i.e. length, width, mass and 
strength); notably occuring two years earlier in females than males (11-13 years for females 
and 13-15 years for males) (Forwood et al. 2004) (Nguyen et al. 2001). Longer periods of 
prepubertal growth in males than females coincides with a larger increase in bone size and 
cortical thickness that may explain the more apparent sex differences in bone structure 
observed towards the end of puberty (Bonjour et al. 1994). Indeed, periosteal apposition in 
females decelerates earlier than males. Although endosteal resorption enlarges the medullary 
67 
 
cavity in males (Neu et al. 2001), no changes in medullary size at some site and medullary 
contraction at others can be observed in females (Bass et al. 1999). In females, similar mean 
cortical thickness for a smaller total and medullary size bone than boys resulted in the cessation 
of periosteal apposition and medullary contraction (Bass et al. 1999). In contrast, trabecular 
thickness increases leading to greater trabecular volumetric bone mineral density (vBMD) in 
both sexes. However, as females enter puberty, estrogen levels increase and inhibit periosteal 
bone formation; promoting bone growth on the endocortical surface (Seeman 2003) (Wang et 
al. 2006). 
 
 
 
Figure 4 - Peak bone mass 
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2.4. Bone strength 
Bone undergoes longitudinal and radial growth during childhood and adolescence. During 
growth, uncompromised bone health is important to potentially offset bone fragility and 
reduce possible risks related to exacerbated bone loss (i.e. osteoporosis) later in life. 
Uncompromised bone health in healthy populations can be defined by the ability of bone to 
resist fracture under challenging conditions such as falling, acute impact, twisting or other 
mechanical stress (Comité scientifique de Kino-Québec 2008).  
 
 
 
Figure 5 – Bone strength influencing factors (adapted from Bouxsein 2005 (Bouxsein 2005)) 
 
 
The measurement of bone strength has to account for multiple parameters including material 
properties (mass, density, stiffness and strength) and geometric properties (shape, cortical 
thickness, cross sectional area and trabecular architecture) (Khan 2001) (Figure 5). Importantly, 
failure to develop a strong skeleton because of factors such as insufficient mechanical loading, 
poor nutrition, hormonal alterations and disease may lead to bone fragility (Kontulainen et al. 
2007). Material properties depend on the quality and quantity of the bone mineral mass. In 
contrast, bone’s geometric properties depend on the resistance of bone to bending and 
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torsional forces. Together, bone material and geometric properties may provide useful 
markers of an individual’s risk of fracture through an estimate of bone strength (Muehleman 
et al. 2000). Specifically, micro fracture risk can accumulate due to low bone turnover activity, 
while the main cause of micro architectural degradation is attributed to higher bone turnover 
activity (bone resorption activity being greater than formation) (Pocock et al. 1987).  
 
It is well established that peak bone mass is an important determinant of future bone health 
and fracture risk (Bonjour et al. 1994) (Clark et al. 2006) (Chevalley et al. 2011). Moreover, 
increasing bone strength during growth is the primary strategy for preventing osteoporosis 
later in life. Bone mass accounts for 50 to 70% of bone strength (Pocock et al. 1987). However, 
bone strength can be independently affected by the site-specific amount and proportion of 
trabecular and cortical bone (Pocock et al. 1987).  
 
According to the Mechanostat theory (Figure 6) bone mass and strength depend on the peak 
forces caused by muscles (Frost 2003). Increasing muscle mass and muscle force during 
development in childhood creates the stimuli for corresponding increases in bone mass and 
strength (Rauch et al. 2004). Subsequently, a linear relationship exists between muscle cross 
sectional area and bone cross sectional area (Schoenau et al. 2002). Childhood growth and 
development support this muscle-bone relationship. In particular, bone strength and mass 
have demonstrated a linear relationship with muscle development (Schoenau 2005).  
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Figure 6 - Frost's Mechanostat theory: modeling and remodeling thresholds (adapted from 
Novotec Medical (Novotec Medical GmbH 2008-2013))  
 
 
Although the muscle-bone relationship has widespread acceptance, researchers remain 
uncertain about the precise mechanisms of the response (Judex et al. 2009) (Kohrt et al. 2009). 
The Mechanostat theory is limited to the mechanical and physical interactions (Isaacson et al. 
2014). Recently the literature extended the traditional mechanical view to mechanical and 
biochemical interactions (Isaacson et al. 2014) (Tyrovola 2017) (Figure 7). Specifically, the 
activation of the osteoclastogenesis function is the response of both biological (described in 
2.5.) and mechanical stimuli.  
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Figure 7 - Biomechanical communication influencing bone development (adapted from 
Isaacson et al. (2014) (Isaacson et al. 2014)) 
 
 
The mechanical and biochemical circles represent both the traditional Mechanostat theory and 
the more recent biochemical interactions, showing the possibilities of the cross talk. The 
largest circle represents the overall human body, influenced by genetics, nutrition and physical 
activity factors (detailed in section 2.5.).  The interconnection between the system, organs, 
tissues and cells on the understanding of the biomechanical interactions are represented with 
double-headed arrows (Isaacson et al. 2014).  
 
2.5. Bone remodeling regulation  
Bone material properties can be influenced by genetic factors, hormones and modifiable 
lifestyle factors such as nutrition, or physical activity. 
Genetics & lifestyle factors
Mechanical 
theory
Bone, muscle 
& adipose tissue 
derived factors
Cellular
Human system Organ
Tissue
Biochemical 
theory
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2.5.1. Genetic factors 
Genetic factors are beyond the scope of this review. However, some important genetic 
determinants of bone density need to be acknowledged. The insulin growth factor I (IGF I) 
gene, 1.25 vitamin D receptor gene polymorphisms and estrogen receptor gene 
polymorphisms may influence genetic variation in bone mass and density. It is recognised that 
genotypes may be of greater importance than environmental factors in predicting bone density 
early in life (Soyka et al. 2000).  
 
2.5.2. The osteoblast lineage cells’ hormonal factors 
2.5.2.1. Bone derived factors 
RANK/RANKL/OPG 
The OPG/RANKL system has an important role in the osteoclastogenesis and is a 
communication mediator between osteoblasts and osteoclasts (Marie 1992). RANKL, are 
expressed by osteoblasts and belong to the cytokine TNFα superfamily. RANKL are critical for 
osteoclast differentiation. When bound to the receptor RANK, RANKL stimulate osteoclast 
formation (Van Wesenbeeck et al. 2002). Osteoblasts also express OPG, another member of 
the TNFα superfamily. OPG has the role of being a RANKL antagonist.  OPG cells aim to block 
RANK/RANKL interactions by binding the RANK receptor and then inhibiting osteoclast 
differentiation (Van Wesenbeeck et al. 2002). By controlling the ratio of OPG/RANKL, 
osteoblasts are capable of regulating osteoclast formation (Clarke 2008).  
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Osteocalcin 
Osteocalcin (OC) is a recognised marker of bone formation. It is secreted by osteoblasts 
through the OC gene, which comprises the major non-collagen protein found in the 
extracellular matrix of bone and directly reflects bone metabolism (Rochefort et al. 2011). 
Osteocalcin is expressed in two different forms that have two independent functions; the 
carboxylated (cOC) form and uncarboxylated (unOC) form. Carboxylated osteocalcin is thought 
to be the active form in the bone. Carboxylated osteocalcin also has a high affinity for 
hydroxyapatite and is mainly stored in bone matrix during osteoblasts mineralisation (Capulli 
et al. 2014). Alternatively, uncarboxylated osteocalcin is postulated to act on energy 
metabolism (Bonnet 2017). Specifically, in response to decreased osteoblast proliferation via 
the central action of leptin, osteoblasts influence energy metabolism through expressing a 
product of the Esp gene (osteotesticular protein tyrosine phosphatase – OT-PTP). The OT-PTP 
inhibits the carboxylated form of osteocalcin. Consequently, the uncarboxylated form permits 
the ß-cells’ proliferation and insulin secretion in the pancreas as well as stimulating adiponectin 
secretion in adipocytes (Wolf 2008). In rodent studies, the uncarboxylated form of osteocalcin 
also contributes to glucose metabolism by increasing insulin signalling in the muscle, while in 
human studies total osteocalcin rather than unOC has been associated with glucose 
homeostasis (Bonnet 2017). Although interest in osteocalcin has increased recently, 
uncertainty surrounds a greater understanding of the carboxylated form of osteocalcin. This 
remains problematic because most of the time, the uncarboxylated and carboxylated forms 
have not been analysed separately. Questions about the specificity of osteocalcin to bone 
metabolism have been raised since the discovery of osteocalcin secretions by adipose tissue 
(Foresta et al. 2010) and the brain (Patterson-Buckendahl et al. 2012).   
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Sclerostin 
Sclerostin is a protein secreted by osteocytes through the SOST gene. It acts on bone formation 
by means of inhibiting osteoblast activity (Morse et al. 2014) and concomitantly, osteocalcin 
secretion. An activation of the canonical Wnt signalling pathway enhances bone formation by 
stimulating osteoblastic activity, differentiation and proliferation. In addition to its action on 
bone, the Wnt signalling pathway acts on glucose homeostasis as is it active in pancreas, 
adipose tissue, liver and skeletal muscle (Bonnet 2017). The bone Wnt pathway can be 
antagonised by secreted inhibitors binding to lipoprotein receptor-related protein 5/6 (LRP) 
(Williams et al. 2009). The LRP5 protein plays important roles in the development and 
maintenance of bones by acting on the regulation of BMD. Sclerostin is the main inhibitor 
involved in mechanical loading (such as exercise) and unloading states (weight-supported 
environments) (Turner et al. 2009).  
 
2.5.2.2. Others hormonal factors arising directly or indirectly from 
adipose tissue  
Growth Hormone/ Insulin-like Growth Factor 1 
The Growth Hormone (GH)/Insulin-like Growth Factor 1 (IGF1) axis is important in growth and 
bone remodeling (Gajewska et al. 2015). The hormone IGF1 is produced by the liver under the 
regulation of GH. However, GH is secreted from the anterior pituitary gland and is regulated 
by hypothalamic factors (E Govoni 2012). Once secreted, GH can act on bone directly or 
indirectly by stimulating the release of IGF1. During the peri-pubertal period, GH/IGF1 are 
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determinants of longitudinal bone growth (Giustina et al. 2008). The GH/IGF1 axis has an 
anabolic effect on bone and stimulates osteoblast proliferation (Giustina et al. 2008).  
 
Estrogen synthase 
Secreted by gonads and adipose tissue, aromatase or estrogen synthase controls the 
biosynthesis of androgen to estrogen. In addition to a widely accepted effect on growth 
(maturation and sexual development), estrogen increases fat storage and regulates bone 
metabolism (Riggs et al. 2002). The main function of estrogen on bone metabolism is to reduce 
bone resorption that subsequently increases bone formation (Alexandre 2005). The action of 
estrogen on osteoclasts is suggested to be indirect and mediated by products secreted from 
osteoblasts (i.e. OPG/RANKL) (Gruber et al. 2002). Estrogen binds to its receptor on the 
osteoblasts and directly increases the production of OPG and reduces the production of RANKL 
(Alexandre 2005).  
 
Insulin 
Insulin is produced by pancreatic β-cells and has an anabolic effect on osteoblasts. By relieving 
the suppression of Runx2 (Runt-related transcription factor 2 - a factor associated with 
osteoblast differentiation) by Twist 2 (Twist-related protein 2) via its signalling pathway, insulin 
stimulates osteoblast differentiation and osteocalcin expression; promoting bone formation 
(Fulzele et al. 2010). Insulin signalling in osteoblasts also enhances osteocalcin activity and 
influences glucose homeostasis (Ferron et al. 2010). The positive loop between insulin 
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signalling in osteoblasts and osteocalcin functions implies that leptin acts as a negative 
regulator. 
 
Leptin 
Secreted by adipose tissue, leptin takes a major role in the regulation of energy homeostasis 
(Thomas et al. 2002). As a satiety hormone (ghrelin antagonist), leptin regulates food intake 
and increases energy expenditure. More recently leptin appears to have either a direct or 
indirect role on bone depending on the signal transduction pathway. By acting directly, leptin 
may impact and regulate bone growth through activation of the fibroblast growth factor (FGF) 
23, and also osteocalcin (Upadhyay et al. 2015). The indirect role of leptin involves activation 
of GH and IGF1 via the hypothalamic pituitary growth hormone axis (Upadhyay et al. 2015).  
 
Leptin also appears to have peripheral and central effects on bone. The peripheral action of 
leptin on bone can occur via autocrine, paracrine or endocrine mechanisms. Leptin receptors 
have been found in osteoblasts and chondrocytes; allowing direct action on bone (Upadhyay 
et al. 2015). The peripheral pathway appeared to stimulate bone growth by acting on specific 
receptors and stimulating cortical bone formation (Thomas 2003). Leptin increases bone mass 
through its interaction with bone marrow mesenchymal stem cells (BMSCs), osteoblasts and 
chondrocytes (Chen et al. 2015). In addition to stimulating the osteoblast cell lineage, leptin 
appears to moderate the OPG/RANKL ratio (Martin et al. 2005) (Thomas 2003) by stimulating 
OPG and inhibiting the production of RANKL. 
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In contrast, the central effects of leptin on bone may counterbalance the positive peripheral 
effects. It is postulated that when serum leptin reaches a critical threshold, the central effects 
of leptin override the peripheral effects (Bonnet et al. 2005). Through the central pathway, 
leptin acts to stimulate bone resorption (Karsenty 2006) and inhibit bone formation (Elefteriou 
et al. 2005). To date, researchers have identified two actions activated by the sympathetic 
nervous system (SNS) after binding to the β2 adrenergic receptor on osteoblasts (Togari 2002). 
On one hand, the adrenergic system suppresses osteoblasts’ proliferation. On the other hand, 
it promotes resorptive effects of osteoclasts by increasing the production of RANKL (Chen et 
al. 2015). Recently, a second pathway has been identified. Leptin appears to stimulate the 
CART pathway (Cocaine and Amphetamine Regulated Transcript) in the arcuate nuclei of the 
hypothamalus. The CART expression then inhibits RANKL production via an unknown 
mechanism and therefore suppresses osteoclast differentiation (Chen et al. 2015).  
 
Adiponectin 
Adiponectin is another adipocyte-secreted hormone known to regulate energy homeostasis, 
glucose and lipid metabolism as well as inflammatory pathways (Williams et al. 2009). 
Adiponectin also affects insulin sensitivity (Abseyi et al. 2012). Because of the regulation of 
adiponectin by osteocalcin it is suggested that bone is another target of this hormone. 
Moreover, adiponectin receptors can be present in either osteoblasts or osteoclasts; 
suggesting a link with bone mass (Williams et al. 2009).  However, the precise action of 
adiponectin on bone is complicated by multiple receptors and signalling pathways (Kajimura 
et al. 2013). In animal models, the existence of two opposing influences of adiponectin on bone 
tissue have been identified (Kajimura et al. 2013). Adiponectin appears to act via two different 
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mechanisms, a local and a central pathway; antagonistic of each other. The local action of 
adiponectin inhibits osteoblast proliferation and stimulates their apoptosis. In contrast, 
adiponectin has the ability to decrease the activity of the SNS and favours osteoblastic 
proliferation. Concomitantly, for peripheral pathways adiponectin increases RANKL expression 
in osteoblasts, while through the brain signalling it inhibits RANKL production (Kajimura et al. 
2013). Adiponectin signals in the brain inhibit the activity of the SNS, thereby increasing bone 
formation. 
 
Ghrelin 
Ghrelin is a gastrointestinal hormone mainly produced by the gastrointestinal track. It acts via 
central or peripheral pathways. Besides a major function in energy homeostasis (Delhanty et 
al. 2014), ghrelin demonstrates a regulatory role in multiple organs including bone. Ghrelin 
functions to promote bone formation and increase bone mass by increasing osteoblastic 
proliferation and differentiation (Pradhan et al. 2013).  However, ghrelin also stimulates 
osteoclastogenesis when acting through the systemic pathway (van der Velde et al. 2012). 
 
Table 1 summarises the hormonal factors influencing bone mass. The table serves to synthesise 
specific actions of the previously described hormones on bone.
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Table 1 - Synthesis of hormonal factors influencing bone mass 
RANKL receptor activator of nuclear factor kappa-B ligand; OPG osteoprotegerin; OC osteocalcin; cOC carboxylated osteocalcin; unOC 
uncarboxylated osteocalcin; GH growth hormone; IGF1 insulin-like growth factor; -R receptor; Ins insulin; ADRß2 β2 adrenoreceptor; LRP5/6 low 
density lipoprotein receptor-related protein 5/6; GHS ghrelin; AT adipose tissue, E2 oestrogen; FGF23 fibrobast growth factor23; FOX01 forkhead 
box protein O1 
Hormones Origin 
Receptors Action on bone cell activity 
Osteoblasts Osteoclasts Osteoblasts Osteoclasts  
B
o
n
e 
ce
lls
 
RANKL osteoblasts  RANK  stimulate osteoclast formation and differentiation 
OPG osteoblasts RANKL   inhibit RANKL antagonist  
OC 
OC  
osteoblasts  OC-R 
 simulate  marker of bone formation 
cOC  stimulate  bone matrix mineralisation 
unOC  inhibit  energy metabolism: stimulate ß-cells, insulin, adiponectin 
Sclerostin osteocytes  LRP5/6-R  inhibit  regulate osteoblast activity and  osteocalcin secretion 
O
th
er
s 
h
o
rm
o
n
es
 
GH/IGF1 
GH pituitary gland GH-R  stimulate  
proliferation of osteoblastic cells, OPG, cOC 
regulate IGF1 secretion 
IGF1 liver, osteoblasts IGF1-R IGF1-R stimulate stimulate osteoblastic function , RANKL  
Estrogen synthase gonads, AT E2-R E2-R  inhibit  RANKL/OPG 
Insulin pancreatic β-cells Ins-R  stimulate   osteoblast differentiation and osteocalcin expression  
Ghrelin 
gastro-intestinal 
track 
GHS-R 
 stimulate  central action:  osteoblastic proliferation and differentiation 
 inhibit  peripheral action:  osteoclastogenesis (stimulate)  
Leptin adipose tissue  
ADRß2,  
OT-PTP  
inhibit  central action: osteoblast differentiation, RANKL, unOC 
Lep-R stimulate  peripheral action: FGF 23, osteocalcin, GH/IGF1, OPG/RANKL 
Adiponectin adipose tissue Adipo-R  
stimulate  central:  osteoblasts proliferation, inhibit local action (FOX01, RANKL) 
inhibit  
peripheral action: inhibit osteoblasts (FOX01), influence insulin 
sensitivity, increase RANKL 
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2.5.3. Lifestyle factors 
2.5.3.1. Physical activity 
In past decades, the effects of physical activity on bone health have been extensively studied, 
with a particular focus during childhood and adolescence. Musculoskeletal gains are foremost 
among the well-established benefits of a physical active lifestyle in the first two decades of life. 
Linked to increased BMD (Bass et al. 1998) and bone strength (Ward et al. 2005), physical 
activity during childhood and adolescence positively influences bone parameters (Tan et al. 
2014). Systematically reviewed, the mechanical component of physical activity strongly 
influences adaptations in the growing skeleton during childhood and adolescence  and may 
improve BMD later in life (Tan et al. 2014) (Specker et al. 2015).   
 
Although sexual dimorphism and maturation are associated with greater benefits during pre 
and peripubertal years (Ducher et al. 2006) (Vicente-Rodriguez et al. 2003) (Tan et al. 2014), 
the effects of physical activity are moderate by the type and intensity of exercise. From a 
musculoskeletal perspective, two major types of exercise are highlighted in the literature: 
osteogenic and non-osteogenic activities (Vico 2008). It is now well recognised that weight 
bearing physical activities; activities against gravity with a relatively high or intermittent impact 
against gravitational forces; (i.e. gymnastics, track and field) have greater osteogenic effects 
than non-weight bearing activities such as swimming or cycling (Greene et al. 2012) (Morel et 
al. 2001) (Courteix et al. 1998). Indeed, bone geometry and micro-architecture are frequently 
reported to be more positively influenced by high-impact sports (Grimston et al. 1993) (Proctor 
et al. 2002), than weight-supported sports (Courteix et al. 1998) (Duncan et al. 2002) (Ferry et 
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al. 2011). Moreover, osteogenic sports (i.e. soccer, runner, volleyball) seem to influence bone 
distribution within the cortical shell of the tibia in a different way (Specker et al. 2013). 
 
Physical fitness levels are declining among adolescents despite an increase participation in 
organised physical activities (Carter et al. 2011). Participating in sports with low levels of fitness 
could lead to acute and chronic sports-related injuries (Carter et al. 2011). There are frequent 
reports of the predominance of musculoskeletal injuries in adolescent sport participants 
(Jacobsson et al. 2012). In addition, global concerns about sedentary behaviour in adolescents 
have triggered bone density comparisons between physically active adolescents and their 
more sedentary peers.  
Although advantages in bone health parameters are frequently observed in young sporting 
populations compared with their less active peers, the cross sectional nature of research might 
be a concern. Statistical analysis is complex and involves scales that can account for the 
variability and impact of growth, so that bone changes can be reported relative to stages of 
growth and development. The benefits of exercise was confirmed in a recent systematic review 
and meta-analysis on exercise intervention trials (Specker et al. 2015). This review on 
longitudinal studies reported higher bone mineral accretion, BMC and BMD without altering 
bone size in adolescents enrolled in physical activity than their less active peers. BMC benefits 
were up to 0.8% (95% CI; 0.3-1.3) for whole body, 1.5% (95% CI; 0.5-25) for femoral neck and 
1.7% (95% CI; 0.4-3.1) greater in intervention than control groups. Greater percentage changes 
for BMD were also seen at the femoral neck 0.6% (95% CI 0.2-3.5) and at the spine 1.2% (95% 
CI; 0.6-1.8), predominantly among prepubertal adolescents. Positive bone adaptations from 
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interventions centred on physical activity appear to be greater in pre-adolescents who are not 
routinely engaged in exercise (Specker et al. 2015).  
 
However, “conflicting” views are held on the overall health of young children participating in 
prolonged and relatively high impact loading exercise.  
High impact loading exercise during puberty was once considered to have the potential to 
delay puberty and damage hormonal secretion (Theintz et al. 1994) (Courteix et al. 1998). Such 
findings were initially used to link exercise to a detrimental effect on normal growth and 
maturation (Daly et al. 2005). Effectively, regular intensive exercise is known to modify 
circulating steroid level so it was hypothesised that prolonged exposure to intensive exercise 
in children may delay the timing of the growth spurt and supress hormonal development (Jaffre 
et al. 2002).  
However, the hypothesis of delayed puberty and compromised endocrine secretion in even 
intensity training young female gymnasts was more recently dismissed on the basis of 
inadequate quality of data (Malina et al. 2013). Specifically, the authors concluded that high 
intensity training associated particularly within the high impact sport of gymnastics was not 
impairing aspects of normal growth beyond those expected in genetically shorter and later 
maturing young people; indicating full adult height was likely to be attained. However, the 
review of the impact of intensive exercise on the growth of young athletes also noted that 
endocrine data were too limited to draw conclusions about hormonal suppression relating to 
growth.  
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From a more positive perspective, it was shown that sports-related bone benefits could be 
observed several years after retirement from elite sports (Bass et al. 1998) (Warden et al. 
2005).   
 
Studies frequently postulate on the specific mechanisms by which physical activity influences 
bone mass. Assessment of bone formation and resorption markers can support observations 
of the acute effects of PA on bone remodeling (Maïmoun et al. 2011). However, in the absence 
of standardised procedures and consistently selected markers, results remain inconclusive. 
Some studies have observed higher values in bone formation markers without concomitant 
changes in resorption markers among young athletes engaged in osteogenic activities 
(Creighton et al. 2001) while others have reported higher values in both formation and 
resorption markers induced by weight bearing physical activities (Maïmoun et al. 2008) 
(Prouteau et al. 2006). Access to multiple measures of bone formation and resorption and 
inconsistencies in the protocols used for analyses have compounded the currently inconclusive 
understanding of the blood-borne, bone-related responses to exercise in young populations. 
 
A mechanistic understanding of how bone responds to exercise may also lie in the impact of 
muscle on bone strength. One recent systematic review highlighted a lack of investigations on 
bone related responses to exercise that have included assessments of the role of muscle in the 
bone strength response (Tan et al. 2014). Indeed out of the 27 studies included, 65% did not 
assess the role of muscle mass (Tan et al. 2014). However, when assessed, a specific influence 
of muscle of bone parameters has been highlighted (Tan et al. 2014). The potential of a 
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mediation role of muscles on bone during weight bearing physical activity requires further 
investigation. 
 
2.5.3.2. Nutrition 
Nutritional factors are of great importance in the development and maintenance of healthy 
growing bones (Bass et al. 2005) (Specker et al. 2007). Calcium and vitamin D are both key 
nutrients in skeletal development during growth (Schoenau et al. 2002). Furthermore, optimal 
bone development is promoted by adequate protein, total energy and nutritional intake (Alexy 
et al. 2005). 
 
Calcium  
Calcium plays a vital physiological function and comprises the structural element of bones 
(Rizzoli 2014) (Higdon 2003). Calcium facilitates optimal gains in bone mass (Specker et al. 
2007). Some questions about recommended calcium intakes to optimise peak bone mass 
remain inconclusive. On one hand, some researchers advocate for the importance of sufficient 
calcium intake during growth to maximise bone health in adulthood (Rizzoli 2014) (Huncharek 
et al. 2008). On the other hand, calcium supplementation during growth may not reduce 
fracture risk (Winzenberg et al. 2006).  
Also, international guidelines differ; with 1300 mg/day recommended dietary intake in 
Australia for males and females aged 12 to 18 years (Capra 2006), 800 mg and 1000 mg/day 
for 11 to 18 year old females and males respectively in the UK (BDA 2014) and 1200 mg/day 
for both sexes (9 to 19 years) in France (ANSES 2016). Nonetheless, to achieve optimal skeletal 
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development, adolescents must consume the recommended amounts of calcium required for 
bone mineral accrual (Sawyer et al. 2007). Indeed, coupled with physical activity, calcium 
intake is considered one of the major factors influencing bone mass. A randomized control trial 
on children aged 3 to 5 years demonstrated that bone response to physical activity was 
positively modified by children’s calcium intake (Specker et al. 2003). In adolescents males, 
calcium intake has been positively associated with BMD (Mouratidou et al. 2013). Coupled with 
physical activity and exercise, calcium supplementation among pre-pubertal children appears 
to promotes bone health in healthy children and adolescents  (Julián-Almárcegui et al. 2015) 
(Specker et al. 2015). However, results from a well-designed randomised controlled trial 
involving monozygotic twins showed the effects of calcium supplementation, at least in healthy 
pre-pubetal children may be transient (Greene et al. 2011).  
 
Vitamin D 
Vitamin D, especially in its active form (1.25(OH)) has an important role in development, 
growth and mineralisation of the skeleton (Holick 1996). Traditionally considered for its role in 
calcium homeostasis (Bouillon et al. 2008), vitamin D is important in the regulation of bone 
formation (Saggese et al. 2015) (Bikle 2016). Similarly, osteoblasts’ differentiation and the 
secretion of bone-specific alkaline phosphatase, osteocalcin, OPG, and other cytokines are 
promoted by vitamin D (Clarke 2008).  However, the precise role of vitamin D on the bone-fat 
and glucose metabolism relationship remains controversial (Giudici et al. 2017) (Reinehr et al. 
2007) (Vanlint 2013). Similarly, because of the scarcity and inconsistency of the available data, 
the role of vitamin D on bone growth remains unclear (Specker et al. 2007). A multi centred 
cross-sectional study on 100 adolescents aged 14.81 (0.99) aimed to evaluate the influence of 
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vitamin D on BMC among adolescents (Valtuena et al. 2012). The results demonstrated two 
possible interactions between vitamin D and physical activity: vitamin D might improve BMC in 
physically active adolescents or physical activity may increase BMC only in adolescents with 
sufficient vitamin D levels. 
 
2.6. Bone health assessment 
2.6.1. Bone densitometry devices 
Several different techniques exist to assess the material properties and geometric 
characteristics of bone, although a no single method can adequately assess bone health (Table 
2). Before deciding which device to use, advantages and disadvantages of each device available 
for assessing the status of overall and site specific bone should be considered. Moreover, the 
International Society for Clinical Densitometry (ISCD) has provided recommendations and a 
nomenclature in order to promote excellence in the assessment of skeletal health (Crabtree et 
al. 2014).  
Dual-energy X-ray absorptiometry (DXA) is the most common non-invasive technique for 
assessing paediatric bone health. However, other methods, such as peripheral quantitative 
computed tomography (pQCT) or quantitative ultrasonography (QUS) may provide important 
insight into bone size, geometry and quality information data (Specker et al. 2005). In addition 
to bone, these techniques have the ability to measure soft tissue such as lean and fat mass as 
well as muscle and fat cross-sectional area.  
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2.6.1.1. Dual-energy X-ray Absorptiometry 
First introduced in the late 1980’s and widely available for paediatric populations since the 
early 1990s, DXA is currently recognised as the most extensively used two-dimensional method 
for measuring BMD. The DXA machine is a high precision and low ironizing radiation device (i.e. 
less than 13 μSv for regional scans and whole body scan) with short scan times (Blake et al. 
2007). However, a major limitation associated with DXA stems from the two dimensional 
design and the inability of the device to accurately determine and adjust results for bone depth 
(Ward et al. 2007). Effectively, DXA is not capable of measuring vBMD; the bone microstructure 
elements contributing to bone strength. Without vBMD, trabecular and cortical bone cannot 
be distinguished (Nishiyama et al. 2012). Often studies reporting results from DXA derived data 
cite limitations around the quality of bone properties compared with 3D techniques and 
devices with more precise imaging capacity. 
 
Classical measures 
Despite some limitations, DXA is able to reliably identify bone mineral tissue, lean tissue, and 
adipose tissue (El Maghraoui et al. 2008). BMD obtained from DXA is known as areal BMD 
(aBMD) and is obtained by dividing the BMC (g) by the projected bone area (cm²). Areal BMD 
is reported in grams/cm². Paediatric bone density (aBMD) and BMC results are recommended 
by the International Society for Clinical Densitometry to be performed at the posterior-anterior 
spine (PA spine) and total body less head (TBLH) sites (Crabtree et al. 2014). The ISCD also 
recommended reporting adjusted data (i.e. bone mineral apparent density (BMAD), height Z 
scores) if delays in growth or short stature have been observed in children and adolescents 
(Crabtree et al. 2014). Z-scores can be defined as the standard deviation (SD) scores compiled 
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from age and sex-specific norms. To assist in the reporting of population specific data, the 
availability of normative data has also evolved. Several normative data bases are now available 
and include data for young populations of diverse backgrounds such as Non-Hispanic whites, 
non-Hispanic blacks, Mexican Americans (Kelly et al. 2009). 
 
Trabecular Bone Score  
Currently, high quality DXA scans provide access to information relative to skeletal 
microstructure. Trabecular Bone Score (TBS) is a variable derived from lumbar spine images. 
Indeed, TBS is a gravy level textural index that mathematically estimates 3D indices from 2D 
projected image (Silva et al. 2014). Access to the TBS application provides an indirect index of 
trabecular micro-architecture. However, some limitations are associated with TBS 
measurements.  These limitations include the absence of recommendations from the 
International Society for Clinical Densitometry for the use of TBS software with children and 
adolescents. Also, TBS has not been validated in obese populations. However, validation in 
populations with obesity may be challenging because TBS measures are affected by excessive 
abdominal soft tissue, that can lower TBS values. In addition, as TBS data are computed from 
DXA images, high quality image acquisition is important for reducing image noise.  Finally, in 
order to adjust the texture of DXA images, given that both bone tissue and soft tissue absorb 
X-rays, it may be necessary to adjust TBS measures for estimates of BMI (Silva et al. 2014). 
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Hip Structural Analysis  
The Hip Structural Analysis (HSA) application within DXA devices allows estimates of geometric 
indices of bone strength at the proximal femur (Beck 2002). Similarly to TBS, HSA provides 
indices related to geometrical and mechanical properties from hip DXA images.  The narrow 
neck (NN), the intertrochanteric (IT) and the femoral shaft (FS) are the three regions analysed 
for HSA (Beck 2002). Derived variables from HSA are the mineralised bone surface cross-
sectional area (CSA), the subperiosteal width (WIDTH), the cross sectional moment of inertia 
(CSMI), the endocortical diameter (ED), the profile center distance (PCD), the center of mass 
position (CMP),  the section modulus (Z), the buckling ratio (BR) and the average cortical 
thickness (ACT) (Beck 2002). Limitations of HSA are similar to TBS and include concerns about 
2D images and the quality of the DXA acquisition scan (Bonnick 2007). Also there is a lack of 
international recommendations for the use of HSA from the International Society for Clinical 
Densitometry. This leading organisation does not recommend the using DXA-derived hip 
analysis during growth due to high variability in skeletal development. However, in some 
conditions such as obesity, even in young people, the hip is a site of additional external load 
(body mass) over a prolonged period of time and may be postulated as a site of significance. 
 
2.6.1.2. Peripheral quantitative computed tomography 
A more advanced understanding of skeletal responses in adolescents is possible using 
peripheral quantitative computed tomography (pQCT), a 3D scanning device. The International 
Society for Clinical Densitometry recommends QCT as the primary research technique to 
characterise bone deficits in children and adolescents (Crabtree et al. 2014). The pQCT device 
provides a more precise image of bone than DXA and permits investigations of bone structure 
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(Rauch 2012). In essence, pQCT provides 3D rather than 2D images. As such, pQCT has the 
advantage of measuring the true vBMD of trabecular and cortical bone separately (Kontulainen 
et al. 2005) (Laskey et al. 2010). Furthermore, pQCT is a relatively portable device that can 
determine muscle cross-sectional area and enhance distinct qualitative differences in muscle 
and bone of individuals (Ashe et al. 2006).  
Peripheral QCT image acquisitions are based on multiple factors including the number of 
blocks, field of view, scan speed, and voxel size (Ashe et al. 2006). Voxel size is particularly 
important when scanning children as it may influence the partial volume effect (PVE). The 
partial volume effect occurs when more than one tissue composed of different densities is 
present in a voxel (Gonzalez Ballester et al. 2002). Multiple and differing tissues in the same 
voxel may cause inaccuracies in volumetric estimates. Because both the partial volume effects 
and potential artefacts attributed to even a small amount of movement during scanning, pQCT 
resolution is usually too low to ensure a perfect image quality (Lespessailles et al. 2006). As 
such, the trabecular BMD reported by pQCT is likely to contain trabeculae and bone marrow.  
 
2.6.1.3. Quantitative UltraSound 
First introduced in 1984, QUS was originally developed to assess calcaneus bone status in 
adults (Langton et al. 1984). Measures of QUS involves a non-ionizing radiation device. The 
velocity and attenuation of the ultrasound wave are provided by measures of the speed of 
sound (SOS) and the broadband attenuation (BUA). The SOS is defined as the ratio of the 
traversed distance to the transit time (m/s) and is dependent on bone stiffness. Bone stiffness 
is an estimate of the combined effects of the density, the micro- and macrostructure, and the 
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elastic modulus within the bone. Broadband attenuation is defined as the frequency 
dependency of the attenuation of ultrasounds signals.   
Commonly used in paediatric population, data from QUS has the potential to provide 
information about bone architecture, which may be a determinant of fracture risks. For some 
researchers, the QUS results are valid predictors of bone health (Weeks et al. 2016). 
Emphasised for its reduced costs (Fielding et al. 2003), researchers have debated its uses in 
osteoporosis diagnosis (Fricke et al. 2005). Interrogations on the validity of QUS on BMD 
assessment  were highlighted (Fricke et al. 2005). In addition, a recent systematic review 
assessing the accuracy of QUS in paediatric osteoporosis did not support its use due to 
insufficient evidence (Wang et al. 2014). A recent systematic review on diagnostic devices for 
osteoporosis in general populations highlighted a modest capacity of QUS to indicate BMD and 
predict fracture (Høiberg et al. 2016). As growth is a particular period during the lifespan, 
abilities of QUS to predict whole body and regional DXA bone mass were reviewed (Weeks et 
al. 2016). Similarly, in the previously cited systematic review, a weak to moderate relationship 
was found between QUS measures and DXA measurement of bone mass. Moreover, the review 
showed the relationships between QUS and DXA measurements of bone were strongest in the 
most physically mature children.  
A major limitation with this device relates to the indirect measure of bone mass via broadband 
attenuation and the speed of sound’s misclassification of children and adolescents into BMD 
categories based on z-scores (Williams et al. 2012). In addition, broadband attenuation and 
speed of sound appear to be influenced by bone density and microarchitecture (Binkley et al. 
2008). The influence of SOS transmission by bone density and micro-architecture may occur 
because the physical distribution of trabecular and cortical bone is not homogeneous within a 
bone’s structure. Indeed, cortical bone distribution changes significantly during growth. 
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Although, in children, particularly in groups with obesity, the speed of sound propagation can 
be reduced due to the increased thickness of the overlying fat tissue (Yao et al. 2011). The 
position of the foot during scanning may influence BUA because of trabecular orientation 
(Khan 2001), which may also be problematic for tracking bone changes during growth. Finally, 
large degree of measurement error was found for small and young children (Weeks et al. 
2016).  
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Table 2 - Comparison of bone densitometry techniques (modified from Binkley et al. 2008 (Binkley et al. 2008)). 
 
 DXA pQCT QUS 
 Classical measures  TBS  HSA     
B
o
n
e 
si
te
 Whole body, Lumbar 
Spine 
Hip 
 PA spine  Proximal femur (NN, IT, FS) 
 
 Radius, Tibia  Calcaneus 
P
ar
am
et
er
s 
Bone area 
BMC 
aBMD 
  TBS  BMD  
Bone geometry (ED, ACT, CSA) 
Bone strength (CSMI, Z, BR)  
Shaft neck angle 
 Bone geometry (periosteal 
and endosteal 
circumferences, cortical 
thickness) 
BMC (total and cortical) 
Volumetric BMD (cortical and 
trabecular) 
Estimate of bone strength 
(CSMI, SSI) 
 SOS 
BUA 
A
d
va
n
ta
ge
s Rapid scan times 
High precision 
Low cost 
Low radiation dose 
Paediatric reference data 
 Same as classical measures 
Derived from DXA images (spine or hip) 
Estimate skeletal micro-architecture 
 Measures true vBMD 
Low radiation dose 
Differentiate bone tissue  
Measure muscle and fat 
Portable scanning device 
 Low cost 
No radiation 
Portable 
scanning device 
D
is
ad
va
n
ta
ge
s No differentiation of bone 
tissue 
No bone geometry 
measure 
Bone size influence aBMD 
 Depend on the acquisition process (image noise) 
Estimation of 3D indices from 2D images  
 Underestimate cortical vBMD 
if cortical shell thickness is < 
2mm 
Only applicable to peripheral 
site 
 Bone size 
(cortical 
thickness) will 
influence SOS 
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DXA dual energy x-ray absorptiometry, pQCT peripheral quantitative tomography, QUS quantitative ultrasounds,  TBS Trabecular Bone Score score, 
HSA hip structural analysis,  PA posterior anterior, NN narrow neck, IT intertrochanteric, FS femoral shaft, BMC bone mineral content, aBMD areal 
bone mineral density, ED endocortical diameter, ACT average cortical thickness, CSA cross sectional analysis, CSMI cross sectional moment of 
inertia, z section modulus, BR buckling ration, SSI strength stress index, SOS speed of sound, BUA broadband ultrasound attenuation, vBMD 
volumetric bone mineral density
IS
C
D
 
Preferred method:  
aBMD and BMC 
Total body less head  
PA spine 
Data adjustment 
 No specific guideline in adolescents’ population 
Not validated in obese population 
Hip not preferred measurement site in growing 
children 
 No preferred method 
Primarily research technique 
to characterise bone deficits 
in children and adolescents 
 Yet to be 
published 
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2.6.2. Bone biomarkers of bone turnover 
Complementary information to BMD can be obtained via biochemical markers of bone 
remodeling. Moreover, in young populations those markers can also reflect physiological 
changes in bone growth (Vasikaran et al. 2011) (Szulc et al. 2000). Indeed, the different phases 
of osteoblasts and osteoclasts development and activities are more accurately represented by 
data that describes activity within bone turnover biomarkers (Vasikaran et al. 2011) than DXA 
when observations occur over relatively short periods of time, such as less than 6 to 8 months. 
Due to the wide number of available bone turnover markers, international standard 
recommendations have been set. In 2010, the International Federation of Clinical Chemistry 
and Laboratory Medicine (IFCC) and the International Osteoporosis Foundation (IOF) bone 
marker working group recommended procollagen type 1 N-terminal propeptide (P1NP) for 
markers of formation and C telopeptide (CTx) for resorption (Vasikaran et al. 2011). The use of 
these markers was later confirmed by the National Bone Health Alliance in 2012 (Bauer et al. 
2012). The bone marker P1NP is cleaved from collagen type I during the bone matrix formation, 
while CTx is released when the collagen within the bone is broken down.  
 
During growth, gender differences have been highlighted in previous sections within this 
review on DXA-derived variables. Increased biomarkers of bone formation and resorption have 
also been noted at the beginning of the pubertal growth spurt. In females, markers of bone 
formation were highest at Tanner Stage 3; the stage at which bone mineral accrual is the most 
important. During the bone mineral consolidation that occurs after the pubertal spurt, activity 
from both biomarkers of formation and resorption are attenuated to reach adult values (Szulc 
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et al. 2000). Similarly, in males after their growth spurt, markers of remodeling attenuated but 
remain higher than in age-matched females (Szulc et al. 2000).  
 
Caution should be used when collecting, analysing  and interpreting data from bone turnover 
markers. Indeed, controllable and uncontrollable factors may affect bone turnover markers. 
Factors include circadian rhythms, renal organs, exercise, diet, and the menstrual cycle 
(Delmas et al. 2000) (Vasikaran et al. 2011). Standardised protocols within and between studies 
appear to be important. Even with well-considered protocols, large confidence intervals are 
typically observed in reporting bone turnover markers; reflecting substantial within and 
between individual variations. Also, in younger populations, biomarkers can simultaneously 
reflect growth, remodeling and nutritional status (Mosca et al. 2016). Moreover, a recent study 
from the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the 
International Osteoporosis Foundation (IOF) working group (Morris et al. 2016) highlighted 
another limitation regarding bone markers. Indeed, standardising clinical analytic methods 
appears to be of importance and without streamlined analysis, reports using results for 
between studies comparisons can lack validity, especially for CTx markers.  
 
2.6.2.1. Analysis of bone remodeling activity 
As outlined in the section above, bone turnover can be assessed by measurements of 
biochemical markers that reflect bone remodeling activity (Eastell et al. 1993). Despite 
standardised recommendations of the most suitable markers to use (IOF-IFCC 2010), different 
markers and methods are found in the literature for describing bone remodeling activity. 
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Diversity in analyses is exemplified by estimates of balance (uncoupling index) or turnover rates 
(bone marker plot). One of the major advantages in bone markers is the insight of a possible 
response within a few months while BMD responses can take longer to occur.  The other major 
advantage lies in the capacity to understand more about the balance between bone formation 
and bone resorption markers. In addition, an association between P1NP and CTx markers and 
bone fracture prediction was shown in a meta-analysis (Johansson et al. 2014).Thus, adding 
measures of bone markers into DXA based studies deepen the richness of the data and provide 
additional options to describe bone metabolism beyond the slower modelling of bone 
properties that are detectable through scanning devices. Although there are multiple ways of 
using bone marker data, the following two approaches have been selected as relevant and 
innovative in this thesis. 
 
The Uncoupling Index 
The uncoupling index (UI) developed by Eastell (Eastell et al. 1993) provides insight into the 
relative formation and resorption balance during bone remodeling process. The UI is derived 
from individual z-scores calculations for formation and resorption markers. The index is 
calculated as the z-score formation marker minus the z-score resorption marker. A positive UI 
indicates an imbalanced of the bone remodeling activity in favour of formation, while a 
negative UI indicates a remodeling activity favouring bone resorption (Lane et al. 2000). 
Calculations of UI were developed to compare individual values with the mean value from a 
reference group (Faulkner 2005). Results of the UI are expressed in standard deviations.  The 
uncoupling index might provide complementary information helping in the understanding of 
DXA measurements. Previously used among elite adolescents practicing rhythmic gymnasts 
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the observed positive uncoupling index was associated with a greater rate of bone remodeling 
provided complementary information on the higher observed bone mass and density 
compared with control (Courteix et al. 2007).  
 
An example of a Z-scores calculation is as follows: Person A’s bone formation marker z-scores 
= (person A’s bone formation marker value - mean of the reference group bone formation 
marker) / standard deviation of the reference group bone formation marker. Person A’s bone 
resorption marker z-scores = (person A’s bone resorption marker value - mean of the reference 
group bone resorption marker) / standard deviation of the reference group bone resorption 
marker.  
 
Thus the status of bone activity is established for an individual compared with normative values 
for bone formation and resorption. 
 
The bone marker plot 
A bone marker plot was developed by Bieglmayer et al. (2009) with the purpose of innovatively 
visualising changes of in the bone resorption and formation balance as well as the bone 
turnover rate (Bieglmayer et al. 2009). Balance and rate of bone turnover are presented 
graphically with a 95% confidence ellipse which circumscribes the groups’ characteristics. As 
shown in Figure 8 dominant resorption with a high turnover (i.e. fast bone resorption) is 
represented in the upper left quadrant on the graph. The left bottom quadrant symbolises slow 
resorption. The right side of the central vertical axis represents fast bone formation (upper 
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right) and slow formation (bottom right). The left side of the central vertical axis represents 
resorption activity. Values above the central horizontal axis represent rapid bone marker 
activity and values below it denote slower responses. To prepare for graphical presentation, 
transformation of bone formation and resorption markers concentrations require three 
calculations: (1) calculation of the multiple of median (MoM), (2) calculation of the balance 
ratio between formation and resorption (MOMF/MOMR) and the turnover rate (√ 
(MoMF²+MoMR²), and (3) logarithmic transformation. 
Interpretation of the marker plot relies on the distributions of participants among the features 
of the four-quadrant graph.  For example, based on Figure 8, the distribution among 
participants was 6% in slow formation, 18% in fast resorption and 76% in fast formation.  
 
 
 
Figure 8 - Bone marker plot four-quadrant graph 
Bone marker plot cross-sectional analysis with 95% confidence ellipse from 17 females’ 
adolescent (data from the normal weight control group of the ADIBOX study) calculated from 
CTX-P1NP.  
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2.7. Summary 
Bone tissue undergoes rapid changes during growth. In childhood and adolescence bone tissue 
continuously adapts to meet functional needs of young populations through synergies 
between non-modifiable and modifiable factors. Childhood and adolescence are recognised as 
critical periods for maximising bone mass and strength.  
During growth, bone strength and muscle mass follow a linear relationship, supporting the 
theory of mechanical stressors that can strongly explain bone modelling and remodeling. 
However, traditional mechanical discussions of bone mass and strength accrual have been 
deepened by including biochemical interactions. The biomechanical communication extends 
the possible explanations of mechanisms within bone responses. Indeed, bone tissue is subject 
to multiple hormone-released products derived from bone and directly or indirectly derived 
from adipose tissue.  
This complex cross talk between bone and adipose tissue highlights bone as an active organ 
reciprocally influencing and influenced by other tissues/organs. In addition to mechanistic 
cross talk, other factors such as physical activity and nutrition influence the human body and 
bone development. Physical activity and nutrition are both important lifestyle factors to 
optimise bone mineral acquisition. Sedentary behaviour, lower physical fitness and poor 
nutrition intake (i.e. lower levels of calcium and vitamin D) constitute global health concerns 
that might decrease metabolic health through suboptimal fitness, as well as potentially 
increasing sports-related injuries and fracture risks.  
Currently, various diagnostic devices are available for the assessment of bone health. However, 
the addition of conditions such as obesity to adolescent growth can confound the reported 
accuracy of these devices. Densitometry devices weakness should be considered as none can 
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adequately assess bone health. However, coupled with bone turnover markers, 
complementary information reflecting physiological changes in bone growth can be obtained. 
Common child and adolescent conditions such as obesity can exacerbate or attenuate some 
typical hormonal functions in bone regulation. Greater focus on the impact of obesity on bone 
during adolescent growth using a combination of densitometry and innovative reporting in 
blood-borne growth and bone marker measures may strengthen the evidence to include bone 
health in future health goals for adolescents with obesity.  
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Obesity and bone tissue: specificity of adolescence 
2.8. Obesity 
According to the World Health Organisation (WHO), obesity is defined as excessive fat 
accumulation that may impair health (WHO 2000). The rising prevalence of overweight and 
obesity in paediatric populations has become a major concern (WHO 2000). Globally, the 
estimated 155 million school-aged children who are overweight or obese represent a 47% 
increase between 1980 and 2013 (Ng et al. 2014). National health promotion strategies have 
been devised to prevent health risks associated with obesity and where appropriate, to 
manage existing overweight obesity in most developed nations. These strategies include the 
“Plan National Nutrition Santé” in France or the NH&MRC’s “Clinical practice guidelines for the 
management of overweight and obesity in adults, adolescents and children in Australia” in 
Australia. However, prevalence rates of overweight or obesity in young people aged less than 
20 years in Australia are 24% in males and 23% in females while in France the prevalence rates 
are 20% for males and 16% for females (Ng et al. 2014).   
 
Obesity is an economic burden and a health care national priority in developed countries, once 
again including France and Australia. Indeed, in France, in 2006, it represented between 2€ to 
6€ /$3 to $7 billion and between 1.5 and 4.6% of the current health expenditure (Emery et al. 
2007). In Australia, the costs of obesity were estimated at $58 billion (Colagiuri et al. 2010). 
Beyond the global economic concern, is the fact that undesirable consequences of unhealthy 
lifestyles during the two first decades of life can lead to long-term serious health problems; 
which can commence even in childhood. More than just fitness, motor and psychological issues 
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(i.e. depression, body image, self-esteem) associated with obesity can lead to metabolic 
complications such as hypertension, dyslipidaemia, insulin resistance and diabetes. Also 
obesity can alter an individuals’ bone health and potentially exacerbate the onset of 
osteopenia (Daniels 2009) (Ebbeling et al. 2002). 
 
2.9. Bone mass in obese youth  
Currently, the complex relationship between fat mass and bone mass is well established 
(Shapses et al. 2012). Obesity effectively leads to hormonal alterations associated with 
increasing pro-inflammatory cytokines and oxidative stress; favouring the accumulation of fat 
mass and loss of bone mass (Shapses et al. 2012). In fact, excess body mass plays an important 
role in the mechanical response of the skeleton (Frost 2003) via dysregulation attributed to 
adipocyte production that leads to metabolic dysfunction (Karsenty 2006) (Lee et al. 2007). 
Moreover, the distribution (subcutaneous, central or visceral) of adipose tissue could be a 
relevant confounder in this complex process that links obesity to osteoporosis (Júnior et al. 
2013). A recent systematic review and meta-analysis (Van Leeuwen et al. 2017) included 27 
studies (only 1 longitudinal study) with population ranging from 2 to 18 years. Results 
highlighted greater unadjusted total body BMC and density in children who were overweight 
or obesity than their lean peers. Authors also noticed an overall trend for higher unadjusted 
bone density at specific site (i.e. spine, femoral neck) in children who were overweight or obese 
compared with their leaner peers. Due to inconsistently reported data within the 27 studies, 
analysis of adjusted data was not described. It is possible that knowledges of the impact of 
obesity on bone, in adolescents would have been more advanced if data could have been 
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reported using adjustments for key factors such as body weight, fat mass, lean mass, and/or 
bone size. 
Subsequently, contrary to adults where obesity has been extensively studied (Zibellini et al. 
2015) (Soltani et al. 2016), the obesity relationship with bone during adolescence lacks analysis. 
As shown in the recently published systematic review and meta-analysis (Van Leeuwen et al. 
2017), most of the available evidence is limited by a combination of overweight plus obesity 
rather than obesity only.  
 
This review targets only obesity (not obesity plus overweight) during adolescence. However, 
due to the paucity of available literature, the review of studies relating to obesity and bone 
within the remainder of this chapter has included children and adolescents with obesity. 
Despite ISCD recommendations, with the exception of one study (Dimitri et al. 2010), none of 
the studies reviewed for this thesis did not reported total body less head BMD. The following 
literature review first synthesises evidence from cross sectional studies (age between 10 to 17 
years) and then extends into current information about obesity and bone from interventional 
designs (age between 9 to 17 years). 
 
2.9.1. Analysis via DXA 
Whole body analysis 
Systematically reviewed, the available literature did not allow a consensus relating to bone 
mass and obesity using the whole body analysis. On the available evidence, some studies 
reported similar (El Hage et al. 2012) (Fintini et al. 2011) (Russell et al. 2010), or higher (Maggio 
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et al. 2011) (Rochefort et al. 2011) (Rocher et al. 2013) or lower (Dimitri et al. 2010) unadjusted 
BMD in children and adolescents with obesity compared with their normal weight peers. When 
BMD data were adjusted for confounders, in order to reduce the risk of measurements 
variance due to body weight and body size, all results showed lower values for WB BMD in 
adolescents with obesity (El Hage et al. 2013) (Ellis et al. 2003) (Rocher et al. 2008) (Rocher et 
al. 2013). Even if results were inconsistent in raw WB BMD findings (El Hage et al. 2013) 
(Maggio et al. 2011), all studies demonstrated higher values for whole body BMC in 
adolescents with obesity (El Hage et al. 2013) (Ellis et al. 2003) (Haroun et al. 2005) (Maggio et 
al. 2011) (Rocher et al. 2008).  
 
An estimate of volumetric whole body mineral density was assessed in two studies: 
adolescents with obesity had lower values while there was no significant difference reported 
in the WB BMD between normal weight and adolescents with obesity (El Hage et al. 2013) 
(Rocher et al. 2008).  
 
Regional analysis 
Similar inconsistency was observed in regional analysis. Indeed, at the lumbar spine higher 
unadjusted BMD or BMC values were observed in some (Fintini et al. 2011) (Hasanoǧlu et al. 
2000) (Rocher et al. 2008) (Rocher et al. 2013) but not all studies (Dimitri et al. 2010) (Fintini 
et al. 2011). When adjustment for body weight was made, significant differences were not 
maintained in some (Rocher et al. 2008) but not all studies (Fintini et al. 2011) (Rocher et al. 
2013). While, after adjustment for lean mass all agree on the absence of differences between 
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obese and controls (Rocher et al. 2008) (Rocher et al. 2013). 
For estimate volumetric data, studies showed higher LS BMAD results in population with 
obesity than their leaner peers (Dimitri et al. 2010) (Rocher et al. 2008) (Fintini et al. 2011).  
 
At the femoral neck and total hip, studies also showed higher BMD in adolescents with obesity 
(El Hage et al. 2012) (Rocher et al. 2013). To further investigate structural geometry of cross-
sections traversing the proximal femur, one study performed hip structural analysis (HSA) at 
the femoral neck and the shaft (Rocher et al. 2013).  Results highlighted a higher cross-sectional 
area (CSA) at the femoral neck only. However, no differences between adolescents with 
obesity and the control participants were found for section modulus at both sites (Rocher et 
al. 2013). After adjustment for body weight, all HSA values became significantly lower in 
adolescents with obesity. 
 
Meta-analysis of cross sectional data 
As the effect of excess body weight on bone health remains inconclusive, we aimed to 
determine by meta-analysis the effect of obesity on bone health in children and adolescents 
(Chaplais E 2017). Twelve cross-sectional studies assessing bone health by DXA were included 
in this meta-analysis. Participants had a mean age ranging between 10 to 17 years. The meta-
analysis methodology and details from included studies can be found in the appendix 
(Appendix 9). Results from the meta-analysis for unadjusted whole body BMC, unadjusted 
whole body BMD, unadjusted lumbar spine BMD and LS BMAD are reported in Table 3.  
The meta-analysis confirmed that children and adolescents with obesity had significantly 
higher raw bone content and density than their normal weight peers (Figure 9). In the present 
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analyses, data were not adjusted for confounders since most of the studies included in the 
meta-analysis present unadjusted data only. 
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Table 3 - Meta-analysis results from cross-sectional studies 
 
n Effect size     95% CI p-value Heterogeneity   
Min Max Mean Min Max 
 
I² Q df p-value 
Whole body BMC 8 0.155 1.750 1.019 0.629 1.409 <0.001 81.75 38.36 7 <0.001 
Whole body BMD 10 -0.131 1.154 0.568 0.273 0.863 <0.001 67.14 27.39 9 <0.001 
Lumbar spine BMD 13 -0.169 1.121 0.529 0.260 0.798 <0.001 72.87 44.23 12 <0.001 
Lumbar spine BMAD 5 0.000 1.100 0.653 0.292 1.013 <0.001 58.29 9.59 4 0.048 
BMC bone mineral content, BMD bone mineral density, BMAD bone mineral apparent density 
 
 
 
Figure 9 - Effect size forest plot for the effects of obesity on lumbar spine bone mineral apparent density (a) and whole body BMD (b). 
  
a b
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2.9.2. Analysis via pQCT 
There is a paucity of literature relating to three-dimensional analysis as only 2 of the 7 studies 
used pQCT on adolescents with obesity. Indeed, most of the studies included both overweight 
and obese adolescents (Laddu et al. 2013) (Farr et al. 2011) (Ehehalt et al. 2011) or late 
adolescents (Viljakainen et al. 2015) (Pollock et al. 2011).  
Bone geometry and volumetric density assessed by pQCT revealed that at the tibial site, similar 
results were observed between an obese and non-obese groups for trabecular and cortical 
volumetric density (Dimitri et al. 2015) (Leonard et al. 2015). Adolescents with obesity had a 
greater cortical section modulus, and a greater cortical periosteal circumference than non-
obese participants at the tibia (Leonard et al. 2015). Also, one study found lower trabecular 
thickness and cortical pore diameter in adolescents with obesity (Dimitri et al. 2015). Similar 
results were found for trabecular and cortical volumetric density between groups at the radius 
(Dimitri et al. 2015) (Leonard et al. 2015). Cortical periosteal circumference at the radial site 
was higher among adolescents with obesity than their normal weight peers (Leonard et al. 
2015) and cortical porosity and cortical pore diameter were lower in obese than non-obese 
groups (Dimitri et al. 2015). 
 
2.9.3. Analysis via biomarkers of bone formation and resorption 
Bone biomarkers were analysed in one cross sectional study recruiting 391 adolescents (105 
obese and 46 extremely obese) aged between 10 to 19 years (Mosca et al. 2016). When 
classified according to age group, higher levels of the bone formation marker osteocalcin (at 
the age of 14 to 15 and 16 to 19 years) and the bone resorption marker CTx (16 to 19 years) 
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were observed in females with excess weight compared with their normal weight peers. In 
males with excess weight, lower levels of both osteocalcin and CTx were observed between 
the ages of 14 and 15 years. In addition, results highlighted a correlation between fat mass and 
bone markers (osteocalcin and CTx) in females but not males. Indeed, levels of bone markers 
were lower when fat mass or fat percentage was higher.    
 
2.10. Factors influencing bone mass 
2.10.1. Puberty and gender 
Whole body analysis 
Puberty and gender effects on bone density are well established (Nagasaki et al. 2004) (Fintini 
et al. 2011). Indeed, females (Rogol et al. 2002) and adolescents with obesity (Wang 2002) 
experience an earlier maturation than males. Unlike normal weight adolescents for whom the 
gain in BMD begins to increase from about 12 years of age, children and adolescents with 
obesity display higher BMD values for bone age compared with reference values before 
puberty and lower BMD values after puberty. Males with obesity could be predicted to have 
higher (Tanner Stage 3-4) or lower (Tanner Stage 5) whole body BMD; depending on 
maturation (Fintini et al. 2011) (Nagasaki et al. 2004). Alternatively, in females with obesity, 
BMD is likely to increase with advancing puberty (Tanner Stages 3-4) (Fintini et al. 2011) 
(Nagasaki et al. 2004). Further gender differences were identified by BMD values in females 
being higher than males with similar levels of obesity (Fintini et al. 2011) (Maggio et al. 2011) 
(Nagasaki et al. 2004). 
Only one study questioned the impact of maturation status on bone over time in adolescents 
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with obesity.  Results showed similar sex-hormones status (oestradiol) among adolescents with 
obesity compared with normal-weight adolescents; however, the control group was of a 
younger chronological age (Klein et al. 1998). 
 
Regional analysis 
Similar to whole body BMD, maturation stages appear to influence lumbar spine BMD. Young 
males with obesity had higher lumbar spine BMD values at Tanner Stages 3 to 4 than Tanner 
Stage 5 (Fintini et al. 2011). While the overall results showed higher LS BMAD for females with 
obesity, when only the participants from Tanner Stages 3 to 4 were considered similar LS BMAD 
was observed between adolescents with obesity and their normal weight peers (Fintini et al. 
2011) (Russell et al. 2010). Therefore, regional analysis in adolescents with obesity may require 
strong consideration for maturational status for data interpretation. 
 
2.10.2. Fat tissue 
Despite an emerging interest in the relationship between fat mass and bone mass among 
adolescents with obesity, results remain contentious. Studies assessing total body fat mass 
suggest a negative association between the percentage of fat and bone measures (Pollock et 
al. 2007) (Rhie et al. 2010) (Ripka et al. 2016). One exception was reported with a positive 
relationship between fat mass and bone mass. However, when adjusted for height and lean 
body mass, no differences between fat mass and bone mass were evident (Shaikh et al. 2014).  
In order to better understand the role of fat mass on bone mass interactions, recent studies 
have more specifically investigated the effects of fat mass distribution on bone health. Using 
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magnetic resonance imaging (MRI), a reciprocal association was observed between 
subcutaneous adipose tissue (SAT), visceral adipose tissue (VAT) and bone density (Russell et 
al. 2010). Specifically, the investigation involved the relative proportion of VAT and SAT which 
determined concentrations of adipokines in the circulation and the subsequent effect of BMD. 
These results are confirmed by others who have reported a negative association between 
abdominal obesity (Júnior et al. 2013), VAT (Campos et al. 2012) and bone density as well as a 
positive association between SAT and bone density (Campos et al. 2012). In addition, a 
systematic review (Sioen et al. 2016) recently demonstrated that the association between fat 
mass and bone parameters was contradictory depending on participants’ age and sex. 
However, the site of fat mass may also be salient factor. 
 
2.10.3. Role of hormones? 
To better understand interrelations, it seems necessary to focus on the potential interactions 
between adipokines and the physiological factors involved in bone metabolism. Indeed, the 
skeletal system is not only stressed from mechanical loading, but also through the metabolic 
effect of some of the proteins (adipokines) secreted by the adipose tissue (Klein et al. 1998). 
Adipokines play important roles in the modulation of biological functions and could potentially 
impair skeletal acquisition in children and adolescents with obesity (Dimitri et al. 2011). 
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2.10.3.1. Leptin and adiponectin: potential contributors to BMD? 
Leptin 
More frequently described in cross sectional than longitudinal studies, higher serum leptin and 
lower adiponectin levels (Cao 2011) (Giudici et al. 2017) are associated with obesity. As stated 
previously, the actions of leptin appear to be complex depending on the activated pathway, 
with the potential for both positive (peripheral pathway) and negative effects (central 
pathway) and may depend on the mode of activation (Bonnet et al. 2005). In addition, a gender 
effect, independent of pubertal status, might be observed in relation to the influence of leptin 
on bone.  
 
Current evidence offers little consistency in discussions around leptin levels or its implication 
on bone in young populations with obesity. Some studies report no difference in leptin levels 
between children and adolescents with obesity and their normal weight peers (Russell et al. 
2010) (Klein et al. 1998). In contrast, others report higher leptin levels in children and 
adolescents with obesity (Vandewalle et al. 2013) (Rhie et al. 2010) (Dimitri et al. 2011) (Giudici 
et al. 2017). However, independent of the age, females with obesity have higher leptin levels 
than males with obesity (Klein et al. 1998) (Campos et al. 2012) (Do Prado et al. 2009). 
Differences in leptin levels might be also mediated and moderated by the maturation process. 
A pubertal stage effect can be observed on leptin levels and be explained by an acceleration of 
the maturation process in the presence of secretions of steroid hormones. Indeed through the 
action of estrogen and progesterone stimulating adipose tissue acquisition, leptin will be 
secreted in higher levels in females than males, whereas in males, testosterone will foremostly 
stimulate muscle mass. Leptin secretion is positively correlated with body fat mass and can 
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lead to leptin “resistance”. Leptin resistance corresponds to a state of hyperleptinemia, when 
elevated leptin levels fail to suppress feeding sensations (Myers et al. 2008) (Crujeiras et al. 
2015). As leptin is a major regulator of bone mass (Karsenty 2006) a leptin deficiency may alter 
BMD (Ducy et al. 2000). Leptin is also increased by emotional stress which is one of the multiple 
environmental factors potentially leading to obesity (Kohlboeck et al. 2014) (Sominsky et al. 
2014). Leptin’s action on bone metabolism remains controversial. There is some support for 
leptin as a positive predictor for BMD in both pubertal and prepubertal females with obesity 
(Russell et al. 2010) (Rhie et al. 2010). However, there is also discussion of a contrasting inverse 
association between leptin and BMD in males with obesity (Do Prado et al. 2009). Moreover, 
others find a negative correlation in females with obesity (Campos et al. 2012).  
 
Adiponectin 
There is a paucity of data on the role of adiponectin in obesity on bone parameters. Obesity 
tends to reduce adiponectin levels independent of the well-established contribution of fat 
mass, gender, ethnicity, and dietary status. 
In contrast, some studies report no relationship between adiponectin levels and weight status 
(Russell et al. 2010) (Rhie et al. 2010) (Abseyi et al. 2012). Moreover, one study reported an 
absence of adiponectin differences between genders in individuals with obesity (Campos et al. 
2012). Only two of the included bone related studies reported lower adiponectin levels in 
adolescents with obesity than their leaner peers (Dimitri et al. 2011) (Giudici et al. 2017). To 
sustain its potential action on bones, an inverse relationship has been suggested between 
adiponectin levels and bone accrual in children, with adiponectin levels that were negatively 
correlated with BMD (Russell et al. 2010) (Rhie et al. 2010). Recently, a study assessing 198 
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adolescents aged between 14 to 18 years highlighted a positive association (r²=0.035, p=0.005) 
between adiponectin and the uncarboxylated form of osteocalcin (Giudici et al. 2017). The 
positive association suggests a role of circulating adiponectin in the osteocalcin and glucose 
homeostasis relationship among adolescents with obesity (Giudici et al. 2017). Also, 
adiponectin levels were found in lower concentrations in young patients with metabolic 
syndrome (Abseyi et al. 2012). 
 
2.10.3.2. Bone hormones: potential actor on energy metabolism? 
Osteocalcin 
The level of circulating osteocalcin remains poorly documented. Some studies observed no 
differences (Rhie et al. 2010), while others reported lower levels of osteocalcin in children and 
adolescents with obesity (Abseyi et al. 2012) (Garanty-Bogacka et al. 2013) (Giudici et al. 2017). 
Independent of its expression (unOC, OC, total), pubertal status does not appear to interact 
with osteocalcin levels (Abseyi et al. 2012) (Garanty-Bogacka et al. 2013). Moreover, no 
association between osteocalcin levels and the presence of metabolic syndrome has been 
reported (Abseyi et al. 2012), which contrasts with other reports of a negative correlation with 
an insulin resistance index (r=-0.33, p<0.001) (Garanty-Bogacka et al. 2013).  A favourable 
function of circulating osteocalcin on glucose homeostasis among children and adolescents 
with obesity is then suggested (Garanty-Bogacka et al. 2013). Although this was not in 
adolescents with obesity, a potential role of ucOC was confirmed in the skeletal regulation of 
energy metabolism in non-obese postmenopausal women (Schafer et al. 2011). The increased 
unOC was associated with decreased body fat, and increased adiponectin levels. Further 
analyses are needed for adolescents with obesity to better understand the implication of 
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osteocalcin in the adipocyte/osteocyte interaction, more specifically, the uncarboxylated form 
that regulates glucose homeostasis (Yang et al. 2011). 
 
Sclerostin 
Sclerostin is yet to be investigated in adolescents with obesity even in cross sectional studies. 
However, its effects on older adults with obesity has been reported (Armamento-Villareal et 
al. 2012). In older adults, exercise prevented an increase of sclerostin, in a similar way that it 
prevents bone loss and increases bone marker turnover. Because sclerostin is released with 
mechanical unloading, sclerostin should be considered as part of the outcome variables in 
intervention involving exercise for young people with obesity.  
 
2.11. Effects of obesity intervention on bone parameters 
Strategies and guidelines to address the high prevalence of obesity have been published and 
are frequently updated. Because obesity is mainly due to an imbalance between energy intake 
and energy expenditure, obesity programs based on caloric restriction and/or physical activity 
training have been proposed.  
 
The effects of exercise training versus caloric restriction on body weight (overweight plus 
obesity) were compared in a systematic review and meta-analysis (Verheggen et al. 2016). 
Results showed that even in the absence of weight loss, exercise training was related to 
decreased-fat tissue, in particular visceral adipose tissue (Verheggen et al. 2016). Also, the 
effectiveness of lifestyle interventions on specific criteria such as weight loss, comorbidities, 
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health behaviour, side effects and quality of life was assessed in overweight children (Reinehr 
2011). Their review highlighted a lack of efficacy within lifestyle interventions. Indeed, most of 
the studies targeted weight loss only, ignoring the sustainability of weight loss and the 
possibilities of other comorbidities (Martin et al. 2014) (Oude Luttikhuis et al. 2009) (Mead et 
al. 2016). A third of the included studies were short-term interventions (from 6 to 12 weeks). 
However, it is well known that long-term interventions (6 to 12 months) rather than short-term 
interventions are more efficient to sustain weight loss (Reinehr 2011). In addition, in the 
context of bone health, short term interventional studies provide some bias as the bone 
remodeling cycle takes 4 to 6 months (Shapses et al. 2012).  
As previously stated, little is known about the effectiveness of structured intervention with a 
physical activity component on bone density in children and adolescents with obesity 
(overweight is not considered here). First, intervention programs focusing only on the physical 
activity effects on bone will be reviewed. In those programs, weight loss was not the primary 
outcome. Specifically, researchers were interested in positive associations between physical 
activity on bone health among adolescents with obesity. Second, obesity programs inducing 
weight loss on bone will be discussed.  
 
2.11.1. Effects of physical activity intervention on bone in the absence of 
reporting weight loss  
Programs only based on physical activity appear counterproductive to bone density accretion 
in adolescents with obesity. Based on the available literature, five studies described the effects 
of exercise training on bone health among adolescents with obesity. Interventions were a 
combination of supervised physical activity performed two (Rochefort et al. 2011) or three 
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times a week (El-Hage et al. 2009) (Lau et al. 2010) (McGuigan et al. 2009) (Tsang et al. 2009). 
All studies included children and adolescents with obesity who were part of single sex groups 
or combined sex groups who were exposed to a physical activity intervention.  
A large heterogeneity between studies in the age of children and adolescents can be observed. 
Indeed, age ranged from 15.8±0.8 (El-Hage et al. 2009), 13.4±2.1 (Tsang et al. 2009), 12.4±1.8 
(Lau et al. 2010), 9 to 12 years (Rochefort et al. 2011) and 7 to 12 years (McGuigan et al. 2009).  
The duration of intervention also varied from 6 weeks (Lau et al. 2010), 8 weeks (McGuigan et 
al. 2009), 12 weeks (El-Hage et al. 2009) and 26 weeks (Tsang et al. 2009) (Rochefort et al. 
2011). Details of the studies can be found in appendix (Appendices 8 & 9). 
Endurance training programs were conducted and assessed by El Hage et al. (2009) and 
Rochefort et al. (2011). One endurance based approach involved a physical activity program 
three times per week. The researchers revaluated the intensity at mid intervention. Details of 
the incremental aerobic training intervention are outlined in Table 4 (El-Hage et al. 2009). 
 
 
Table 4 - Aerobic based intervention described by El Hage et al. 2009 (El-Hage et al. 2009) 
Weeks Session 1 Session 2 Session 3 
1 to 6 
90 minutes 
 
 predominantly aerobic  
+ strength, proprioceptive 
exercise and stretching 
60 minutes 
 
aerobic 
@ 70% max aerobic speed 
90 minutes 
 
sports based 
7 to 
12 
90 minutes 
 
 individual sports 
(badminton, tennis) 
30 minutes 
 
high intensity interval 
training: 15s at ~100% max 
exercise 15s rest 
90 minutes 
 
modified sports 
(larger area or few 
players) 
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In the other endurance based study the impact of aerobic activities on skeletal changes was 
tested in three groups: obese trained, obese untrained, and for baseline only, an age matched 
non-obese group (Rochefort et al. 2011). The intervention involved 6 months of individualised 
aerobic program running for 90 minutes, twice a week (cycling, rowing, jumping, games, hip 
hop). Few details were specified within the exercise intervention. 
 
Some interventions have involved resistance training for adolescents with obesity (Lau et al. 
2010) (McGuigan et al. 2009). Specifically, a weekly load for resistance training over the 6 
weeks comprised of three sets of 5 to 8 repetitions at 75/85% 1RM. Exercises for the upper 
body included shoulder press and biceps curls and for the lower body, leg press and extensions. 
Then participants also performed 3 sets of a custom designed circuit based training. 
Adolescents were allowed 3 to 5 minutes of rests between sets (Lau et al. 2010). An alternative 
resistance training regime centred on a combination of different body weight and power 
exercises varying training loads and increasing intensity (McGuigan et al. 2009). An outline of 
this program is presented in Table 5. 
 
 
Table 5 - Aerobic based intervention described by McGuigan et al. 2009 (McGuigan et al. 2009) 
Weeks Session 1 Session 2 Session 3 
1 to 8 
 
 
3 sets - 8 to 10 
repetitions, with 90s 
rest 
 
e.g. squats, bench 
press, sit-ups 
high volume moderate 
intensity 
 
3 sets - 10 to 12 repetitions, 
with 60s rest 
 
e.g. squats, biceps curls, heel 
raises 
moderate to high 
explosive exercise 
 
3 sets - 5 to 8 repetitions, 
with 1800s rest 
 
e.g. squats jumps, rows, 
hang pulls 
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Innovatively, a sport related intervention was also conducted for adolescents with obesity by 
comparing the effects of Kung Fu participation with Tai Chi over 26 weeks (Tsang et al. 2009). 
Three 60 minute sessions comprising approximately 40 minutes of active exercise used basic 
non-contact Kung Fu technique focusing on mitts and kicking with these adolescents (Tsang et 
al. 2009). 
 
At the end of each of this exercise intervention, major finding emerged. The exact impact of 
physical activity interventions (aerobic, resistance or sports related activity) on bone health 
remains unclear. Indeed, 3 of the 5 physical activity studies recorded higher (El-Hage et al. 
2009) (Lau et al. 2010) or similar (McGuigan et al. 2009) whole body BMC following the 
intervention, however results with comparison groups were not reported. Despite some 
reports of higher values of BMD in the targeted groups after the physical activity (El-Hage et 
al. 2009) (Tsang et al. 2009) (Rochefort et al. 2011), the two studies with comparison groups 
lacked differences between their trained and untrained groups. Thus an intervention effect 
was not supported in these two studies for which the duration of the intervention exceeded 6 
months (Tsang et al. 2009) (Rochefort et al. 2011). It is possible that higher BMD values in 
young populations over prolonged period of time can be attributed to growth, independent of 
physical activity interventions. The absence of comparison groups in some studies precludes 
any strong trends for the impact of physical activity intervention on whole body bone 
parameters in adolescents with obesity.  
With equivocal results from WB BMD analysis, the site-specific nature of weight bearing 
physical activity may show greater sensitivity in regional rather than WB analysis. Similar to 
results from WB analysis significance regional changes in the exercise group failed to reach 
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significance in comparison with untrained groups (Tsang et al. 2009). The absence of 
differences in regional bone density between both obese and comparative groups may once 
again be attributed to skeletal growth.  
Finally, a dearth of literature currently describes the bone marker responses to training in 
adolescents with obesity. Only one endurance based study reported that training increased 
insulin, osteocalcin and uncarboxylated osteocalcin levels and decreased adiponectin levels 
compared with normal-weight controls and obese baseline measures (Rochefort et al. 2011). 
However, only the uncarboxylated form of osteocalcin was significantly higher in the trained 
than untrained group at program completion (Rochefort et al. 2011). The lack of significant 
difference in total osteocalcin levels between trained and untrained adolescents with obesity 
after 6 months, may be attributed to elevated uncarboxylated osteocalcin while the 
carboxylated form stored in the bone matrix decreased; unfavourably up-regulating glucose 
homeostasis. These results highlight the necessity of additional analysis to distinguish between 
carboxylated and uncarboxylated osteocalcin for outcomes relating to metabolic profiles.  
Only one study could report that leptin levels remained unchanged even when the relative 
leptin (leptin/FM) value decreased to improve leptin sensitivity following the intervention (Lau 
et al. 2010).  
 
2.11.2. Effects of intervention directly targeting the impact of weight loss on 
bone 
The positive effects of weight loss interventions combining nutrition and physical activity on 
BMI and fat mass are well established (Gajewska et al. 2013) (Campos et al. 2012) (Campos et 
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al. 2013) (Reinehr et al. 2010) (Stettler et al. 2008) (Campos et al. 2014). However, the effects 
of such interventions on the dialogue between adipokines and bone density remain uncertain.  
Beyond the primary outcome of weight loss via decreases in BMI and fat mass, secondary 
markers of overall health most frequently disregard bone.  
Protocols include combination of nutrition education and restriction, physical activity and 
psychological support (Campos et al. 2012) (Campos et al. 2013) (Reinehr et al. 2010) (Stettler 
et al. 2008); nutrition education and restriction and physical activity (Campos et al. 2014) 
(Gajewska et al. 2013); or physical activity, diet counselling and psychological support (Blüher 
et al. 2014). The duration of interventions ranged between 12 weeks (Gajewska et al. 2013), 
and 52 weeks (Campos et al. 2013) (Campos et al. 2014) (Campos et al. 2012) (Stettler et al. 
2008) (Blüher et al. 2014) (Reinehr et al. 2010). Details of the studies can be found in appendix 
(Appendices 8 & 9). 
 
Nutritional advice largely focused on recommended dietary intakes for adolescents with low 
levels of physical activity, based on age and gender. Targeted ranges for balanced macro-
nutrients described approximately 30 to 38% fat, 13 to 20% protein and the remaining intake 
in carbohydrate (Campos et al. 2012) (Campos et al. 2013) (Reinehr et al. 2010) (Stettler et al. 
2008) (Campos et al. 2014) (Gajewska et al. 2013). Often a nutrition education approach was 
adopted. Only one study offered generic diet counselling (Blüher et al. 2014).  
More diversity was seen in the prescription of physical activity. Some intervention used 
supervised aerobic and/or resistance training (Campos et al. 2012) (Campos et al. 2013) 
(Campos et al. 2014) (Reinehr et al. 2010) (Blüher et al. 2014), while others provided 
unsupervised exercise sessions (Stettler et al. 2008) (Gajewska et al. 2013) (Blüher et al. 2014).      
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Descriptions of weight loss targeted interventions using aerobic and/or resistance training are 
summarised in Table 6. More detailed exercise prescription is largely observed in the most 
recent studies compared with the first reports of exercise training for weight loss in 
adolescents with obesity. Moreover, the absence of considerations about weight bearing 
activities to facilitate bone health, prescribed intensity and progression within the duration of 
the program to assist in increasing metabolic activity may be majors limitations to the existing 
literature. 
Densitometry investigation showed higher baseline BMC in adolescents with obesity than 
normal weight controls. However, after 12 months of weight loss programs no changes were 
observed in the BMC of the intervention groups (Campos et al. 2013) (Stettler et al. 2008). 
Total bone density decreased concurrently (Campos et al. 2013) or a decrease in upper and 
lower limbs BMD was observed. Also, results included increases in whole body and lumbar 
spine bone density (Stettler et al. 2008). In contrast, increases in BMC were reported without 
changes in BMD (Campos et al. 2012). The absence of changes in BMD may be related to some 
additional investigations involving bone markers. For example, after 3 months of weight loss 
intervention, there were lower levels of bone alkaline phosphatase, which is a sensitive and 
reliable indicator of bone turnover (Gajewska et al. 2013).  
 
At the end of weight loss interventions involving exercise prescription, inconsistent results 
were observed for bone biomarkers. Indeed, some researchers reported that a substantial 
weight loss was associated with lower insulin (Campos et al. 2012), higher osteocalcin levels 
(Reinehr et al. 2010), lower leptin levels (Reinehr et al. 2010) (Gajewska et al. 2013) (Blüher et 
al. 2014) (Campos et al. 2014) and higher adiponectin levels (Reinehr et al. 2010) (Campos et 
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al. 2013). In contrasts, others report no within group changes in adiponectin (Blüher et al. 
2014) (Campos et al. 2012) and leptin levels (Campos et al. 2012) (Campos et al. 2013) 
following the intervention. Only one study has investigated the relationship between ghrelin 
and bone metabolism in response to weight loss in adolescents with obesity.  
 
Table 6 - Outlines of weight loss targeted interventions 
Authors Years 
Training descriptions 
Aerobic training Resistance training 
Campos 
et al. 
2012 
60 minutes /week combining: 
30 minutes of moderate 
intensity aerobic training  
 
e.g. treadmill and cycle 
ergometer 
 
+ 30 minutes of resistance training 
(ACSM guidelines) 
 
e.g. chess press, leg press 
 
2013 
Campos 
et al. 
2014 
1st group: 
60 minutes of moderate 
intensity aerobic training  
 
e.g. treadmill and cycle 
ergometer 
 
 
 
2nd group: 60 minutes /week combining: 
30 minutes of moderate 
intensity aerobic training  
 
+ 30 minutes of resistance training  
as described in Campos et al. 2012 and Campos et al. 2013 
 
Reinehr 
et al. 2010 
 
aerobic exercise only 
 
once weekly with sports related 
activity 
 
 
Blüher  
et al. 2014 
120 minutes /week combining: 
90 minutes 
 
supervised aerobic + resistance 
+ 60 minutes 
 
unsupervised activity 
 
Stettler 
et al. 
2008 
 
120 minutes (weekly goals 
setting) of unsupervised exercise 
 
e.g. walking or other aerobic 
activity 
 
 
Gajewska 
et al. 
2013 
No details provided 
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Although ghrelin levels remained unaltered between groups, the potential role of ghrelin was 
hypothesised to be a predictor of reduced total body BMD. However, without correlation 
analysis between these factors, this hypothesis remains untested. Also, cautious interpretation 
of results is required due to unequal baseline values between groups with the combined 
aerobic and resistance training group showing lower baseline ghrelin concentrations than the 
aerobic group (Campos et al. 2014).  
 
Conclusions on the most efficacious exercise and dietary prescriptions for promoting weight 
loss and bone health in adolescents with obesity remain elusive. Results from a systematic 
review on weight loss in young people with obesity recently highlighted the need for structured 
exercise with strategic prescription planning that centred on the intensity, exposure time and 
frequency of physical activity in combination with dietary restriction/education (Hernandez et 
al. 2015). However, increased metabolic activity required for weight loss may or may not 
simultaneously promote bone health. For example, high intensity interval training can increase 
metabolic activity and facilitate weight loss. However, the impact on bone may depend on 
whether the prescribed medium of exercise is weight bearing or weight supported (Vico 2008). 
If high intensity interval training is performed on a weight supported cycle ergometer, exercise 
may be more sustainable than weight bearing activity on a treadmill under the same prescribed 
intensity. Future challenges may lie in investigations optimising exercise prescriptions to 
increase sustainable metabolic activity that also promotes both weight loss and bone health. 
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2.11.3. Meta-analysis on the effects of structured intervention on bone 
parameters 
A meta-analysis was performed in this thesis to assess the effect of interventions that included 
physical activity on bone health in children and adolescents with obesity (Chaplais E 2017). The 
meta-analysis search strategy, method and details from included studies are located in 
appendix (Appendix 10). In the present analyses, data were not adjusted for confounders such 
as body weight, fat mass and lean mass, since most of the included studies present unadjusted 
data only. Including only bone and physical activity related studies inducing weight loss would 
have been ideal but the scarcity of studies would have limited the capacity for a meta-analysis 
and meta-regression. Therefore, the following results include some physical activity 
intervention affecting bone health without reporting weight changes. 
 
Contrary to the studies reviewed previously, the analysis was limited to studies with 
participants having a mean age between 9.7 to 17 years. This limitation related to a goal of 
describing peri and post pubertal populations. Within this thesis selected variables for the 
meta-analysis involved only whole body BMC and BMD. Table 7 summarises a number of key 
data comparisons. Figure 10 shows the effects size plot for the structured physical activity 
interventions on the whole body BMD and percentage of FM loss in adolescents with obesity.  
In addition, a meta-regression was performed (Table 8) on the influence of the length of the 
intervention on BMC and BMD, the influence of BMI variation on BMC, fat mass variation on 
BMC and BMD as well as fat free mass variation on BMC and BMD.   
 
The meta-analysis revealed that structured physical activity interventions did not influence 
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BMC and BMD among adolescents with obesity. Of interest, 4 of the 8 interventions combined 
structured physical activity and nutrition while the other 4 exclusively involved physical activity. 
The diversity of the proposed interventions may contribute to the difficulties encountered in 
understanding the real effects of physical activity. Moreover, no information regarding the 
intensity and progression of physical activity was provided, which might be of particular 
importance given that exercise performed at light to moderate intensities do not influence 
bone mineral parameters (Ivuškāns et al. 2015). The meta-regression results were non-
significant. However, it provides indicative information on interventions length on WB BMC 
outcomes, on greater loss of fat mass on WB BMC and BMD outcomes and increased muscle 
mass on variability of WB BMC and BMD. 
 
These inconclusive results can be influenced by significant weight loss being observed in only 
50% of the included studies. Yet, weight loss and its magnitude might be suggested as key 
factors to induce bone changes in response to physical activity. At the end of the structured 
weight loss interventions, three out of the four studies with significant weight loss found that 
children and adolescents with obesity increased their whole body BMC (Campos et al. 2014) 
(Campos et al. 2012) (Stettler et al. 2008), while in one study, participants lost BMD (Campos 
et al. 2013).  
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Table 7 - Meta-analysis results from longitudinal studies 
 
n             Effect size        95% CI p-value Heterogeneity 
    Min Max  Mean Min Max    I² Q df p-value 
WB BMC 8 -0.457  0.713  0.159 -0.039  0.356 0.116 6.28 7.47 7 0.38 
WB BMD 9 -1.000  0.600 -0.031 -0.319  0.258 0.834 37.67 12.84 8 0.12 
FM_g 9 -1.074 0.736 -0.369 -0.814  0.076 0.104 82.61 46.00 8 0.00 
FM_pct 8 -1.198 -0.017  0.552 -0.820 -0.284 <0.001 37.90 11.27 7 0.13 
FFM_g 8  0.014 0.477  0.236   .033  0.438 0.023 0.00 2.40 7 0.93 
BMC bone mineral content, BMD bone mineral density, FM fat mass, g grams, pct percentage, FFM fat free mass, n number of 
possible group comparison within studies  
 
 
a b
Figure 10 - Effect size forest plot for the effects of structured physical activity intervention on bone mineral density (a) and percentage of fat mass 
(b) 
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Table 8 - Meta-regression results from longitudinal studies 
 
n Coef. 95% CI   t p-value Heterogeneity 
    Mean SD Min Max      I² Q 
Intervention’s length on BMC 8  0.001 0.005 -0.012 0.014  0.27 0.79 18.35 7.35 
Interv.’s length on BMD 9 -0.015 0.018 -0.057 0.028 -0.83 0.44   0.00 6.76 
BMI on BMC 4 -0.218 0.345 -1.704 1.267 -0.63 0.59   0.00 0.01 
FM on BMC 7 -0.118 0.182 -0.585 0.349 -0.65 0.54 26.67 6.82 
FM on BMD 6 -1.543 1.245 -4.999 1.914 -1.24 0.28   0.00 3.83 
FFM on BMC 6  1.297 0.653 -0.515 3.109  1.99 0.12   0.00 3.25 
FFM on BMD 6  1.430 0.932 -1.156 4.015  1.53 0.20   0.00 3.12 
BMC bone mineral content, BMD bone mineral density, BMI body mass index, FM fat mass, FFM fat free mass 
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Limitations and gaps of the current literature 
The available literature proposes contradictory results for the effects of obesity on bone health 
in children and adolescents.  
 
First, the large heterogeneity between study designs (including gender, age, pubertal status, 
maturation stage) may explain the inability to reach a consensus on the effects of obesity on 
bone health in young populations. Diversity in populations’ gender, age, pubertal status and 
maturational stage as well as inconsistencies in methodologies best describes the 
heterogeneity in this review.  
Maturation status is of particular importance in young populations. Indeed, adolescents with 
obesity usually demonstrate an advanced biological maturation for the same chronological age 
as their normal weight peers. Also, there are complex and strong associations between 
maturation phases and bone accrual that body size and age cannot explain. Indeed, the effects 
of fat mass on peak bone mass and bone mass accrual are gender and maturation dependent 
(Shapses et al. 2012) (Wang 2002) (Dimitri et al. 2012). In addition, this relationship may be 
moderated by specific growth phases (Dimitri et al. 2012). Unfortunately, most of studies did 
not take into consideration sex-hormone status and pubertal stages which are important 
factors as adolescence is a critical period of bone development, fat distribution (VAT and SAT) 
(Karlsson et al. 2013) and hormones secretion. Study age ranges often crossed puberty, which 
may have masked growth-stimulated responses.  
 
Second, the accuracy of the techniques used to measure parameters might contribute to 
conflicting findings. Even if DXA is an acceptable standardised method to evaluate bone health, 
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limitations can apply due to an overestimation of BMD in adolescents with obesity (Crabtree 
et al. 2014).  Moreover, DXA does not provide information on bone architecture and 
subsequently has questionable validity for reflecting structural changes due to growth or 
mechanical loading (Khan 2001). Normalisation of BMD values is important especially when 
comparing growing populations of different sizes and shapes (Kröger et al. 1995) (Katzman et 
al. 1991). Also, when assessing bone strength, whole body scans should be combined with 
regional data from weight bearing sites such as the spine and hip. Both these sites have interest 
for sensitivity to bone change including indices of fracture risk.  
 
Third, to better understand structural changes in bones, blood and/or urine markers of bone 
metabolism are required. These markers include such as P1NP, CTx, OC (unOC, COC, tOC), the 
OPG/RANK/RANKL, sclerostin, vitamin D. Yet, few studies of adolescents with obesity have 
analysed such bone markers.  
 
Fourth, the accuracy of techniques known to assess body composition have to be considered. 
Currently, MRI is the most accurate technique used to differentiate VAT and SAT (Karlsson et 
al. 2013), yet, high costs and poor availability preclude frequent use. Body composition 
changes detected from DXA, ultrasound (US) and bioelectrical impedance do not provide direct 
measures of visceral adiposity despite lower cost and improved accessibility.  
 
Fifth, another limitation may lie in the number of studies that have been specifically designed 
and adequately powered to question the effect of structured lifestyle interventions on bone 
health of adolescents with obesity. Only half of the intervention studies had a control group, 
and comparison with obese population were less frequent. Also, few studies considered the 
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effect of structured physical activity programs alone on bone health as a primary outcome 
measure and fewer of these studies included reports of weight loss. Although, the central role 
of weight bearing physical activity to enhance bone parameters in children and adolescents is 
well known (Tan et al. 2014), little is known regarding bone specific responses in adolescents 
with obesity.  
 
Finally, the absence of reported compliance within the intervention studies weakened the 
rigour of the available literature. Also the consistency of reporting who delivers the 
intervention and the type of experience in this population might be useful. Understanding how 
adolescents responded to the intervention would also have improved the quality of reporting 
within these studies and helped inform future research plans/ clinical practice. 
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Research questions 
 
 
2.12.1. Do adolescents with obesity have altered bone mass compared with 
maturation-matched lean peers? 
 
Hypotheses 
i. Adolescents with obesity will display lower bone density at the whole body and specific 
weight bearing sites. 
ii. Adolescents with obesity will display altered bone geometry and strength. 
 
Aim 
To profile bone parameters among maturation-matched adolescents of various weight. 
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2.12.2. Can the negative effects of weight loss on bone health in adolescents 
with obesity be attenuated with a lifestyle intervention?  
 
Hypotheses 
i. The WL induced by physical activity and nutrition will prevent the loss of bone mass 
caused by weight loss in adolescents with obesity. 
ii. The WL induced by physical activity and nutrition can prevent estimates of fracture risk. 
 
Aim 
To investigate the impact of a multidisciplinary weight loss program combining nutrition and 
physical activity on the bone health of adolescents with obesity, including estimate of fracture 
risk 
. 
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2.12.3. Does exposure to an 8-month WL intervention involving physical 
activity and nutrition normalise bone health in adolescents with obesity? 
 
Hypotheses 
i. The WL intervention will support positive adaptations in bone parameters reaching the 
bone parameters values in normal weight adolescents. 
ii. Bone parameters at weight bearing sites will be more responsive than whole body 
measures following weight loss induced by a lifestyle intervention in adolescents with 
obesity. 
 
Aim 
To investigate the impact of body weight changes induced by a structured weight loss 
intervention on bone parameters in adolescents with obesity compared with normal weight 
maturation-matched peers. 
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2.12.4. Do weight status and weight changes influence bone markers in 
adolescents with obesity? 
 
Hypotheses 
i. Obesity in adolescents is associated with altered bone remodeling markers. 
ii. The 8-month weight loss intervention will stimulate the remodeling activity in favour 
of bone formation in adolescents with obesity. 
iii. The weight loss intervention experienced by adolescents with obesity will induce a shift 
of bone turnover towards positive bone formation compared with an obese control 
group; trending towards bone formations values similar to a lean control group.  
 
Aim 
To investigate the influence of body weight status and weight loss intervention on bone 
remodeling in adolescents with obesity and normal weight controls. 
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CHAPTER THREE  
 
 
 
 
 
 
 
Methodology 
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The review of literature (Chapter 2) supported the alternative hypothesis that limited data 
currently exist in understanding more about body composition and changes in body 
composition can alter bone in adolescents with obesity. The chapter specifically highlighted 
deficits in:  
 
i. longitudinal research;  
ii. in obese rather than obese plus overweight recruitment;  
iii. problems when maturation differed within groups in the same age;  
iv. scarcity of data on site-specific bone parameters that body weight changes could alter;  
v. the need to combine both bone parameters assessed with DXA with biomarkers of 
bone remodeling;  
vi. the need to incorporate key adipokines and bone related hormones that may or may 
not be altered in adolescents with obesity.     
 
To address these gaps, this methodology chapter begins with an outline of the intervention 
design, ethical approval and trial registration.  The next section describes participants’ 
selection, recruitment and sample size calculations. Primary and secondary outcomes 
measures are next to be detailed. Data analytical technics that may be considered as innovative 
within this thesis are defined. Then the intervention is described. The chapter ends with details 
of the statistical treatment of the data.  
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3.1. The ADIBOX study design  
The ADIBOX study was developed as a 8-month longitudinal study with repeated measures on 
three occasions (baseline, 4 months and 8 months). This protocol has been set in order to 
understand the effect of physical activity-induced weight loss on the bone adipocyte cross-talk 
in adolescents with obesity (Chaplais et al. 2016).  
 
3.2. Ethics Approval and Clinical Trial registration  
Approval was obtained from the Hospital Sud Est 1 committee (2015-33) (Appendices 3, 4, 5 & 
6). In accordance with Ethical considerations, the chief investigator is responsible of ensuring 
that participants understand potential risks and benefits of taking part in the study. Moreover, 
the chief investigator is responsible for obtaining writing consents from both the adolescents 
and their legal guardians/parents. 
The study was registered as a Clinical Trial (registration number: NCT02626273 - 
https://clinicaltrials.gov/ct2/show/NCT02626273) (Appendix 7). 
 
3.3. Participants  
A total of 65 adolescents (42 with obesity including 10 males) were enrolled in the study. 
Participants were aged between 12 to 16 years with a self-reported pubertal status equal to or 
above Tanner Stage 4. The adolescent stage of development was selected to understand more 
about maturation processes, growth changes and the possible exploratory aspects of weight 
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changes on bone parameters. Although all participants were French nationals, race and 
ethnicity of participants were mixed. Table 9 synthetised the participants recruited. 
 
This intervention primarily targeted adolescents with obesity; a population that can be 
problematic to recruit. To address this issue, recruitment was strategically aligned to a single 
centred tertiary referral clinic treating adolescents with obesity either as residential or none-
residential patients.  
For the intervention group, a paediatrician first checked the suitability of adolescents to 
complete the intervention. This process partially involved reviewing medical records for key 
information such as medical history of the family, early childhood development and the history 
of obesity.  
 
Adolescents with obesity were recruited to the obesity intervention clinic from the “Tza Nou” 
Children Obesity Center (SSR Tza Nou, UGECAM, La Bourboule, France) (n=31, 6 males, 
Intervention group) and the Local Ambulatory Nutrition-Obesity Hospital (SSR Nutrition 
Obésité UGECAM, Clermont-Ferrand, France) (n=11, 4 males, Control group with obesity). In 
addition, a normal weight control group was enrolled a related ongoing project in the 
paediatric department of the University Hospital G.Montpied (Clermont-Ferrand, France). 
 
3.4. Sample size calculation  
Sample size estimation centred on the expected variability within participants’ body fat mass 
relative to variability in a key marker of bone mass (BMD) measured at the lumbar spine. 
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Indeed, lumbar spine is a representative site of fracture risk for young population (Silva et al. 
2014). The index difference between the two most extreme groups was estimated to be 1.3 
(standard deviations) based on existing research (Campos et al. 2014). To highlight statistically 
significant differences with a statistical power of 90% and two-sided type I-error less of 5%, a 
minimum of 21 participants (without drop-out) per group were required for recruitment.  
 
3.5. Inclusion/exclusion criteria  
Inclusion criteria 
Obese participants were required to have a BMI above the 95th percentile (McCarthy et al. 
2006), while the normal weight control group had a BMI between the 5th and 85th percentiles 
(McCarthy et al. 2006). To reduce bias, participants who were invited to take part in this study 
were aged between 12 and 16 years, with a self-reported pubertal status equal to or above 
Tanner Stage 4. Females were required to have reached menarche at least one year prior to 
the study. Of note, adolescents in the intervention group had already consented to take part 
in a residential program described later in this chapter (section 3.8.). 
Participants had to be free of any recent history of hospitalisation (past two years) and without 
history of systemic illness lasting more than two weeks in the past 12 months. In addition, the 
recruited adolescents had to be free of any contraindications for physical activity or extreme 
dietary allergies.  
 
The non-inclusion criteria related to a known history of bone or muscle disease, metabolic 
diseases such as diabetes, insulin-resistance, and or, hypo- or hyper- thyroid activity. Additional  
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Table 9 - Synthesis of the recruited population 
Population 
Num-
ber  
Sexe 
ratio 
M/F 
Intervention 
Obesity 
history 
Maturation-matched criteria Criteria 
Blood 
Menarche 
age 
Tanner 
stages (TS) 
Inclusion Non-inclusion 
Obese intervention 
(from TZA NOU obesity 
center) 
31 6/25 
Structured 
weight loss 
program 
Obtained 
by the 
paedia-
trician 
when they 
enter the 
cure 
Estrogen 
Obtained by the 
paediatrician when they 
enter the cure 
- Aged 12 to 16 years 
- ≥ TS 4 
- BMI  the 95th percentile  
- No recent history of 
hospitalisation (past 2 years) 
- No history of systemic illness 
lasting more than two weeks in the 
past 12 months 
- No contraindications for physical 
activity and dietary allergies 
- History of bone or muscle disease, 
- Metabolic diseases such as 
diabetes, insulin-resistance, and or, 
hypo- or hyper- thyroid activity 
- Congenital cardiovascular disease, 
- Alcohol, smoking, and the use of 
drugs 
Obese control  
(from the SSR list of 
adolescents) 
11 4/7 None 
Not 
obtained 
Estrogen 
Obtained by the 
paediatrician during the 
first visit 
- Aged 12 to 16 years 
- ≥ TS 4 
- BMI  the 95th percentile  
- No recent history of 
hospitalisation (past 2 years) 
- No history of systemic illness 
lasting more than two weeks in the 
past 12 months 
- No contraindications for physical 
activity and dietary allergies 
- History of bone or muscle disease, 
- Metabolic diseases such as 
diabetes, insulin-resistance, and or, 
hypo- or hyper- thyroid activity 
- Congenital cardiovascular disease, 
- Alcohol, smoking, and the use of 
drugs 
Normal weight control 
(from an other ongoing 
project at the CHU of 
Clermont Ferrand)  
23 0/23 None None Estrogen 
Obtained by the 
paediatrician during the 
first visit 
- Aged 12 to 16 years 
- ≥ TS 4 
- BMI between the 5th and 85th 
percentiles 
- No recent history of 
hospitalisation (past 2 years) 
- No history of systemic illness 
lasting more than two weeks in the 
past 12 months 
- No contraindications for physical 
activity and dietary allergies 
- History of bone or muscle disease, 
- Metabolic diseases such as 
diabetes, insulin-resistance, and or, 
hypo- or hyper- thyroid activity 
- Congenital cardiovascular disease, 
- Alcohol, smoking, and the use of 
drugs 
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non-inclusion criteria were congenital cardiovascular disease, alcohol use, smoking, and the 
use of drugs known to alter bone metabolism, hormones or calcium supplements. 
 
Exclusion criteria 
Exclusion criteria applied only to participants from the interventional weight loss program. 
Adolescents were excluded if educators at the residential site of the intervention observed 
major treatment and/or protocol deviations (i.e. non-adherence to the Obesity Center rules, 
to physical activity or nutritional programs). Educators were asked to complete a “daily journal” 
reporting adolescents’ involvement (attendance and perceived compliance) during physical 
activity sessions. This journal allowed us to assess adolescents’ compliance to the physical 
activity program.  
 
3.6. Data collection Overview  
Data collection was undertaken three times between September 2015 and 2016: (1) at 
baseline; (2) four months; (3) and height months. Measures were performed at the “Tza Nou” 
Obesity Center (La Bourboule (63), France) and at the University Hospital G.Montpied 
(Clermont-Ferrand (63), France).  Figure 11 summarises the primary and secondary outcomes 
selected to meet the study aims. 
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Figure 11 - Summary of the primary and secondary outcomes measures 
 
 
3.6.1. Primary outcomes  
Bone density assessed using DXA 
BMD (g/cm2), BMC (g) and bone area (cm2) were determined using DXA device (DXA, QDR-
4500A, Hologic, Inc., Waltham, MA). In agreement with the ISCD recommendations (Crabtree 
et al. 2014) measurements were: whole body (WB), total body less head (TBLH) and lumbar 
spine (LS). Recommended bone data also included the trabecular bone score (TBS), derived 
from bone texture analysis of the spine (TBS iNsight® version 2.1). Also, due to the likely 
excessive loading on the hip of adolescents with obesity investigations included the non-
dominant hip. Specifically, hip bone density provided data on parameters at the femoral neck, 
as well as the trochanteric and intertrochanteric regions (Figure 12).  
 
DXA 
Densitometry
WB, LS
Maturation
Hip Structure 
Analysis
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The in vivo coefficients of variability of the DXA for obese individuals were 0.35 and 0.9% after 
repositioning for BMD, and 0.57 and 1.2% for BMC at the lumbar spine and total body, 
respectively. Bone mineral apparent density (BMAD, g.cm-3) was calculated using the following 
equation: WB BMAD = BMC/(WB bone area²/body height) and LS BMAD: LS BMC/LS bone 
area1.5   (Katzman et al. 1991).  
 
 
 
 
 
Quality Assurance and Radiation dosage 
All DXA scans were conducted by the same investigator and quality assurance checks were 
performed routinely. The DXA scans were analysed by the same experienced investigator using 
the APEX software (APEX version 5.5.3., Hologic, Inc., Waltham, MA). Measures of body 
composition and bone properties provided by DXA exposed participants to low level radiation: 
0.0056 mSv from DXA scans (whole body, lumbar and hip) (Damilakis et al. 2010).  Parents were 
informed about the radiation dosage involved in the research project as well as the risks 
associated with this low level of exposure (Appendix 6). 
Figure 12 - Whole body, lumbar spine and hip positioning DXA scans 
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3.6.2. Secondary outcomes 
Anthropometric characteristics 
Assessment of anthropometric measures for stature (m) and body mass (kg) occurred in 
accordance with the International Society for the Advancement of Kinanthropometry (Marfell-
Jones et al. 2012) and were conducted by a researcher accredited in anthropometry. Body 
mass was measured with participants wearing light clothing on a digital electronic scale (SECA 
813, Hamburg, Germany, ±0.1 kg) and stature on a stadiometer (Seca 240, UK, ±0.2 cm). Body 
mass index was calculated by dividing the body mass by the stature squared (Kg.m-2). We 
converted BMI into BMI z-score relative to age using the references recommended by the 
Center for Disease Control and Prevention (Ogden et al. 2002). 
 
Maturation 
Maturation was estimated using self-reported Tanner Stages (TS) at baseline. Although, self-
assessment can lack clinical precision it has some acceptance in the literature (Morris et al. 
1980) (Taylor et al. 2001). Also, the age of menarche (defined as the onset of menstruation in 
females) was self-reported for female.  
 
Body composition 
Whole body composition was measured using the same DXA device with the capacity to assess 
lean mass (LM, g), fat mass (FM, % and g), android fat mass (aFM, %), gynoïd fat mass (gFM, 
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%), as well as estimating visceral fat (VFAT %, g and cm3) (Figure 13). Visceral fat is derived by 
subtracting the subcutaneous fat from the total aFM. 
 
 
Figure 13 - Body composition analysis by Dual energy X-ray Absorptiometry (DXA) 
 
 
Hip Structure Analysis 
The DXA provided the opportunity for additional geometric and strength analyses including 
regional analysis of the narrow neck (NN), the femoral shaft (FS) and the intertrochanteric area 
(IT) (Figure 14). At each region, we analysed multiple variables: the BMD (g.cm-2), the 
endocortical diameter (ED, cm), the average cortical thickness (ACT, cm), the width (WIDTH, 
cm), the cross-sectional moment of inertia (CSMI, cm), the cross-sectional area (CSA, cm2), the 
section modulus (Z, cm3) and the Buckling ratio (BR). The intra-observer CV following 
repositioning for hip structure analysis in our laboratory was 1.35%. 
 
148 
 
 
Figure 14 - Hip Structural Analysis by Dual energy X-ray Absorptiometry (DXA) 
 
 
Endocrine markers 
Blood samples were collected by a qualified paediatric nurse after participants had fasted 
overnight. The blood was centrifuged at a rotor speed of 4000 RPM for 10 minutes and aliquots 
were frozen for subsequent analyses. The bone formation marker P1NP (Cloud-Clone Corp, 
Houston, US), the bone resorption marker CTx (Cloud-Clone Corp, Houston, US), leptin 
(BioVendor, Czech Republic) and estradiol (BioVendor, Czech Republic) were measured at the 
University Hospital’s accredited laboratory following manufacturers’ recommendations. Table 
10 shows intra, inter-assay coefficient of variation and sensitivity results for blood markers 
used in this thesis.  
 
 
Table 10 - Outline of the intra, inter-assay coefficient of variation and sensitivity results for 
blood markers 
Hormones 
Coefficient of variations 
Sensitivity 
Intra-assay  Inter-assay 
Oestradiol <10% <12% 10pg/ml 
Leptin <8% <7% 0.2 ng/ml 
P1NP <10% <12% <12.3 pg/ml 
CTx <10% <12% <44.3pg/ml 
 
Narrow neck 
Intertrochanteric 
Femoral shaft 
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3.7. Details of analysis involving key endocrine markers 
Uncoupling index 
To address the study aims it was necessary to understand more about changes in bone 
remodeling markers such as the uncoupling index. To do this a series of t-score and z-score 
calculations were used.  
Within-study reference data were compiled using baseline values from each group as 
reference data. For example, baseline data for normal weight controls could be compared with 
changes in the normal weight group (t-score) or changes in either of the groups with obesity 
(z-score). Specifically, an uncoupling index (UI) (Eastell et al. 1993) favouring formation was 
denoted by a positive value, while a negative UI suggested an imbalance in favour of resorption 
(Lane et al. 2000). 
 
Bone marker plot 
Calculations of markers concentrations were based on the work of Bieglmayer and 
collaborators (Bieglmayer et al. 2009) (Grimm et al. 2010). As described in Chapter 2, (section 
2.6.2.1), bone biomarkers can be converted to visually displayed balance vectors based on the 
following equation: Balance=MoMF/MoMR (Bieglmayer et al. 2009). A balance vector is a 
surrogate for formation and resorption forces representing the ratio between both factors. 
Then, the calculation of the rate of bone turnover follows (Turnover rate = √(MoMF²+MoMR²)) 
(Bieglmayer et al. 2009). Data from obese groups were normalised to control group(s), as well 
as their own baseline data.  
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In line with the bone marker plot recommendations, data were log transformed for graphic 
representation in order to demonstrate symmetrical distribution patterns. All calculations and 
scatter plots were derived using Microsoft Excel and XLSTATS. Scatter plots were presented 
with a 95% confidence ellipse, based on Fisher.   
 
3.8. Clinical intervention  
Adolescents from the intervention group joined the residential program provided by “Tza Nou” 
Children’s Obesity Center for the whole school year. The Obesity Center program is a French 
National initiative, combining physical activity, nutrition education and psychological support. 
 
Physical activity intervention 
Four physical activity sessions were planned and supervised per week. Two of these sessions 
comprised approximately 70 minutes of aerobic or resistance training. Aerobic training 
sessions had the following structure: 10 minutes of warm-up, 20 minutes of interval training, 
30 minutes of continuous exercise and 10 minutes for cooling-down (stretching, relaxation). 
Also, adolescents in the intervention group had swimming lessons once a week (60 min). The 
final session provided 120 to 150 minutes of various opportunities for sports and recreational 
activities such as ball and racquet sports or trekking and snowshoeing for recreation. The 
physical activity intervention focused more on physical practice than on specific osteogenic 
and metabolically challenging modalities. 
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Nutrition intervention 
The nutrition of adolescents in the obesity center conformed to a normo-caloric diet. Food and 
drink consumption was strategically planned to comply with recommended levels of dietary 
intake relative to predicted physical activity level, age and gender (Murphy et al. 2002). 
Adolescents also received fortnightly nutrition education sessions including topics such as 
weight loss, food sensation, macronutrient recommendations, home-based nutrition choices, 
nutrition choices during festivities, cooking skills and interpreting food labels. Also, 
approximately every 10 weeks adolescent’s and their family met with the clinic’s dietician.  
 
Psychological support 
Similarly, psychological support consisted of meetings with the adolescent’s and their family 
approximately every 10 weeks during the intervention. Also monthly individual meetings with 
a clinical psychologist addressed the following topics: motivation, how to prepare for holidays 
and/or going home, how to cope with emotions such as stress and anxiety and mindfulness 
around food.  
 
Participant compliance 
Participants’ daily engagement and adherence to the weight loss lifestyle intervention were 
monitored by educators working at the Obesity Center. Educators were asked to complete an 
individualised daily journal on the compliance of each participant. 
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3.9. Statistical treatment of the data  
Statistical analyses were performed using Stata software (version 13, StataCorp, College 
Station, US). The tests were two-sided with a type I error set at α = 0.05. Data were presented 
as the mean ± standard deviation or median and interquartile range, as appropriate. When 
data were adjusted for key explanatory variables, data were presented as mean and 95% 
confidence intervals. Assumption of normality was assessed using the Shapiro-Wilk test. A 
cross tabs chi-square test was performed to test the homogeneity of the sample.  
For blood markers only, at baseline comparisons involved all three groups. Therefore baseline 
comparisons used ANOVA or Kruskal-Wallis (KW) test if two key assumptions for ANOVA were 
not met. These assumptions were normality and homoscedasticity using the Bartlett test.  
To initially explore the relationships among body composition, bone and endocrine 
parameters, correlation coefficients (Pearson or Spearman, according to statistical 
distribution) were determined. Repeated correlated data (parameters measured 
longitudinally) were investigated using mixed models to take into account between and within 
participant variability (as random effect) while studying the impact of fixed effects for group, 
time point evaluations and their interactions. In multivariate analysis, these regression models 
adjusted for baseline body weight, fat mass or lean mass depending on univariate results and 
clinical relevance. Additional regression modelling included adjustment for changes in body 
weight and whole body fat mass during the intervention.
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CHAPTER FOUR 
 
 
 
 
 
 
 
Results 
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This chapter presents the results of the methods described in the previous chapter, dealing 
first with a review of aims and then results from each separate aim are described and 
summarised. Primary outcomes of bone parameters are addressed first but secondary 
outcomes are often blended into the results through adjustments using variables for key 
“explanatory” data such as body weight, fat mass and lean mass. 
 
The first 3 aims share the same population and methods. The fourth aim involved separate 
method, analysis and a slightly different comparison group. Therefore, to minimise repetition 
in the first section of this results chapter, the first 3 aims and their hypothesis are presented 
together and the fourth aim is presented separately.  
 
Also of note was the “imperfect” data collection. In addition to some incomplete numbers 
within groups, not all groups were available for all primary and secondary measures during the 
intervention period (Table 11). 
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Table 11 - Outline of the data collection for primary and secondary outcomes 
Groups
Baseline 4-month 8-month
Anthropometry, 
body 
composition,  
maturation
Densitometry 
Blood collection Anthropometry, 
body 
composition
Densitometry 
Blood 
collection
Anthropometry, 
body 
composition
Densitometry 
Blood 
collection
Other BoneDXA HSA Other Bone DXA HSA Other Bone DXA HSA
In
te
rv
en
ti
o
n
              
n = 31 (6 ♂) n=29 (4 ♂) n = 24 (3 ♂)
C
o
n
tr
o
l
            
n = 23 (♀) n = 23 (♀) n = 23 (♀)
         
n = 11 (4 ♂) n = 11 (4 ♂)
Normal weight 
adolescents
Adolescents with 
obesity
no-residential program
Adolescents with 
obesity
residential WL program 
(physical activity & 
nutrition)
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To address the hypothesis that: 
i. Adolescents with obesity will display lower bone density at the whole body and specific 
weight bearing sites. 
ii. Adolescents with obesity will display altered bone geometry and strength. 
 
iii. The weight-loss induced by physical activity and nutrition will prevent the loss of bone 
mass caused by weight loss in adolescents with obesity. 
iv. The weight-loss induced by physical activity and nutrition can prevent estimates of 
fracture risk. 
 
v. The weight loss intervention will support positive adaptations in bone parameters 
reaching the bone parameters values in normal weight adolescents. 
vi. Bone parameters at weight bearing sites will be more responsive than whole body 
measures following weight loss induced by a lifestyle intervention in adolescents with 
obesity. 
 
The following aims were addressed:  
i. To profile bone parameters among maturation-matched adolescents of various weight. 
 
ii. To investigate the impact of a multidisciplinary weight loss program combining 
nutrition and physical activity on the bone health of adolescents with obesity, including 
estimate of fracture risk 
 
iii. To investigate the impact of body weight changes induced by a structured weight loss 
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intervention on bone parameters in adolescents with obesity compared with normal 
weight maturation-matched peers. 
 
 
 
WL weight loss 
 
 
To answer the first 3 aims of this thesis, a total of 54 adolescents: 31 obese (Ob) (89% of 
female) and 23 normal-weight (NW) adolescents females were recruited. Adolescents with 
obesity were enrolled in a structured weight loss intervention that combined physical activity 
Adolescents with obesity 
enrolled in the WL intervention 
n=31 (6 ♂) 
  
Consented to blood collection 
n=23 (6 ♂) 
  
Total of participants 
n=54 
Normal weight adolescents 
n=23 
Consented to blood collection 
n=17 
Drop out from the WL intervention 
n=7 (3 ♂) 
Consented to blood collection 
n=6 (3 ♂) 
  
Completed the whole study 
n=24 (3 ♂) 
  
Blood sample at each time 
n=10  
Blood collection withdrawals 
T0 n=2 (1 ♂) 
T1 n=4 (1 ♂) 
 T2 n=1 (1 ♂) 
  
Figure 15 - Flow charts of participants of the 3 first aims of this thesis 
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and nutrition. However, the participant flow chart shows that not all participants consented to 
the blood collection at each of the three scheduled periods of data collection. Figure 15 
highlights the complexities of recruiting even from clinical populations. The low number of 
adolescents with obesity who dropped out of the intervention (n = 7) was noted and less than 
planned numbers in the blood collection periods weakened the statistical power within the 
analyses. 
 
The inclusion of males within the results of the WL weight loss intervention. 
A chi-square test was performed to demonstrate if the presence of 6 males had an influence 
on the distribution of the data in the group. Despite lower estradiol levels in males than females 
results from other variables showed no influence of the inclusion of males; with results 
showing acceptable homogenous data (p=0.08). 
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4.1. Do adolescents with obesity have altered bone mass compared with 
maturation-matched lean peers? 
 
  
Aim 
To profile bone parameters among maturation-matched adolescents of various weight. 
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Table 12 - Outline of the data collection and participants for the first aim 
 
 
Table 12 indicates that participants targeted in meeting the first aim of the research were the 
adolescents with obesity who underwent the intervention and the normal weight control 
group. The shading indicates that only baseline comparisons were analysed.    
Groups Baseline 4-month 8-month
In
te
rv
en
ti
o
n
  
n = 31 (6 ♂) n=29 (4 ♂) n = 24 (3 ♂)
C
o
n
tr
o
l
  
n = 23 (♀) n = 23 (♀) n = 23 (♀)
 
n = 11 (4 ♂) n = 11 (4 ♂)
Normal weight 
adolescents
Adolescents with 
obesity
no-residential program
Adolescents with 
obesity
residential WL program 
(physical activity & 
nutrition)
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Body composition comparison between adolescents with obesity and their leaner 
peers 
Descriptive characteristics relating to body composition are first presented. Table 13 presents 
the results from anthropometric characteristics of the obese and normal weight. Body Mass 
Index and body weight were both higher in the Ob group than their normal weight (NW) peers 
(p<0.001 for all). Similarly, estradiol levels did not differ between the two groups (median [IQR], 
Ob 56 [97]; NW 49 [46]). Height and years since menarche of the females was similar in both 
groups, despite the older chronological age of the NW group (p<0.001). Using data derived 
from DXA, at baseline, compared with the NW group, the Ob group had 19% higher lean mass, 
67% more whole body FM, 56% more android FM and 36% more gynoïd FM (p<0.001 for all). 
Measures of visceral tissue (%, g and cm3) were also higher in Ob than NW (p<0.001 for all).  
 
 
  
162 
 
Table 13 - Descriptive statistics at baseline in the Ob group and NW control group 
  Ob (n= 31)   NW (n= 23)     
  Mean SD   Mean SD   
Age (years) 13.61 1.27 * 15.90 0.43 * 
Menarche age (years) 12.50 0.76  13.21 1.31  
BMI 32.30 4.15 * 20.48 1.32 * 
zBMI 2.26 0.30 * -0.12 0.48 * 
Height (cm) 161.38 8.62   164.48 5.48   
Body weight (Kg) 86.32 15.21 * 55.91 5.90 * 
WB Lean Mass (Kg) 51.99 8.38 * 42.19 4.20 * 
WB FM (%) 39.49 3.82 * 20.33 3.82 * 
WB FM (Kg) 34.33 7.94 * 11.43 2.80 * 
Android (%) 42.31 4.56 * 18.53 4.80 * 
Gynoid (%) 41.17 3.78 * 26.19 4.15 * 
V FAT (%) 43.33 4.22 * 19.37 5.06 * 
V FAT (g) 315.71 97.67 * 128.25 54.35 * 
V FAT (cm3) 341.31 105.59 * 138.64 58.76 * 
 
* p<0.05 in comparison between Ob and NW 
Ob obese group, NW normal weight control group, SD standard deviation, BMI body mass 
index, WB LM whole body lean mass, WB FM whole body fat mass, V FAT visceral fat 
 
 
Baseline results from bone parameters between adolescents with obesity and lean 
Results from group comparisons of the primary outcomes of bone measurements expressed 
as unadjusted and adjusted values (body weight (BW) or fat mass (FM) or lean mass (LM)) are 
presented in Table 14.  
Adolescents with obesity had lower total body less head bone density (TBLH BMD) (p<0.001), 
lower hip BMD (p=0.022), lower whole body BMC (p=0.048) lower spine BMC (p<0.001) and 
lower hip BMC (p=0.008) than the NW group. In addition, Ob had a lower bone mineral 
apparent density at the whole body (p<0.001). Even when raw scores for bone parameters 
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were adjusted for body weight (BW) or fat mass (FM), or lean mass (LM) the Ob group, still 
displayed lower quantitative bone at all sites than the NW group. However, one exception to 
the trend of lower BMD values in the Ob than NW group were noted with LS BMAD (p>0.05) 
when adjusted to FM. 
 Similarly, unadjusted bone parameters from the hip structure analyses showed the Ob group 
had lower femoral shaft (FS) density (p=0.008), lower FS cortical thickness (p=0.009) and higher 
FS endocortical diameter (p=0.040) and buckling ratio (p=0.028) than NW. When adjusted for 
body weight, or fat mass, or lean mass, Ob displayed lower bone density at the 
intertrochanteric (IT) (p<0.005 adjusted BW, p=0.012 adjusted LM and p=0.038 adjusted FM) 
and femoral shaft (p=0.001 adjusted BW or LM, p=0.022 adjusted FM).  
In addition, results showed lower width at all sites (NN, IT FS) in Ob than the NW group 
(p=0.001 adjusted BW, p<0.009 adjusted FM and p<0.010 adjusted FM at NN and FS, p=0.002 
at IT). At the narrow neck, lower endocortical diameter was observed in the Ob than NW group 
after adjustment for BW (p=0.002) and FM (p=0.001). Finally, results showed lower cortical 
thickness at the intertrochanteric and the femoral shaft in Ob than NW after adjusting for body 
weight or lean mass (p<0.008 adjusted BW and p<0.005 adjusted LM).  
At baseline, Ob had a unfavourable higher raw buckling ratio at the shaft (p=0.028) than the 
NW group. Otherwise, all data were similar between both groups. Once differences in body 
weight, fat mass, or lean mass were accounted for, adolescents with obesity compared with 
NW peers, displayed lower cross sectional area, cross sectional moment of inertia and section 
modulus at all site (NN, IT, FS) (p<0.001), mainly adjusted for BW adjustment (Table 15). 
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Table 14 - Bone variables at baseline. A. Unadjusted mean.  B. Body weight adjusted.  C. Fat mass adjusted. D. Lean mass adjusted. 
A 
WB (TBLH BMD) Lumbar Spine  Hip Neck 
Ob n=31 NW n=23  Ob n=31 NW n=23  Ob n=31 NW n=23  Ob n=31 NW n=23  
mean SD mean SD  mean SD mean SD  mean SD mean SD  mean SD mean SD  
BMD (g/cm2) 0.941 0.088 1.054 0.071 * 0.964 0.150 1.030 0.107  1.021 0.137 1.102 0.100 * 0.953 0.139 1.005 0.102  
BMC (g) 2082.98 379.55 2275.94 285.84 * 49.62 11.69 63.55 10.79 * 33.42 5.83 38.00 5.41 * 4.71 0.85 5.05 0.60  
BMAD (g/cm3) 0.092 0.009 0.102 0.010 * 0.971 0.152 1.029 0.109            
 
 Narrow Neck Intertrochanteric Femoral Shaft 
 Ob n=31 NW n=23  Ob n=31 NW n=23  Ob n=31 NW n=23  
 mean SD mean SD  mean SD mean SD  mean SD mean SD  
BMD (g/cm2) 1.179 0.187 1.183 0.137  1.104 0.177 1.178 0.133  1.515 0.171 1.651 0.152 
* 
ED (cm) 2.75 0.22 2.75 0.3  4.50 0.39 4.46 0.4  1.81 0.30 1.65 0.23 
* 
ACT (cm) 0.23 0.05 0.23 0.03  0.48 0.09 0.52 0.06  0.58 0.08 0.65 0.09 
* 
WIDTH (cm) 3.20 0.25 3.21 0.27  5.45 0.39 5.51 0.38  2.99 0.25 2.91 0.2  
CSA (cm2) 3.60 0.68 3.6 0.42  5.75 1.06 6.17 0.69  4.27 0.67 4.58 0.56  
CSMI (cm4) 2.90 0.84 2.81 0.72  14.94 4.04 15.16 3.12  3.49 1.12 3.51 0.80  
Z (cm3) 1.69 0.42 1.67 0.31  4.93 1.07 4.96 0.76  2.27 0.56 2.31 0.38 
 
BR 7.70 1.56 7.41 1.4  6.48 1.22 5.87 0.81  2.70 0.51 2.36 0.39 
* 
 
B 
WB (TBLH BMD) Lumbar Spine  Hip Neck 
Ob n=31 Ob n=31 Ob n=31 Ob n=31 
 mean 95% CI  mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 0.891 (0.858 - 0.925) * 0.890 (0.834 - 0.946) * 0.966 (0.914 - 1.018) * 0.908 (0.855 - 0.960) * 
BMC (g) 1847.56 (1727.28 - 1967.83) * 44.73 (40.04 - 49.41) * 30.57 (28.33 - 32.82) * 4.32 (4.03 - 4.61) * 
BMAD (g/cm3) 0.091 (0.082 - 0.093) * 0.93 (0.860 - 0.992) *       
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 Narrow Neck Intertrochanteric Femoral Shaft 
 Ob n=31 Ob n=31 Ob n=31 
 mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 1.130 (1.056 - 1.204)  1.066 (0.995 - 1.137) * 1.467 (1.392 - 1.541) * 
ED (cm) 2.59 (2.48 - 2.70) * 4.32 (4.14 - 4.51)  1.65 (1.52 - 1.78)  
ACT (cm) 0.22 (0.21 - 0.24)  0.46 (0.42 - 0.49) * 0.57 (0.52 - 0.61) * 
WIDTH (cm) 3.02 (2.92 - 3.12) * 5.24 (5.08 - 5.40) * 2.77 (2.67 - 2.86) * 
CSA (cm2) 3.27  (3.06 - 3.50) * 5.17 (4.684 - 5.51) * 3.87 (3.62 - 4.12) * 
CSMI (cm4) 2.34 (2.07 - 2.61) * 12.50 (11.17 - 13.82)) * 2.78 (2.41 - 3.15) * 
Z (cm3) 1.47 (1.32 - 1.61) * 4.19 (3.84 - 4.52) * 1.91 (1.73 - 2.10) * 
BR 7.49 (6.77 - 8.20)  6.32 (5..78 - 6.85)  2.60 (2.38 - 2.81)  
 
C WB (TBLH BMD) Lumbar Spine  Hip Neck 
 Ob n=31 Ob n=31 Ob n=31 Ob n=31 
 mean 95% CI  mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 0.901 (0.857- 0.945) * 0.894 (0.823 - 0.964) * 0.974 (0.909 - 1.039) * 0.914 (0.849 - 0.980) * 
BMC (g) 1863.54 (1695.02 - 2032.05) * 45.59 (39.63- 51.53) * 31.25 (28.30 - 34.21) * 4.37 (3.99 - 4.75) * 
BMAD (g/cm3) 0.091 (0.091 - 0.100) * 0.949 (0.868 - 1.021)        
 
 Narrow Neck Intertrochanteric Femoral Shaft 
 Ob n=31 Ob n=31 Ob n=31 
 mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 1.144 (1.053 - 1.235)  1.070 (0.984 - 1.156) * 1.485 (1.395 - 1.576) * 
ED (cm) 2.55 (2.42 - 2.67) * 4.32 (4.10 - 4.60)  1.63 (1.48 - 1.78)  
ACT (cm) 0.23 (0.20 - 0.25)  0.47 (0.42 - 0.51)  0.58 (0.53 - 0.62)  
WIDTH (cm) 2.97 (2.85 - 3.09) * 5.24 (5.04 - 5.44) * 2.76 (2.64 - 2.88) * 
CSA (cm2) 3.28 (2.99 - 3.57) * 5.21 (4.75 - 5.66) * 3.91 (3.59 - 4.24) * 
CSMI (cm4) 2.29 (1.93 - 2.66) * 12.62 (10.82 - 14.42) * 2.80 (2.30 - 3.30) * 
Z (cm3) 1.48 (1.29 - 1.66) * 4.21 (3.73 - 4.69) * 1.93 (1.68 - 2.18) * 
BR 7.16 (6.34 - 7.98)  6.28 (5.65 - 6.91)  2.54 (2.28 - 2.80)  
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D WB (TBLH BMD) Lumbar Spine  Hip Neck 
 Ob Ob Ob Ob 
 mean 95% CI  mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 0.910 (0.8862 - 0.934) * 0.922 (0.877 - 0.967) * 0.991 (0.950 - 1.032) * 0.934 (0.893 - 0.976) * 
BMC (g) 1958.88 (1872.87 - 2044.89) * 47.20 (43.54 - 50.86) * 31.90 (30.25 - 33.56) * 4.50 (4.28 - 4.73) * 
BMAD (g/cm3) 0.092 (0.081 - 0.089) * 0.951 (0.892 - 0.990) *       
 
 Narrow Neck Intertrochanteric Femoral Shaft 
 Ob Ob Ob 
 mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 1.159 (1.099 - 1.218)  1.096 (1.038 - 1.154) * 1.490 (1.430 - 1.549) * 
ED (cm) 2.67 (2.57 - 2.76)  4.40 (4.25 - 4.55)  1.71 (1.60 - 1.82)  
ACT (cm) 0.23 (0.21 - 0.24)  0.47 (0.44 - 0.50) * 0.57 (0.53 - 0.60) * 
WIDTH (cm) 3.11 (3.02 - 3.20) * 5.33 (5.20 - 5.45) * 2.84 (2.77 - 2.92) * 
CSA (cm2) 3.44 (3.27 - 3.61) * 5.45 (5.21 - 5.70) * 4.05 (3.86 - 4.23) * 
CSMI (cm4) 2.61 (2.40 - 2.83) * 13.63 (12.66 - 14.59) * 3.09 (2.82 - 3.37) * 
Z (cm3) 1.57 (1.46 - 1.68) * 4.51 (4.27 - 4.75) * 2.07 (1.94 - 2.20 * 
BR 7.61 (7.02 - 8.20)  6.30 (5.85 - 6.75)  2.64 (2.45 - 2.82)  
 
* p<0.05 Ob different from NW. 
Ob obese intervention group, NW normal weight control group, SD standard deviation, WB whole body, TBLH total body less head, LM lean mass, 
FM fat mass, BMD bone mineral density, BMC bone mineral content, BMAD bone mineral apparent density, ED endocortical diameter, ACT average 
cortical thickness, WIDTH width, CSA cross sectional area, CSMI cross sectional moment of inertia, Z section modulus, BR buckling ratio
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To summarise, despite maturational similarities, size and indices of body composition 
differed between adolescents with obesity and normal weight controls. With the exception 
of the neck and the spine, adolescents with obesity had lower unadjusted primary outcomes 
in BMD and BMC than their leaner peers. Those differences exacerbated after adjustment 
to body weight, fat mass or lean mass. In addition, bone geometric and strength indices 
were lower in adolescents with obesity after body composition adjustments. 
  
168 
 
4.2. Does nutrition and physical activity inducing WL can reverse the negative 
effects of WL on bone health? 
 
  
Aim 
To investigate the impact of a multidisciplinary weight loss program combining nutrition 
and physical activity on the bone health of adolescents with obesity, including estimate of 
fracture risk. 
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Table 15 - Outline of the data collection and participants for the second aim 
 
 
Table 15 indicates that participants targeted in meeting the second aim of the research were 
only the adolescents with obesity who underwent the intervention. The shading indicates that 
baseline, 4-month and 8-month comparisons were analysed.  
Groups Baseline 4-month 8-month
In
te
rv
en
ti
o
n
  
n = 31 (6 ♂) n=29 (4 ♂) n = 24 (3 ♂)
C
o
n
tr
o
l
  
n = 23 (♀) n = 23 (♀) n = 23 (♀)
 
n = 11 (4 ♂) n = 11 (4 ♂)
Normal weight 
adolescents
Adolescents with 
obesity
no-residential program
Adolescents with 
obesity
residential WL program 
(physical activity & 
nutrition)
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Analysis addressing this aim involve the 24 participants that completed the 8 months 
intervention.  Seventy-seven percent of the recruited adolescents with obesity completed the 
whole study including three males (Figure 15). As explained previously, groups were 
homogenous and the presence of males did not influence the distribution of the data.   
 
Statistical comparisons performed using mixt models occurred between participants who 
remained in the study and those who dropped out. However, the low numbers of adolescents 
not completing study may require cautious interpretation of the following bivariate analyses. 
Statistical analyses of this aim included only the adolescents with obesity that completed the 
whole study (n=24). Data are presented in Table 20. 
 
Baseline descriptive characteristics (body composition) did not differ between the adolescents 
who dropped out of the weight loss intervention (n=7) and the rest of the intervention sample 
(n=24). However, significant differences were observed in bone parameters (Table 16).  
Indeed, lower TBLH BMD (p=0.005), WB BMC (p=0.006), WB BMAD (p=0.002), LS BMD 
(p=0.02), LS BMC (p=0.01), LS TBS (p=0.004), hip BMC (p=0.046), neck BMC (p=0.029) were 
observed in the adolescents with obesity who dropped out the study compared with those 
who completed it.  
Results in geometry parameters also showed lower BMD (p=0.007) and cortical thickness 
(p=0.029) at the shaft.  
In addition, strength parameters were lower for the cross section area at the IT (p=0.043) and 
FS in the adolescents with obesity who dropped out and those who did not. Results were 
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similarly lower for the cross sectional moment of inertia (p=0.018) at the shaft and for section 
modulus at the narrow neck (p=0.020), the intertrochanteric (p=0.023) and the femoral shaft 
(p=0.008) sites in the adolescents with obesity who dropped out the study than those who 
completed it. 
 
Body composition changes over the 8-month weight loss program in adolescents 
with obesity 
Longitudinal analysis revealed that adolescents with obesity reduced their body weight and fat 
mass (total (kg, %) over the time of the intervention (p<0.007).  (Figure 16). Although the data 
are not presented in this figure, similar changes were also observe for BMI, android, gynoïd 
and visceral fat (g, %, cm3) during the 8-month weight loss program. Lean mass remained 
unchanged (Figure 15). 
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Figure 16 - Body composition measurement (kg) of the obese interventional group during the 
weight loss intervention 
 
* Significant difference between T0 and T1; $ significant differences between T1 and T2;  
significant differences between T0 and T2; WB whole body  
20
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100
T0 T1 T2
Body Weight (kg) WB Fat Mass (kg) WB Lean Mass (kg)
* $  
* $  
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Table 16 - Unadjusted bone variables at baseline between the adolescents who dropped out of the weight loss intervention and the rest of the 
intervention sample 
A 
WB (TBLH BMD) Lumbar Spine  Hip Neck 
Ob n=24 Ob_out n=7  Ob n=24 Ob_out n=7  Ob n=24 Ob_out n=7  Ob n=24 Ob_out n=7  
mean SD mean SD  mean SD mean SD  mean SD mean SD  mean SD mean SD  
BMD (g/cm2) 0.943 0.087 0.854 0.588 * 0.985 0.146 0.834 0.121 * 1.038 0.141 0.937 0.069  0.978 0.145 0.889 0.081  
BMC (g) 2148.33 363.67 1734.51 264.03 * 52.25 10.87 40.16 7.35 * 34.51 5.80 29.61 3.80 * 4.88 0.82 4.11 0.60  
BMAD (g/cm3) 0.092 0.005 0.084 0.005 * 0.953 0.147 0.977 0.188            
TBS      1.306 0.109 1.15 0.79 *           
 
 Narrow Neck InterTrochanteric Femoral Shaft 
 Ob n=24 Ob_out n=7  Ob n=24 Ob_out n=7  Ob n=24 Ob_out n=7  
 mean SD mean SD  mean SD mean SD  mean SD mean SD  
BMD (g/cm2) 1.212 0.198 1.090 0.102  1.129 0.188 1.082 0.148  1.557 0.163 1.364 0.115 
* 
ED (cm) 2.75 0.19 2.72 0.34  4.56 0.39 4.32 0.38  1.81 0.29 1.72 0.43 
 
ACT (cm) 0.24 0.05 0.21 0.02  0.49 0.1 0.44 0.04  0.59 0.08 0.515 0.07 
* 
WIDTH (cm) 3.2 0.23 3.15 0.35  5.53 0.36 5.20 0.43  2.99 0.25 2.75 0.33 
* 
CSA (cm2) 3.72 0.69 3.23 0.48  5.96 1.05 5.03 0.82  4.45 0.66 3.56 0.38 
* 
CSMI (cm4) 3.04 1.16 2.40 0.76  15.81 0.72 12.35 3.77  3.72 0.21 2.55 0.73 * 
Z (cm3) 1.79 0.41 1.37 0.30  5.14 1.04 4.02 1.19  2.4 0.57 1.74 0.32 
* 
BR 7.43 1.49 8.40 1.74  6.48 1.36 5.98 1.23  2.63 0.47 2.86 0.63  
 
* p<0.05 Ob significantly different than Ob_out. 
Ob obese intervention group, Ob_out obese adolescents that dropped out the study, SD standard deviation, WB whole body, TBLH total body less 
head, LM lean mass, FM fat mass, BMD bone mineral density, BMC bone mineral content, BMAD bone mineral apparent density, NN narrow neck, 
IT intertrochanteric, FS femoral shaft, ED endocortical diameter, ACT average cortical thickness, WIDTH width, CSA cross sectional area, CSMI cross 
sectional moment of inertia, Z section modulus, BR buckling ratio 
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Bone parameters changes over the 8-month weight loss intervention in 
adolescents with obesity 
BMD increased within the first four months of the weight loss intervention (∆ mean variation 
(SD)) LS BMD ∆ 2.66 (2.94) % p<0.001) as well as at the end of the 8 months compared with 
baseline (TBLH BMD (∆ 3.22 (3.58) % p<0.001, WB BMD (∆ 3.82 (3.06) % p<0.001,LS BMD (∆ 
3.67 (4.04) % p<0.001, LS TBS (∆3.41 (4.11) % p=0.001).  
Additional analysis showed at 4 months an increase in TBLH BMC (p=0.003), WB BMC 
(p<0.001), WB BMD (p=0.027), LS BMC (p<0.001), LS BMD (p<0.001) and neck BMD (p=0.042) 
after adjusted to body weight changes and fat mass changes. Between 4 and 8 months, BMD 
continued to increase for TBLH, WB (p<0.001) and the neck (p=0.038) as well as for WB BMAD 
(p=0.028) and BMC for TBLH and WB (p<0.001).  
In conclusion, between baseline to the end of the program, adolescents with obesity 
significantly increased TBLH / WB BMC, TBLH / WB BMD (p<0.001), LS BMAD (p=0.015), LS BMC 
(p=0.003), LS BMD (p=0.014) after adjustment for body weight and fat mass changes. Results 
from data adjusted can be found in appendix (Appendices 28 & 29). 
 
At 4 months, reduced NN BMD (∆ -4.35 (6.19) % p<0.001) and NN cortical thickness (ACT) (∆ -
7.19 (8.79) % p<0.001) were observed. Also, the NN endocortical diameter (ED) (∆ 2.85(0.26) 
% p=0.009) and width (WIDTH (∆ 5.48(10.84) % p=0.016) increased. At the IT reduced BMD 
was observed (∆ -1.64 (3.24) % p=0.02) along with increased ED (∆ 4.24 (5.24) % p=0.010) and 
width (∆ 3.49 (4.40) % p=0.01). Also, the FS endocortical diameter (∆ 5.15 (8.09) % p=0.010) 
and WIDTH increased (∆ 3.14 (2.68) % p<0.001).  
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From mid-intervention to the end of the 8-month intervention, adolescents with obesity 
significantly increased cortical thickness as both the intertrochanteric and femoral shaft. 
However, compared with baseline value, at program completion adolescents with obesity 
demonstrated a reduction in NN BMD (∆ -4.74 (6.07) % p<0.001) and an increase in their 
endocortical diameter (∆ 6.20 (6.77) % p<0.001) and width (∆ 6.16 (7.69) % p<0.001) compared 
with their baseline scores. Moreover, IT BMD reduced (∆ -3.43 (4.62) % p<0.001) while 
intertrochanteric ED (∆ 4.00 (4.31) % p<0.001) and width (∆ 3.06 (2.79) % p<0.001) continued 
to increase. Finally, the FS cortical thickness (ACT) (∆ 4.49 (5.21) % p=0.002) increased (Figure 
17).  
The observed changes in unadjusted data at 4 and 8 months were confirmed after adjustment 
for each body composition changes. In addition, at the end of the weight loss program, 
increased in femoral shaft endocortical diameter and lower average cortical thickness at the 
narrow neck were observed after adjustment. 
 
At 4 months, bone strength variables showed increases in FS buckling ratio (BR) (∆ 4.95 (9.28) 
% p=0.020), IT BR (∆ 3.66 (7.09) % p=0.020) and femoral shaft cross sectional moment of inertia 
(CSMI) (∆ 3.88 (1.27) p=0.030). NN section modulus (Z) (∆ -1.70 (0.39) p=0.039) significantly 
decreased. 
No changes were observed between 4 months to 8 months. However, at the end of the 
intervention compared with baseline values, narrow neck BR (∆ 8.24 (2.00) % p=0.005), 
intertrochanteric BR (∆ 9.25 (6.43) % p<0.001), femoral shaft cross-sectional area (∆ 4.67 (5.29) 
% p<0.001) and FS cross sectional moment of inertia (CSMI) (∆ 7.09 (15.99) % p=0.030) also 
increased (Figure 18).   
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When adjusted for ∆ BW or ∆ FM similar results were observed at 4 months and 8 months. In 
addition, at 4 months, after adjustment for body weight changes, cross sectional area at the 
narrow neck significantly decreased (p=0.044). 
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* Significant difference between T0 and T1; $ significant differences between T1 and T2;  significant differences between T0 and T2 
ACT average cortical thickness, ED endocortical diameter, WIDTH width 
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Figure 17 - Unadjusted bone geometric evolution at NN, IT and FS of the obese interventional group during the weight loss program 
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Figure 18 - Unadjusted bone strength changes at NN, IT and FS of the obese interventional 
group during the weight loss program 
 
* Significant difference between T0 and T1; $ significant differences between T1 and T2;  
significant differences between T0 and T2 
CSA cross sectional area, Z section modulus, BR buckling ratio 
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Biomarkers changes over the 8-month weight loss program in adolescents with 
obesity 
Results from non-parametric analysis of leptin, estradiol and P1NP showed similar 
concentration throughout the weight loss program (Table 17). However, a lower CTx 
concentration at 4 months were observed (p=0.037), while an increase was shown at 8 months 
(p=0.013). Secretions level of CTx at 8 months was similar to baseline secretions level.   
 
The uncoupling index and z- scores were calculated from the Ob baseline data (Table 18). 
Despite an acute formation phase observed in the UI at 4 months (0.98 (2.19)) before declining 
at 8 months (0.32 (1.80)) no changes were observed over the weight loss intervention in the 
uncoupling index of bone remodeling. 
 
 
Table 17 - Biochemical characteristics of the Ob during the weight loss program 
  Ob n=10 
 T0 T1 T2 
  median IQR median IQR median IQR 
Leptin ng.ml-1  29.83 19.63 19.01 29.85 * 25.14 18.04 $ 
Estradiol pg.ml-1  56.67 97.49 80.77 104.59 * 80.08 72.47 $ 
P1NP ng.ml-1  41.30 4.09 38.55 9.46 * 41.22 7.74 $ 
CTx ng.ml-1  4.42 1.50 3.47 0.94 * 4.34 1.31 $ 
 
* Significant difference between T0 and T1; $ significant differences between T1 and T2;  
significant differences between T0 and T2 
Ob obese intervention group, IQR interquartile range, P1NP Procollagen type 1 N-terminal 
propeptide, CTx collagen type 1 cross-linked C-telopeptide. Note that non-parametric tests were 
used to compare biomarkers. 
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Table 18 - Bone remodeling scores and uncoupling index 
  Ob n=10 
 T0 T1 T2 
  mean SD mean SD mean SD 
score F 0.00 1.00 -0.03 2.05 * -0.36 1.90 * 
score R 0.00 1.00 -1.01 1.00 * 0.05 0.68 $ 
UI 0.00 1.74 0.98 2.19 * 0.32 1.80 * 
* Significant difference between T0 and T1; $ significant differences between T1 and T2;  
significant differences between T0 and T2 
Ob obese intervention group, SD standard deviation, F formation, R resorption, UI uncoupling 
index 
 
Additional exploration of bone parameters using correlations 
At the end of the intervention, changes in leptin was positively associated with changes in bone 
density (LS) (p=0.02) and cortical thickness (narrow neck, intertrochanteric, femoral shaft) 
(p=0.002, p=0.046, p=0.049 respectively).  
 
In contrast, the bone resorption marker of CTx displayed an inverse correlation with bone 
density (WB p=0.002; LS p<0.001; neck p<0.001, hip p=0.012, NN p<0.001, IT p=0.046), cortical 
thickness (NN p<0.001, IT p=0.026), cross sectional area (NN p<0.001, IT p=0.013) and section 
modulus (NN p=0.004, IT p=0.016) and was positively correlated with the buckling ratio (NN 
p=0.016) (data and coefficients are detailed in  Table 19). Correlational analysis at the 
completion of the weight loss intervention showed no association of VFAT (% or g) with bone 
parameters. However, body weight (g) and fat mass (g) were moderately correlated with all 
bone parameters, except for NN BR (BW p=0.006), while lean mass (g) was strongly associated 
with bone geometry and strength parameters (data and coefficients are detailed in Table 18). 
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Table 19 - Correlation analysis.  A. Between hormones and bone parameters. B. Between body composition parameters and bone parameters. 
A BMD CTx 
TBLH LS neck hip  
r p r p r p r p r p 
Leptin ng.ml-1   0.397 0.02     -0.419 0.02 
CTx ng.ml-1 -0.552 0.002 -0.625 <0.001 -0.565 <0.001 -0.462 0.012   
 
 
BMD Average Cortical Thickness Cross Sectional Area Section Modulus BR 
 NN IT NN IT FS NN IT NN IT NN 
 r p r p r p r p r p r p r p r p r p r p 
Leptin ng.ml-1     0.502 0.002 0.345 0.046 0.339 0.049           
CTx ng.ml-1 -0.614 <0.001 -0.374 0.046 -0.579 <0.001 -0.414 0.026   -0.594 <0.001 -0.457 0.013 -0.517 0.004 -0.443 0.016 0.443 0.016 
 
B TBLH LS  Hip Neck 
BW LM (g) BW LM (g) BW FM (g) LM (g) BW FM (g) LM (g) 
r p r p r p r p r p r p r p r p r p r p 
BMD (g/cm2) 0.511 <0.001 0.735 <0.001 0.455 0.001 0.533 <0.001 0.568 <0.001 0.334 0.025 0.695 <0.001 0.562 <0.001 0.330 0.027 0.687 <0.001 
BMAD      0.305 0.035 0.450 <0.001             
 
 Narrow Neck Intertrochanteric Femoral Shaft 
 BW FM (g) LM (g) BW FM (g) LM (g) BW FM (g) LM (g) 
 r p r p r p r p r p r p r p r p r p 
BMD (g/cm2) 0.553 <0.001 0.349 0.017 0.648 <0.001 0.505 <0.001   0.625 <0.001 0.562 <0.001 0.319 0.033 0.705 <0.001 
ACT (cm) 0.341 0.021   0.324 0.028           0.316 0.033 
WIDTH (cm)     0.349 0.017 0.342 0.020   0.498 <0.001 0.389 0.008   0.503 <0.001 
CSA (cm2) 0.635 <0.001 0.401 0.006 0.743 <0.001 0.587 <0.001 0.314 0.034 0.754 <0.001 0.623 <0.001 0.347 0.019 0.791 <0.001 
Z (cm3) 0.678 <0.001 0.462 <0.001 0.753 <0.001 0.606 <0.001 0.325 0.027 0.778 <0.001 0.585 <0.001 0.355 0.015 0.702 <0.001 
BR -0.398 0.006   -0.480 <0.001             
 
BW body weight, FM fat mass, LM lean mass, BMD bone mineral density, BMAD bone mineral apparent density, TBLH total body less head, LS lumbar spine, 
CTx collagen type 1 cross-linked C-telopeptide, NN narrow neck, IT intertrochanteric, FS femoral shaft, CSA cross sectional area, ACT average cortical 
thickness,  WIDTH width, Z section modulus, BR buckling ratio 
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Table 20 - Body composition parameters (A) and bone variables (B) of the 24 adolescents with obesity at baseline, 4 and 8 months.  
A 
Ob n=24 
T0  T1  T2  
mean SD mean SD mean SD 
Age (years) 14.05 1.08 14.39 1.09 14.74 1.09 
BMI 33.02 4.02 29.89 2.38 28.19 2.89 
Height (cm) 163.83 7.11 164.49 6.57 165.41 6.42 
Body weight (kg) 90.37 13.93 82.80 12.09 79.86 11.06 
Fat mass (g) 35813.94 7695.14 29204.10 6247.12 26666.43 6274.81 
FM (%) 39.35 3.85 35.03 4.07 33.07 5.01 
Lean mass (g) 54559.85 7451.10 53597.40 7285.22 53198.28 6722.13 
a FM (%) 42.50 4.81 37.72 4.39 35.30 5.53 
g FM (%) 41.25 3.83 36.94 4.24 35.47 5.14 
VFAT (g) 310.63 102.46 233.14 63.72 197.02 61.51 
VFAT (%) 43.40 4.39 38.52 4.69 36.70 5.78 
VFAT (cm3) 335.81 110.77 252.05 68.89 213.00 66.49 
 
B 
WB TBLH LS 
T0 T1 T2 T0 T1 T2 T0 T1 T2 
mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD 
BMD (g/cm2) 1.102 0.091 1.111 0.091 1.143 0.085 0.943 0.087 0.969 0.084 0.988 0.078 0.985 0.146 1.011 0.133 1.037 0.128 
BMC (g) 2148.33 363.67 2228.51 365.18 2305.14 362.92 1667.65 283.80 1712.30 287.78 1788.79 285.26 52.25 10.87 55.89 10.79 58.56 10.43 
BMAD (g/cm3) 0.092 0.01 0.092 0.005 0.093 0.005 0.092 0.005 0.091 0.005 0.091 0.005 0.953 0.147 0.992 0.138 1.037 0.128 
TBS             1.306 0.109 1.324 0.111 1.345 0.113 
 
 Hip  Neck 
 T0 T1 T2 T0 T1 T2 
 mean SD mean SD mean SD mean SD mean SD mean SD 
BMD (g/cm2) 1.038 0.141 1.035 0.135 1.039 0.140 0.978 0.145 0.962 0.131 0.969 0.132 
BMC (g) 34.51 5.80 34.61 4.85 35.10 5.88 4.88 0.82 4.82 0.84 4.92 0.79 
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 NN IT FS 
 T0 T1 T2 T0  T1 T2 T0 T1 T2 
 mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD mean SD 
BMD (g/cm2) 1.212 0.198 1.158 0.197 1.152 0.189 1.129 0.188 1.107 0.168 1.091 0.174 1.557 0.163 1.532 0.168 1.572 0.162 
ED (cm) 2.75 0.19 2.85 0.26 2.92 0.31 4.56 0.39 4.75 0.42 4.74 0.44 1.81 0.29 1.90 0.34 1.89 0.34 
ACT (cm) 0.24 0.01 0.22 0.01 0.23 0.01 0.49 0.02 0.48 0.02 0.52 0.01 0.59 0.02 0.58 0.01 0.65 0.02 
WIDTH (cm) 3.2 0.23 3.37 0.30 3.40 0.28 5.53 0.36 5.72 0.38 5.70 0.35 2.99 0.25 3.08 0.27 3.04 0.37 
CSA (cm2) 3.72 0.69 3.64 0.67 3.69 0.63 5.96 1.05 6.03 1.00 5.92 0.97 4.45 0.66 4.50 0.67 4.65 0.58 
CSMI (cm4) 3.04 1.16 2.95 0.88 3.10 0.80 15.81 0.72 16.50 4.06 16.10 3.77 3.72 0.21 3.89 1.27 3.94 1.16 
Z (cm3) 1.79 0.41 1.70 0.39 1.73 0.38 5.14 1.04 5.21 1.05 5.07 1.00 2.40 0.57 2.41 0.59 2.45 0.57 
BR 7.43 1.49 7.89 1.64 8.25 2.00 6.48 1.36 6.70 1.43 6.85 1.56 2.63 0.47 2.76 0.56 2.73 0.54 
 
Ob adolescents with obesity, SD standard deviation, BMI body mass index, FM fat mass, a FM android fat mass, g FM gynoïd fat mass, VFAT visceral fat, WB 
whole body, TBLH total body less head, BMD bone mineral density, BMC bone mineral content, BMAD bone mineral apparent density, TBS Trabecular Bone 
Score, NN narrow neck, IT intertrochanteric, FS femoral shaft, ED endocortical diameter, WIDTH width, CSA cross sectional area, ACT average cortical 
thickness, Z section modulus, BR buckling ratio 
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To summarise, an overall increase in BMD was observed at whole body and site-specific 
lumbar spine in adolescents with obesity over the weight loss intervention. However, bone 
geometry and strength appeared to be weakened during the weight loss program, 
particularly at the narrow neck with a score moving closer to the fracture prediction 
threshold. Furthermore, uncoupling index observations suggested bone remodeling activity 
in favour of formation only during the first 4 months of the intervention, but without 
reaching significance and returning to baseline at 8 months.   
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4.3. Does 8 months WL induced by physical activity and nutrition result in normal 
bone health? 
 
  
Aim 
To investigate the impact of body weight changes induced by a structured weight loss 
intervention on bone parameters in adolescents with obesity compared with normal 
weight maturation-matched peers. 
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Table 21 - Outline of the data collection and participants for the third aim 
 
 
 
Table 21 indicates that participants targeted in meeting the third aim of the research were the 
adolescents with obesity who underwent the intervention and the normal weight control 
group. The shading indicates that only baseline and 8-month comparisons were analysed.    
Although the influence of lean mass (g) on bone is well demonstrated (Courteix et al. 1998), 
lean mass did not change through the weight loss program; justifying only adjusting for lean 
mass at baseline. 
Groups Baseline 4-month 8-month
In
te
rv
en
ti
o
n
  
n = 31 (6 ♂) n=29 (4 ♂) n = 24 (3 ♂)
C
o
n
tr
o
l
  
n = 23 (♀) n = 23 (♀) n = 23 (♀)
 
n = 11 (4 ♂) n = 11 (4 ♂)
Normal weight 
adolescents
Adolescents with 
obesity
no-residential program
Adolescents with 
obesity
residential WL program 
(physical activity & 
nutrition)
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Out of the 54 participants, 47 (87%) of them completed the whole study including three males 
(Figure 15). As explained previously, baseline body composition descriptive characteristics 
were similar but bone variables differ between the adolescents who dropped out and the 
other. Only the adolescents with obesity that completed the whole study (n=24) were 
considered for statistical analysis using mixt-model analysis and multivariate analysis. In 
addition, groups are homogenous and the presence of males do not influence the distribution 
of the data. 
 
Bone parameters time-related differences 
Bone measurements expressed as unadjusted and adjusted values are presented Table 23. 
Differences in lower bone density unadjusted values were observed for TBLH BMD, BMAD 
(p<0.001) and hip BMD (p=0.017) between Ob and NW. However, once the longitudinal 
changes in body weight (BW), or fat mass (FM) were accounted for results changed. Compared 
with their NW peers, adjusted data from adolescents with obesity showed lower density at 
TBLH (p<0.008 for all adjustment), neck (p<0.001 adjusted BW, p=0.031 adjusted FM), hip 
(p<0.008 for all) and lower bone mineral apparent density (p<0.008 for BW and FM) at the 
whole body. Differences in the changes of bone parameters (∆ LS BMAD (p=0.02), ∆ neck BMD 
(p=0.03), ∆ hip BMD (p<0.001)) between both groups were explained by variations in BW and 
∆ FM. Only ∆ hip BMD remained significantly different after adjustment ∆BW.  
 
Compared with changes over time in NW, at the end of the weight loss intervention Ob showed 
greater values in narrow neck endocortical diameter (ED) (p=0.005), NN width (p=0.003), 
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intertrochanteric endocortical diameter (p=0.005), IT width (p=0.017) and femoral shaft ED 
(p=0.006). In contrast, lower values were observed in adolescents with obesity than their NW 
peers for IT BMD (p=0.009), IT cortical thickness (ACT) (p=0.031), FS BMD (p=0.004) and FS ACT 
(p=0.001) (Figure 19). When data were corrected for longitudinal changes in body weight (BW), 
or fat mass (FM) adolescents with obesity had continued to show lower bone density and 
cortical thickness at IT (p<0.010) and FS (p<0.010). Lower cortical thickness remained at NN 
(p=0.05) in the Ob than NW groups after adjustment for body weight changes. In addition, 
higher endocortical diameter after adjustments for BW (FS p=0.014) and FM (IT p<0.05, FS 
p=0.018) changes were seen in adolescents with obesity than their NW peers. Time-related 
changes in bone parameters between adolescents with obesity and NW were at least partially 
explained by changes in body weight or ∆ fat mass. Only the ∆IT BMD maintained significance 
when adjusted for ∆BW.  
 
Differences in raw strength indices were observed for NN buckling ratio (BR) (p=0.008), IT BR 
(p=0.004) and FS BR (p=0.004). When adjusted for ∆BW, cross-sectional area (IT and FS) was 
higher than NW (p<0.003 for all). Cross-sectional area at IT (p=0.020) was also higher when 
corrected for ∆FM. Higher buckling ratio at IT and FS for adolescents with obesity than NW 
were observed once the adjusted for changes in BW or FM (p<0.004). Time-related changes of 
bone parameters (time-by-group interactions) between groups for ∆IT BR (p< 0.001), ∆FS BR 
(p= 0.022), were explained by variations in BW or ∆ FM.  
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 p<0.05 between baseline and 8 months; * p<0.05 at 8-months between Ob and NW when adjusted to fat mass changes 
NW normal weight control group, Ob obese group, ED endocortical diameter, CSA cross-sectional area, ACT average cortical thickness, WIDTH 
subperiosteal width, BMD bone mineral density
WIDTH baseline                    WIDTH 8-months                    ED baseline                   ED 8-months  
WIDTH +1.67% 
ED +4.42%*  
CSA +4.49%  
ACT -1.70% * 
BMD +1.29% * 
NW 
Unchanged weight Reduced weight 
WIDTH +1.35% 
ED +4.15%*  
CSA +3.34%  
ACT -3.47%*  
BMD +0.17%* 
OBESE 
All adolescents Adolescents’ girl only 
WIDTH +0.69% 
ED -2.11% 
CSA +4.30%   
ACT +6.13%  
BMD +3.77%  
Figure 19 - Schematic representation of unadjusted geometric changes at the femoral shaft at 8-months. Over the 8 months, CSA significantly 
increased with a similar magnitude in both group.  ACT and BMD significantly increased only for the NW group. 
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Biomarkers time-related differences 
At the end of the weight loss intervention, no difference was observed in estradiol levels 
between groups. (Table 13).  
 
 
Table 22 - Biochemical characteristics of the groups at baseline (T0) and 8 months (T2) 
  Ob    NW   
  median IQR   median IQR 
Leptin ng.ml-1 T0 29.83 19.63    
Leptin ng.ml-1 T2 25.14 18.04    
Estradiol pg.ml-1 T0 56 97  49 46 
Estradiol pg.ml-1 T2 80 72.47  42 30 
 
* p<0.05 in comparison between OB and NW 
OB obese intervention group, NW normal weight control group, SD standard deviation. Note 
that non-parametric tests were used to compare biomarkers. 
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Table 23 - Bone variables at 8 months. A. Unadjusted mean.  B. Body weight adjusted.  C. Fat mass adjusted. 
A 
WB (TBLH BMD) Lumbar Spine  Hip Neck 
Ob NW   Ob NW   Ob NW   Ob NW   
mean SD mean SD  mean SD mean SD  mean SD mean SD  mean SD mean SD  
BMD (g/cm2) 0.988 0.078 1.092 0.065 * 1.037 0.128 1.048 0.099  1.039 0.140 1.130 0.101 * 0.969 0.132 1.021 0.093  
BMC (g) 2305.14 362.92 2363.88 276.79  58.56 10.43 64.95 10.72 * 35.10 5.88 38.10 5.21  4.92 0.79 5.09 0.49  
BMAD 
(g/cm3) 
0.093 0.005 0.102 0.005 * 1.037 0.128 1.037 0.086  
 
        
 
 
 Narrow Neck Intertrochanteric Femoral Shaft 
 Ob NW   Ob NW   Ob NW   
 mean SD mean SD  mean SD mean SD  mean SD mean SD  
BMD (g/cm2) 1.152 0.189 1.214 0.120  1.091 0.174 1.219 0.144 * 1.572 0.162 1.711 0.144 * 
ED (cm) 2.92 0.31 2.67 0.27 * 4.74 0.44 4.36 0.43 * 1.89 0.34 1.61 0.30 * 
ACT (cm) 0.22 0.03 0.24 0.03  0.48 0.09 0.53 0.06 * 0.58 0.10 0.69 0.11 * 
WIDTH (cm) 3.40 0.28 3.15 0.24 * 5.70 0.35 5.42 0.39 * 3.04 0.37 2.93 0.25  
CSA (cm2) 3.69 0.63 3.63 0.35  5.92 0.97 6.28 0.71  4.65 0.58 4.76 0.53  
CSMI (cm4) 3.10 0.80 2.78 0.60  16.10 3.77 15.20 3.28  3.94 1.16 3.77 0.99  
Z (cm3) 1.73 0.37 1.69 0.26  5.06 1.00 5.03 0.79  2.44 0.57 2.44 0.41  
BR 8.25 2.00 6.92 1.08 * 6.85 1.56 5.72 0.91 * 2.73 0.54 2.27 0.47 * 
 
B 
WB (TBLH BMD) Lumbar Spine  Hip Neck 
Ob Ob Ob Ob 
 mean 95% CI  mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 0.966 (0.926 - 1.006) * 0.969 (0.917 - 1.021) * 0.972 (0.910 - 1.035) * 0.910 (0.850 - 0.969) * 
BMC (g) 2024.60 (1915.29 - 2133.90) * 51.38 (46.87 - 55.88) * 31.43 (28.73 - 34.13) * 4.47 (4.15 - 4.78) * 
BMAD 
(g/cm3) 
0.094 (0.091 - 0.097) * 0.975 (0.924 - 1.025) *      
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 Narrow Neck Intertrochanteric Femoral Shaft 
 Ob Ob Ob 
 mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 1.084 (1.001 - 1.167)  1.047 (0.953 - 1.141) * 1.504 (1.414 - 1.593) * 
ED (cm) 2.86 (2.69 - 3.03)  4.76 (4.50 - 5.02)  1.95 (1.77 - 2.15) * 
ACT (cm) 0.21 (0.19 - 0.23) * 0.44 (0.39 - 0.49) * 0.55 (0.49 - 0.62) * 
WIDTH (cm) 3.33 (3.17 - 3.48)  5.64 (5.42  5.87)  3.08 (2.89 - 3.28)  
CSA (cm2) 3.47 (3.17 - 3.76)  5.61 (5.12 - 6.11) * 4.42 (4.09 - 4.75) * 
CSMI (cm4) 2.78 (2.38 - 3.18)  15.10 (13.03 - 17.18)  3.78 (3.15 - 4.44)  
Z (cm3) 1.59 (1.41 - 1.78)  4.78 (4.25 - 5.31)  2.34 (2.04 - 2.64)  
BR 8.30 (7.33 - 9.26)  7.40 (6.68 - 8.13) * 2.92 (2.63 - 3.21) * 
 
C WB (TBLH BMD) Lumbar Spine  Hip Neck 
 Ob Ob Ob Ob 
 mean 95% CI  mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 0.966 (0.926 - 1.006)  1.019 (0.955 - 1.083)  1.003 (0.932 - 1.073) * 0.933 (0.867 - 0.999) * 
BMC (g) 2240.34 (2061.47 - 2419.20)  57.90 (51.98 - 63.82)  33.08 (29.89 - 36.27) * 4.82 (4.42 - 5.21)  
BMAD 
(g/cm3) 
0.092 (0.089 - 0.095) * 1.023 (0.961 - 1.084)       
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 Narrow Neck Intertrochanteric Femoral Shaft 
 Ob Ob Ob 
 mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 1.128 (1.036 - 1.220)  1.043 (0.953 - 1.134) * 1.523 (1.434 - 1.611) * 
ED (cm) 2.84 (2.68 - 3.00)  4.76 (4.51 - 5.01) * 1.94 (1.75 - 2.12) * 
ACT (cm) 0.22 (0.20 - 0.23)  0.44 (0.40 - 0.49) * 0.56 (0.50 - 0.62) * 
WIDTH (cm) 3.31 (3.17 - 3.46)  5.66 (5.44 - 5.88)  3.07 (2.88 - 3.25)  
CSA (cm2) 3.52 (3.23 - 3.81)  5.61  (5.13 - 6.08) * 4.49 (4.16 - 4.81)  
CSMI (cm4) 2.83 (2.44 - 3.23)  15.19 (13.18 - 17.20)  3.85 (3.22 - 4.46)  
Z (cm3) 1.63 (1.44 - 1.81)  4.80 (4.29 - 5.31)  2.37 (2.07 - 2.66)  
BR 8.10 (7.16 - 9.03)  7.34 (6.63 - 8.04) * 2.86 (2.58 - 3.15) * 
 
* p<0.05 OB significantly different than NW. 
Ob obese intervention group, NW normal weight control group, SD standard deviation, WB whole body, TBLH total body less head, LM lean mass, 
FM fat mass, BMD bone mineral density, BMC bone mineral content, BMAD bone mineral apparent density, NN narrow neck, IT intertrochanteric, 
FS femoral shaft, ED endocortical diameter, WIDTH width, CSA cross sectional area, CSMI cross sectional moment of inertia, ACT average cortical 
thickness, Z section modulus, BR buckling ratio 
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To summarise, despite favoured bone density adaptation over the 8 months, adolescents 
with obesity demonstrated lower bone parameters than their normal weight peers after 
adjustment for body weight. Yet, some positive adaptations were seen for hip geometry 
most specifically at the narrow neck. However, as stated in the previous chapter, the index 
of fracture prediction at the narrow neck remained of concern. Finally, bone accretion 
among adolescents with obesity appeared to follow androgen like adaptations, which was 
not apparent in the normal weight control group. 
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The final aim addresses the hypothesis that: 
i. Obesity in adolescents is associated with altered bone remodeling markers. 
ii. The 8-month weight loss intervention will stimulate the remodeling activity in favour 
of bone formation in adolescents with obesity. 
iii. The weight loss intervention experienced by adolescents with obesity will induce a shift 
of bone turnover towards positive bone formation compared with an obese control 
group; trending towards bone formations values similar to a lean control group.  
 
Aim 4:  
i. To investigate the influence of body weight status and weight loss intervention on bone 
remodeling in adolescents with obesity and normal weight controls. 
 
To answer the final aim of this thesis, we used the data of 38 adolescents recruited for the 
program of research. Data in this section were collected from 10 adolescents with obesity (Ob) 
enrolled in a weight loss intervention, 17 normal-weight (NW) adolescent females and 11 Ob 
controls (4 ♂).   
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4.4. Does weight status and weight changes influence bone markers? 
 
 
  
Aim 
To investigate the influence of body weight status and weight loss intervention on bone 
remodeling in adolescents with obesity and normal weight controls. 
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Table 24 - Outline of the data collection and participants for the fourth aim 
 
 
 
Table 24 indicates that participants targeted in meeting the final aim of the research were the 
adolescents with obesity who underwent the intervention, the normal weight control group 
and the adolescents with obesity who did not receive the intervention and therefore acted as 
a control group. The shading indicates time points used for this analysis.
Groups Baseline 4-month 8-month
In
te
rv
en
ti
o
n
  
n = 31 (6 ♂) n=29 (4 ♂) n = 24 (3 ♂)
C
o
n
tr
o
l
  
n = 23 (♀) n = 23 (♀) n = 23 (♀)
 
n = 11 (4 ♂) n = 11 (4 ♂)
Normal weight 
adolescents
Adolescents with 
obesity
no-residential program
Adolescents with 
obesity
residential WL program 
(physical activity & 
nutrition)
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Table 25 - Bone markers concentration 
  Baseline 4 months  8 months 
  P1NP *,$ CTx*,$ P1NP*,$ CTx*,  P1NP CTx  
 median IQR median IQR median IQR median IQR  median IQR median IQR  
Ob 41.30 4.09 4.42 1.50 38.55 9.46 3.47 0.94 £ 41.22 7.74 4.34 1.31 ¤ 
NW 120.00 77.50 7.04 2.27 136.00 69.50 6.76 2.68       
Ob control 41.76 7.28 5.60 1.97 39.67 4.75 6.30 2.07 £      
* Significant difference between Ob and NW; $ significant differences between Ob control and NW;  significant differences between Ob and Ob 
control, £ significant differences between baseline and 4 months, ¤ significant differences between 4 months and 8 months, µ significant 
differences between baseline and 8 months  
IQR interquantile range, Ob obese group, NW normal weight control group, Ob control obese control, CTx collagen type 1 cross-linked C-
telopeptide, P1NP Procollagen type 1 N-terminal propeptide 
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Analysis of biomarkers used the non-parametric Wilcoxon test. Bone marker plot analyses 
occured on data from baseline and 4 months for both control groups and at baseline, 4 and 8 
months for the Ob group. Table 25 described bone markers concentration of each group. 
 
 
Table 26 - Descriptive statistics at baseline  
  Ob n= 10  NW n= 17 Ob control n= 11 (4 ♂) 
  Mean SD Mean SD Mean SD 
 
Age (years) 14.12 1.39 16.06 0.39 14.02 1.39 *, £ 
Menarche age  12.33 0.86 13.00 1.15 12.29 0.95  
BMI 33.70 4.85 20.71 1.42 30.80 4.80 *, £ 
Height (cm) 161.60 8.26 164.38 5.08 165.82 7.25   
Body weight (Kg) 88.17 15.65 57.19 5.93 87.71 16.83 *, £ 
WB Lean Mass (g) 52393.42 8970.61 45454.15 4648.97 52912.17 9669.91 *, £ 
WB FM (%) 40.35 4.08 20.46 3.12 37.75 3.43 *, £ 
WB FM (g) 35783.42 8067.86 11734.42 2380.31 33414.61 8127.23 *, £ 
Android (%) 43.39 5.62 18.06 4.03 40.87 4.84 *, £ 
Gynoid (%) 42.70 3.87 26.00 3.12 40.12 3.28 *, £ 
V FAT (%) 44.01 5.32 19.08 4.37 39.51 5.57 *,£ 
V FAT (g) 274.79 71.47 140.33 54.86 407.64 185.04 *,£,$ 
V FAT (cm3) 297.07 71.47 151.70 59.31 398.25 163.45 *, £, 
 
* p<0.05 comparisons between Ob and NW, $ p<0.05 comparisons between Ob and Ob control, 
£ p<0.05 comparisons between Ob control and NW 
 
Ob obese group, NW normal weight control group, SD standard deviation, BMI body mass 
index, WB LM whole body lean mass, WB FM whole body fat mass, V FAT visceral fat 
 
 
Mean and Standard Deviation (SD) at the baseline of adolescents with obesity in the 
intervention group, adolescents with obesity who formed a control group and normal-weight 
control groups are summarised in Table 26. As expected, compared with normal weight 
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participants, both of the groups with obesity were greater in term of body mass index (kg.m-
2) (p<0.001), body weight (kg) (p<0.001) but were younger in age (years) (p<0.001). However, 
no differences in height (m) were observed. 
 
At baseline, both groups with obesity had higher values for lean mass (g) than their NW peers 
(Ob p=0.032, Ob control p= 0.017). Similarly, compared with the NW group, both groups with 
obesity had higher values for whole body FM (% and g), as well as for android FM (%), gynoïd 
FM (%)(p<0.001) and visceral fat (%, g and cm3) (% p<0.001; g: Ob p=0.021, Ob control p<0.001; 
cm3: Ob p=0.006, Ob control p<0.001). However, a difference for VFAT (g) was observed 
between both obese group (p=0.034), with higher value in the control group.  
 
Bone markers changes among adolescents of various weight normalised to their 
respective baseline median 
Data were normalised to group’s respective baseline median to observe each group’s changes 
over time (Figure 20). Table 27 details bone remodeling scores and uncoupling index. 
 
For the normal weight adolescents (NW), confidence ellipses of bone turnover overlapped at 
baseline and 4 months. At baseline, the distribution of adolescents relating to bone remodeling 
activity was 53% in fast formation, 35% in fast resorption and 12% in slow resorption.  With 
the exception of one adolescent, all data were close to the balance central axis, in the upper 
quadrant of the turnover axis, which defines the separation between fast/slow activities. At 4 
months, the ellipse appeared to shift towards dominant formation. Indeed, the distribution 
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among the features of resorption and formation were 76% for fast formation, 17% for fast 
resorption and 7% for slow formation.   
To confirm the observed graphical representation and the uncoupling index favouring bone 
formation (p= 0.028; 0.47 (0.78)), statistical differences were reported for the median of the 
balance between baseline and 4 months (p=0.044). The shift towards bone formation might 
be explained by an increase of the balance in favour of formation, while bone turnover did not 
change.  
 
At baseline, bone markers of the adolescents with obesity who did not receive the intervention 
favoured bone formation. Surprisingly, confidence ellipse of this Ob control group appeared to 
move backward to a fast bone resorption state after 4 months. The accelerated bone 
resorption was visualised by a shift of the ellipse towards the left upper quadrant. Also at 
baseline, data were more scattered than at 4 months. The calculated distributions of data from 
adolescents for fast formation and fast resorption at baseline and 4 months for CTx-P1NP were 
56% to 44% and 27% to 73%, respectively.  
The resorption state of the adolescents with obesity enrolled in the control group was 
confirmed by differences over time in the median value for balance (p=0.010) and turnover 
(p=0.050); indicating accelerated bone resorption. However, changes in the UI (from 0.00 
(1.20) to -1.32 (1.43)) were not observed between baseline to 4 months in this group 
(p=0.075). 
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Finally, for the adolescents enrolled in the WL intervention, the three ellipses overlapped. At 
baseline, adolescents with obesity in the intervention demonstrated bone remodeling activity 
favouring fast resorption/fast formation. The distribution of the adolescents among the bone 
marker plot was approximately 50% in fast resorption and 50% in fast formation.  At the mid-
point of the intervention, a shift occurred in bone turnover. Indeed, during this period of 
weight loss (∆ weight loss %, mean (SD) -9.04 (4.57)) bone remodeling activity appeared to 
induce bone formation, with 90% of the adolescents in the “formation” quadrant of the bone 
plot. Data from the uncoupling index supports a formation bias. Indeed, at 4 months 
adolescents enrolled in the weight loss intervention demonstrated a positive UI (0.98 (2.19)). 
However, the UI was not significantly different from baseline.  At the end of the weight loss 
intervention bone turnover in adolescents with obesity returned towards baseline distribution 
with 40% of the population in fast resorption and 60% in fast formation (∆ weight loss %, mean 
(SD) -3.28 (4.20)). Although the uncoupling index remained positive (0.32 (1.80)) bone 
formation had slowed down.  
To more quantitatively support the observed shifts in bone marker plots, differences in median 
values were assessed using non-parametric statistics. Between baseline and 4 months, the 
bone formation process was promoted by a lower turnover rate (p=0.037), and higher balance 
between formation and resorption (p=0.037). In addition, differences in median values were 
also observed between 4 and 8 months. The return of the bone remodeling activity to baseline 
values (fast resorption/fast formation) is explained by a lower median for balance suggesting 
higher resorption (p=0.007) and a higher median for turnover (p=0.009). 
  
203 
 
 
 
 
 
Figure 20 - Bone turnover changes of the three groups: normal weight (A), Ob (B) and Ob control (C), normalised to their respective baseline 
median  
NW normal weight control group, Ob obese intervention group, Ob control obese control 
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Table 27 - Scores, UI and bone markers plot normalised to groups’ respective median 
  Ob  NW  Ob control 
  Baseline 4 months 8 months  Baseline  4 months  Baseline 4 months 
 mean SD mean SD mean SD  mean SD  mean SD  mean SD mean SD  
score F 0.00 1.00 -0.03 2.06 0.36 1.90  0.00 1.00  0.18 0.87  0.00 1.00 -0.69 1.13  
score R 0.00 1.00 -1.01 1.00 0.05 0.68 £, ¤ 0.00 1.00  -0.29 1.22  0.00 1.00 0.63 0.86 £ 
UI 0.00 1.75 0.98 2.20 0.32 1.80  0.00 0.87  0.47 0.78 £ 0.00 1.20 -1.32 1.43  
Balance 0.00 0.12 0.13 0.17 0.00 0.07 £, ¤ -0.02 0.18  0.06 0.09 £ 0.01 0.11 -0.08 0.09 £ 
Turnover 0.15 0.04 0.09 0.06 0.15 0.05 £, ¤ 0.16 0.11  0.15 0.12  0.14 0.05 0.16 0.05 £ 
£ significant differences between baseline and 4 months, ¤ significant differences between 4 months and 8 months, µ significant differences 
between baseline and 8 months 
Ob obese group, NW normal weight control group, Ob control obese control, F formation, R resorption, UI uncoupling index,  
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Bone markers comparison over time normalised to baseline NW median  
Bone remodeling markers were also assessed in the two groups with obesity relative to 
baseline median values from the normal weight peers. In contrast to previous observation, 
when normalised to NW baseline medians, ellipses of both obese groups shifted towards bone 
resorption area (Figure 21). However, the shape of the ellipses mostly remained unchanged. 
 
The confidence ellipse of the Ob control group were subsequently located in the lower left 
quadrant, suggesting altered remodeling activity compared with normal development.  The 
distributions of adolescents with obesity in the control group indicated fast resorption and slow 
resorption at baseline and 4 months for CTx-P1NP were 18% to 82% and 45% to 55%, 
respectively. Also, the resorption state of the adolescents with obesity enrolled in the control 
group was confirmed by the UI (p= 0.004; from -0.71 (0.76) at baseline to -1.25 (0.68) at 4 
months) (Table 29). Moreover, observation of resorption were confirmed by the difference 
between baseline and 4 months in the median values for balance (p=0.010) and turnover 
(p=0.004); accelerating bone resorption (Table 28). 
 
Similar observations were noted in data from the adolescents with obesity enrolled in the WL 
intervention. Indeed, at baseline, with the exception of one participant (fast resorption), all 
data were in the slow resorption quadrant of the graph. The UI confirmed the graph plot (-0.16 
(0.65)). When analysing the distribution of those data, approximately half of the participants 
were located in the upper quadrant near to the fast resorption line, while the other half were 
closer to the slow formation area.  
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At 4 months, the bone marker plot showed that the weight loss intervention may potentially 
have influenced the adolescents’ bone turnover by a shift towards slow formation (p=0.037 
differences between baseline and 4 months for both balance and turnover median). Closer 
examination of the distribution within the graph showed 80% were in slow resorption and 20% 
in slow formation. However, with the exception of one participant, all adolescents in the 
intervention group moved closer to the slow formation quadrant (n=7), or were in the slow 
formation quadrant (n=2). The positive score of the UI (p=0.022; 0.46 (0.62)) supported this 
information (Table 29).  
Finally, at 8 months, the bone marker plot returned to slow resorption with a tighter scatter of 
data than previously observed. A similar pattern was calculated in the UI at 8 months (p=0.007; 
-0.17 (0.40)).  
The lower turnover rate previously observed in this group using bone marker plots was 
supported quantitatively by a tendency for a lower turnover rate between baseline and 4 
months (p=0.069). The return to baseline between 4 and 8 months was associated with a lower 
median for balance, suggesting higher resorption (p=0.007) and a higher bone turnover 
(p=0.005) (Table 28). 
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Table 28 - Balance and turnover normalised to NW baseline median 
  Baseline 4 months 8 months 
 Balance Turnover Balance  Turnover  Balance  Turnover  
 median IQR median IQR median IQR  median IQR  median IQR  median IQR  
Ob -0.27 0.20 -0.15 0.10 -0.17 0.15 £ -0.23 0.11 £ -0.24  0.05 ¤ -0.15  0.11 ¤ 
NW 0.01 0.15 0.17 0.20 0.06 0.11 £ 0.16  0.22        
Ob control -0.36 0.18 -0.06 0.15 -0.47 0.17 £ -0.02 0.13 £       
 
£ significant differences between baseline and 4 months, ¤ significant differences between 4 months and 8 months 
Ob obese group, NW normal weight control group, Ob control obese control, IQR interquartile range 
 
Table 29 - Scores and UI normalised to NW baseline 
  Ob  NW  Ob control 
  Baseline 4 months 8 months  Baseline  4 months  Baseline 4 months 
 mean SD mean SD mean SD  mean SD  mean SD  mean SD mean SD  
z-score F -1.78 0.06 -1.79 0.11 -1.76 0.11  0.00 1.00 *,$ 0.18 0.87 *,$ -1.77 0.07 -1.82 0.08  
z-score R -1.62 0.62 -2.25 0.62 -1.59 0.42 £,¤ 0.00 1.00 *,$ -0.29 1.22 *, -1.06 0.78 -0.57 0.67  
UI -0.16 0.65 0.46 0.62 -0.17 0.40 £,¤ 0.00 0.87 $ 0.47 0.78 $,  -0.71 0.76 -1.25 0.68  
* Significant difference between Ob and NW; $ significant differences between Ob control and NW;  significant differences between Ob and Ob 
control, £ significant differences between baseline and 4 months, ¤ significant differences between 4 months and 8 months, µ significant 
differences between baseline and 8 months  
Ob obese group, NW normal weight control group, Ob control obese control, F formation, R resorption, UI uncoupling index, Procollagen type 1 N-
terminal propeptide 
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Figure 21 - Bone turnover changes of both obese groups: Ob (A) and Ob control (B), the baseline median of NW control was used for normalisation 
Ob obese intervention group, Ob control obese control 
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Bone markers comparison over time normalised to baseline Ob control median  
To compare bone turnover changes of adolescents with obesity undertaking a weight loss 
intervention with a control group of adolescents with obesity, the baseline median value for 
the control group with obesity was used for normalisation (Figure 22). As stated previously, 
despite the same characteristics for sedentary behaviour, body composition and bone 
parameters, adolescents enrolled in the control group with obesity had higher VFAT (g) at 
baseline.  
Although, no significant differences in bone parameters were observed for unadjusted and 
adjusted values (VFAT,g) at baseline between both obese groups (Appendix 30), adolescents 
with obesity enrolled in the weight loss program had bone turnover values mostly favouring 
fast formation compared with the “control” adolescents with obesity.  The UI confirmed the 
graph plot (0.57 (1.40)).  
 
Moreover, similarly to previous observations of the intervention group at 4 months, the bone 
marker plot showed that the weight loss intervention program may potentially have influenced 
bone turnover. More specifically, normalising data against the control group with obesity 
showed a shift towards bone formation after 4 months of the intervention in these adolescents 
(p=0.037 differences between baseline and 4 months for balance median; p=0.066 for 
turnover median). The positive score of the UI (1.35 (1.77)) supported the graphical trends, 
however, data did not differ from baseline.  
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Finally, at 8 months, the bone marker plot returned to baseline characteristics, with three 
adolescents with obesity in the fast resorption quadrant, while others were in the fast 
formation quadrant but closer to the central axis delimiting the resorption area. Similarly, this 
observation was confirmed by the UI at 8 months (p=0.037; -0.32 (1.80)). The shift back from 
4 to 8 months was associated with a lower median for balance, suggesting higher resorption 
(p=0.005) and a higher bone turnover (p=0.005).  
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Figure 22 - Bone turnover evolution of both obese groups: Ob (A) and Ob control (B), the baseline median of Ob control was used for normalisation 
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Bone turnover of one randomly selected adolescent from each group  
To confirm the observed results one adolescent from each group was randomly selected for 
additional analysis (Figure 23). When normalised to their respective group baseline median 
values (Figure 23.B), the NW adolescent appeared to benefit from perhaps growth related 
activity via a shift towards accelerated bone formation. The NW adolescent had a bone 
turnover favouring fast formation. However, both adolescents with obesity had bone turnover 
predominantly located in the fast resorption quadrant, possibly due to their excess body 
weight and fat. Interestingly, at 4 months, the turnover activity of the two adolescents with 
obesity followed different trajectories. Indeed, the bone turnover activity of the adolescent 
with obesity from the control group deteriorated, while the adolescent enrolled in the WL 
intervention showed remodeling activity favouring formation, despite a slowdown of its 
activity at 8 months.   
 
When normalising to the baseline NW median value (Figure 23.A), similar to the results from 
the previously presented groups’ ellipses, the turnover pattern of each adolescent with obesity 
remained similar. However, both adolescents with obesity showed that their remodeling 
activity had shifted towards a slower resorption phase. Nonetheless, results for these two 
adolescents with obesity showed an overall dominance of resorptive bone remodeling activity. 
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Figure 23 - Bone marker plot of 3 participants (one from each group) normalised to baseline NW median (A) and normalised to group’s baseline 
median (B)  
NW normal weight control group, Ob obese intervention group, Ob control obese control 
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To summarise, after 4 months, with the exception of the adolescents with obesity in the 
control group, normal weight adolescents as well as adolescents with obesity in the weight 
loss intervention showed both quantitative and qualitative markers of bone formation.  
However, bone formation had slowed by 8 months in the obese state. Despite a positive 
remodeling activity, when compared with normal weight controls, adolescents with obesity 
generally displayed altered bone remodeling favouring resorption. 
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CHAPTER FIVE 
 
 
 
 
 
 
 
Discussion and conclusion 
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This thesis comprised four inter-related investigations sharing the overarching purpose of 
determining the impact of weight loss induced by physical activity and nutrition on the bone 
health of adolescents with obesity. Critical appraisal of current literature highlighted the 
equivocal understanding of how obesity and then weight loss might impact the typically 
anabolic status of adolescent bone growth. Few studies have isolated overweight and obese 
individuals so existing results for adolescents with obesity may lack strong external validity. 
Maturation always complicates research-targeting adolescents. Maturation is an issue that few 
studies into obesity address in recruitment and subsequent data analyses. A paucity of 
research into adolescent obesity has extended metabolic investigations into the area of bone 
health. Arguably, bigger bones can be healthier. However, when bigger bones are subjected to 
perhaps growth-related stimuli, unusual hormonal activity related to nutrition and sedentary 
behaviour with prolonged exposure to excessive load bearing on the skeleton, bone health 
may be compromised.  
The methods selected for the program of research therefore focussed on the identified gaps 
in the literature; choosing methods that would advance the understanding of investigation into 
the status of bone health in adolescents with obesity compared with maturation-matched 
peers, who had a normal weight status. Bone health measurements extended from whole body 
and regional bone scans a using DXA device, to new thinking around relationships among bone 
biomarkers of bone remodeling, maturation and adiposity. Then, more innovatively, responses 
to a residential intervention for adolescents with obesity were investigated and compared with 
normal weight peers. Also, using blood biomarkers, comparisons of the impact of the 
intervention on bone markers were compared with a group of adolescents with obesity who 
did not receive the intervention and a normal weight group of adolescents.  
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5.1. Summary of major findings 
The ADIBOX study first investigated bone parameters among maturation-matched 
adolescents. Then, the effects of a multidisciplinary weight loss program combining nutrition 
and physical activity on bone parameters in adolescents with obesity were assessed. A weight 
status comparison was also performed over the same timeframe. Finally, the influences of 
body weight status and weight loss on the bone remodeling activity were analysed. 
 
Summary of the primary outcomes major findings 
Results for the primary outcome variables showed (1) lower bone parameters of key BMD and 
BMC measures, among adolescents with obesity compared with normal weight controls even 
when data were adjusted for significant body composition variables (BW, FM, LM for baseline 
and BW and FM for the whole study). (2) Some improvements in BMD for the whole body and 
lumbar spine were observed in adolescents with obesity during the intervention. However, 
BMD adjusted values to body weight remained lower than their normal weight peers.  
 
Summary of the secondary outcomes major findings 
Results from site-specific bone changes (geometry and strength) were novel among the 
adolescents with obesity. Specifically, additional major findings from secondary outcomes 
were (3) that geometric indices of bone strength at a significant weight bearing site (NN) for 
individuals with obesity remained altered. Specifically, despite positive adaptations of some 
geometric properties, the weight loss intervention in adolescents with obesity remained 
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associated with a compromised estimate of fracture risk. (4) Also, the results highlighted more 
subtle but significant trends by finding that bone accretion in adolescents with obesity followed 
an androgen-like growth adaptation through a stimulation of periosteal expansion and 
endocortical resorption associated with weight loss. (5) Furthermore, bone remodeling activity 
positively responded during the first four months of the weight loss intervention. However, at 
8 months, values obtained returned to numbers obtained at baseline.  Table 30 summarise the 
major findings from the present thesis. 
219 
 
Table 30 - Outline of the major findings within this thesis 
Aims  Experimental hypothesis  Majors findings 
To profile bone parameters 
among maturation-
matched adolescents of 
various weight. 
 
Compared with their normal weight peer, 
adolescents with obesity will display: 
- lower bone density at whole body and 
specific weight bearing sites  
- altered bone geometry and strength  
 
 
 - Adolescents with obesity displayed lower unadjusted and 
adjusted BMD at whole body and most site-specific regions 
than their normal weight peers. 
- Geometric indices of bone strength were compromised 
when adjusted for body composition variables of body 
weight, fat mass and lean mass. 
To investigate the impact 
of a multidisciplinary 
weight loss program 
combining nutrition and 
physical activity on the 
bone health of adolescents 
with obesity, including 
estimate of fracture risk. 
 
The structured weight loss intervention 
combining physical activity and nutrition will: 
- prevent the loss of bone mass caused by 
weight loss in adolescents with obesity. 
- prevent estimates of fracture risks.  
 
 
- Induced WL favoured positive adaptations in bone 
parameters at whole body and lumbar spine.  
- Geometric indices of bone strength at the weight-bearing 
site of the narrow neck remained compromised with scores 
nearing the fracture prediction threshold. 
- Bone remodeling activity in favour of formation was 
observed during the WL intervention with higher values 
during the first 4 months of WL intervention but values from 
the UI did not reach significance. 
 
To investigate the impact 
of body weight changes 
induced by a structured 
 
The 8 months WL intervention will: 
 
 
- Despite positive adaptation, bone density of adolescents 
with obesity participating in a weight loss intervention 
remained compromised when adjusted for body weight.  
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weight loss intervention on 
bone parameters in 
adolescents with obesity 
compared with normal 
weight maturation-
matched peers. 
- support positive adaptations in bone 
parameters reaching the bone parameters 
values in NW adolescents. 
- induce a higher responsiveness in bone 
parameters at weight bearing sites than 
whole body. 
- Positive geometric adaptations were observed with weight 
loss, with better responses at the narrow neck than the shaft. 
However, strength indices remained compromised (i.e. aim 2) 
- Bone accretion in adolescents with obesity participating in a 
weight loss intervention appeared to follow an “androgen 
like” growth adaptation through a stimulation of periosteal 
expansion and endocortical resorption. 
To investigate the 
influence of body weight 
status and weight loss 
intervention on bone 
remodeling in adolescents 
with obesity and normal 
weight controls. 
 
 
- Obesity is associated with altered bone 
remodeling markers during adolescence.  
- The 8 months WL program will stimulate the 
remodeling activity in favour of bone 
formation in adolescents with obesity. 
-  The WL program will induce a shift of bone 
turnover towards positive bone formation 
compared with Ob control; trending towards 
bone formation values similar to a normal 
weight control group. 
 
- Normalised to their baseline value, adolescents with obesity 
from the WL intervention demonstrated an acute remodeling 
activity in favour of bone formation after 4 months. 
- Normalised to NW, both obese groups demonstrated 
remodeling activity favouring bone resorption. 
- Weight loss may benefit bone health in adolescents with 
obesity during the initial phase of an intervention. 
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5.2. Discussion of major findings 
Bone parameters among maturation-matched adolescents 
The current literature shows inconsistency in the status of BMD in adolescents with obesity 
(Dimitri et al. 2010) (Rocher et al. 2013) (Goulding et al. 2000) (Rocher et al. 2008) (El Hage et 
al. 2012) (Russell et al. 2010) (El Hage et al. 2012) (Leonard et al. 2004).  In accordance with 
some studies (Dimitri et al. 2010) (Rocher et al. 2013) (Goulding et al. 2000) (Rocher et al. 2008) 
(El Hage et al. 2012), but not all studies (Russell et al. 2010) (El Hage et al. 2012) (Leonard et 
al. 2004), the results from baseline comparisons showed lower unadjusted data for BMD 
measures involving WB (less head) BMD, WB BMAD, LS BMAD and no differences at LS BMD, 
neck BMD, hip BMD in adolescents with obesity compared with NW. In contrast, the current 
findings agree with all previous studies of lower BMD when data from adolescents with obesity 
were adjusted for the key body composition variables of body weight (kg), or fat mass (g) and 
compared with their normal weight peers. Although the influence of lean mass (g) on bone is 
well demonstrated (Courteix et al. 1998), lean mass did not change through the weight loss 
program; justifying only adjusting for lean mass at baseline.  
 
The differences (BMD) observed in the literature might be related to between study 
inconsistencies in pubertal (Garabédian et al. 2009) (Dimitri et al. 2012) and maturation status 
(Wang 2002), single or mixed sex among participants (Shapses et al. 2012) or, the degree of 
obesity (Pollock et al. 2007) (Laddu et al. 2013) (Campos et al. 2012) (Ripka et al. 2016).  In the 
present study, adolescents shared a similar maturation status despite adolescents in the 
obesity groups being younger than their normal weight peers. Indeed, both groups had similar 
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oestradiol levels, age at menarche and all participants from this study were at least at Tanner 
Stage 4. In addition, only adolescents above the 95th percentile for BMI were included (BMI 
percentile mean and SD of the adolescents in the weight-loss program group was 98.25 (1.89)). 
Moreover, all the adolescents with obesity enrolled in the present research had a history of 
early onset obesity; with a BMI above the 97th percentile at a mean age of 3.76 (1.54) years.  
The incidence of obesity in early childhood among children aged between 2 to 7 years is a 
critical time for developing bone parameter weaknesses (Garabédian et al. 2009). The 
reviewed literature in this thesis showed that hormones related to excessive obesity can 
compromise bone health.  It can be speculated that any mineralisation delay potentially 
occurring in the prepubertal years due to the early onset of obesity was too substantial to be 
corrected during pubertal years.  
  
Influence of the WL program on bone parameters 
During the weight loss intervention, trabecular and cortical bone appeared to change in 
association with body weight changes. This change was not always consistent with previous 
observations of negative associations between weight loss and BMD (Whipple et al. 2004). In 
the current thesis, adolescents with obesity increased their BMD (WB and LS). However, when 
compared with changes in NW, adolescents with obesity had similar unadjusted bone density 
values at WB, LS and neck but lower values at the hip. With adjustments for body weight 
changes, BMD became lower in adolescents with obesity than NW at all sites except the LS. 
When adjusted for fat mass changes, similar LS BMD was identified in both groups but 
adolescents with obesity showed lower BMD at WB, neck and hip than their NW peers. Despite 
the well-known effects of excessive body weight-stimulating mechanical loading (Shapses et 
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al. 2015), adolescents with obesity seemed to have less WB and site-specific bone density than 
their normal weight peers to cope with their relative body weight. 
 
Even if fat-bone mechanisms remain uncertain, fat mass plays an important role during bone 
growth depending of the degree of obesity (Pollock et al. 2007) (Laddu et al. 2013) (Campos et 
al. 2012) (Ripka et al. 2016). Growing bones are fashioned into a structure adapted to support 
the skeleton. During adolescence, changes in modular volume depend on endocortical 
resorption. This reportion enlarges the marrow cavity and is stimulated by bone growth and 
endocortical apposition of bone mineral, often in response to physical activity (Parfitt 1994). 
Moreover, most increases of cortical thickness are attributed to gains in bone width (Seeman 
2001). Impairment of periosteal apposition might result in smaller bones and increased 
fracture risks in response to bending loads (Seeman 2001). In this thesis, adolescents with 
obesity demonstrated lower quantitative bone parameters. Reduced weight appeared to 
cause higher fragility at the narrow neck than the shaft. This could be explained by 
modifications in compressive and tensile stresses attributed to weight loss. Results from 
investigations with peripheral Quantitative Computed Tomography (pQCT) (Laddu et al. 2013) 
(Farr et al. 2010) support the finding that skeletal adaptations may be compromised during 
growth relative to body mass and location of the fat mass.  It is possible that regardless of the 
weight bearing effects of excess loading through obesity, the location of fat mass may 
independently act to compromise bone health during growth. 
 
In addition, when focusing on the bone geometric findings from the shaft of the hip, the results 
highlighted a significant increase in cortical area with a similar magnitude of change in 
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adolescents with obesity and their normal weight peers. However, only the normal weight 
group increased cortical thickness and bone density. Typically, during normal bone growth 
during late puberty bone growth is stimulated by periosteal apposition and medullary 
contraction (endocortical apposition); increasing cortical thickness (Seeman 2003) (Bass 2003) 
(Forwood et al. 2004).  In the adolescents with obesity who received the intervention, reduced 
weight was associated with periosteal expansion and endocortical resorption, a typical male 
rather than female growth response. Yet, during pubertal growth, estrogen in young females 
is known to inhibit periosteal expansion and stimulate endocortical acquisition (Bass 2003). 
The finding of periosteal expansion in the predominantly female group of adolescents with 
obesity occurred despite demonstrating similar oestradiol values as their normal weight peers. 
Because of the observation of androgen-like growth within the bone, it could be speculated 
that the presence of males (three boys) influenced geometric development. As such, additional 
analyses involved withdrawing the males from the data set. As shown in Figure 19, similar 
results were observed between groups with or without the inclusion of males in the analysis. 
Despite low numbers of males, less compromised cortical thickness within a female only 
adolescent group with obesity was hypothesised. Surprisingly, the decline observed in cortical 
thickness worsened with the female group. Strengthening the observation of androgynous-like 
adaptations in bone distribution in female with obesity who experienced weight loss. It is 
possible that an 8-month weight loss intervention would produce a similar or even more 
exaggerated pattern in pubertal growth in boys who experience a typical dimorphic stimulation 
of periosteal expansion and endocortical resorption. 
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The investigation into hip bone strength and geometry could be regarded as controversial 
given it lies outside the ISCD recommendations. Hip investigations were included as it is a site 
of considerable and prolonged loading for adolescents with obesity. Results from HSA analysis 
reflect a bone’s ability to withstand forces generated during walking or during a fall. The impact 
of weight loss on local modifications at specific bone sites is of interest at least in this 
population. Section modulus (Z) represents an endpoint in mechanical homeostasis in long 
bones, able to show adaptation through bone geometry, depending on the demand of 
environmental load (Beck et al. 2001). Conflicting findings about bone strength have been 
reported in adolescents with obesity. Cross-sectional pQCT studies reported higher bone 
strength in adolescents with obesity, which was mainly explained by higher maturational levels 
(Vandewalle et al. 2013) (Leonard et al. 2015), while HSA studies have reported similar (Gong 
et al. 2012) or lower (Rocher et al. 2013) (El Hage 2012) bone strength at the hip. 
 In the current thesis, baseline data showed that adolescents with obesity had lower resistance 
to bending, torsional and axial stresses at the narrow neck, the intertrochanteric site and 
femoral shaft after adjustment to body weight or fat mass. Changes in hip loading are 
associated with mechanical alteration of section modulus and are likely to weaken femoral 
neck (cortical and trabecular bone) than shaft (cortical bone) (Beck et al. 2001). The 8-month 
WL program unfavourably reduced these values for adolescents with obesity. This was 
exemplified by results for the bone buckling ratio at narrow neck, with scores trending closer 
to the fracture prediction threshold at the end of the intervention. Indeed, results showed 
estimates of fracture risk worsened in adolescents with obesity when changes were adjusted 
for weight loss. Higher fracture risk in adolescents who lose weight is a major concern and must 
be addressed in the exercise prescriptions used in future interventions. It is postulated that 
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progressive load bearing exercise can better support bone strengthening than the sport-
related experiences offered to adolescents with obesity in the present intervention.  
  
Correlation analyses confirmed previous associations between body composition and bone 
mass parameters (Lanyon et al. 1984) (Forwood et al. 1995) (Frost 1997). In the current study, 
lean mass and bone parameters (density, geometry and strength) correlated strongly, while 
body weight and fat mass were moderately associated with geometry and strength 
parameters. In a pQCT study (Farr et al. 2010) assessing the relationship between WB fat mass 
and bone geometry on pre-pubertal females it was highlighted that females with higher WB 
FM had attenuated volumetric BMD, geometry and bone strength at femur and tibia than 
females with lower WB FM. In addition, others (Campos et al. 2012) (Russell et al. 2010) have 
demonstrated links between fat mass location and BMD, suggesting that visceral fat or visceral 
fat/subcutaneous fat ratio were negative predictors of BMD in adolescents with obesity after 
pubertal growth. Whole body fat mass was inversely correlated to lean mass, making it difficult 
to determine whether bone parameters were influenced by either the fat mass or the lean 
mass percentages (Specker et al. 2001).  However, in this thesis, during the weight loss 
intervention, adolescents with obesity did not significantly change their lean mass and 
significantly decreased their fat mass. Maintenance of lean mass suggested that the observed 
effect after adjustment for weight change might be linked to the improvement of the fat 
mass/lean mass ratio. The absence of variation of lean mass during the weight loss intervention 
was unexpected. Indeed, most of the studies report an increase in lean mass during WL 
interventions (Campos et al. 2014) (Campos et al. 2012) (Stettler et al. 2008). Although this 
study did not aim specifically for lean mass changes, a possible explanation for the lack of 
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increased lean mass might be that the physical activity program was more focused on sports-
related experiences than on specific osteogenic modalities. 
 
Influence of body weight status and weight loss on the bone remodeling activity 
Finally, the assessment of the bone remodeling activity assists in the understanding of skeletal 
growth and allows a rapid response by providing complementary information on slower 
changes in bone density (Vasikaran et al. 2011). The relationship between weight status and 
markers of bone turnover among maturation-matched adolescents was assessed. The 
threefold purpose of the graphical representation of the bone remodeling activity was: (1) To 
understand the balance of bone turnover in the adolescents with obesity who received the 
intervention and bone turnover changes over time. (2) To observe the changes pattern of the 
bone turnover in the group of adolescents with obesity who received the intervention by 
comparing them with an obese control group. (3) To observe and set the balance of the bone 
turnover in adolescents with obesity who received the intervention compared with a normal 
weight control group. 
 
Lower baseline concentrations of the bone markers (P1NP and CTx) were observed for both 
obese groups compared with their normal weight peers.  The results from these bone markers 
concentrations are in accordance with some (Viljakainen et al. 2014) but not all (Dimitri et al. 
2011) previous studies. Bone markers in adolescents and young adults with obesity (15-25 
years of age) have shown lower bone turnover activity when compared with their maturation-
matched lean peers (Viljakainen et al. 2014). Other researchers have assessed the bone 
formation marker P1NP and bone resorption marker CTx in younger populations; 103 children 
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and adolescents aged 5 to 16 years (Dimitri et al. 2011). Contrary to the results from the 
current thesis, circulating CTx level were found to be higher in children with obesity while no 
difference in P1NP was reported compared with normal weight peers (Dimitri et al. 2011). Also, 
the results from the study with younger children suggested an increased rate of the bone 
formation in favour of resorption. 
To observe changes in bone turnover, each group’s data were normalised to their respective 
baseline values. Overall, at baseline, the three groups showed a bone remodeling activity that 
favoured bone formation.  
Surprisingly, over the 4 months, bone remodeling biomarkers of the adolescents with obesity 
from the control group were in favour of bone resorption. This observation was not expected. 
Indeed, both the normal weight control and the adolescents with obesity enrolled in the WL 
program showed bone remodeling activity in favour of formation during the first four months. 
An association between fat mass and bone resorption has been highlighted among children 
with obesity (Dimitri et al. 2011). Higher circulating leptin levels due to higher fat mass induces 
a diminution in OPG secretion. Reduced OPG leads to osteoclastogenesis due to higher bone 
resorption and lower formation, or a reduction in osteoblast numbers, inducing CTx and P1NP 
secretion (Dimitri et al. 2011). Moreover, others have speculated that under obese conditions, 
bone turnover is regulated by leptin secretion (Viljakainen et al. 2014). However, in the current 
thesis, no differences in baseline circulating leptin levels, were observed between both obese 
groups. This finding does not support the notion that the higher visceral fat profile of the 
control group with obesity than the intervention group would lead to increased circulating 
leptin levels. One explanation might be because of higher level of visceral adipose tissue in the 
adolescents with obesity than the intervention group. Visceral adipose tissue has been shown 
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to be negatively associated with bone parameters in population with obesity (Schorr et al. 
2016) (Zhang et al. 2015) (Donner et al. 2015) (Gilsanz et al. 2009) (Russell et al. 2010). 
Interestingly, in the first four months, the period during which adolescents lost the most weight 
a marked response of the bone remodeling activity in favour of formation was observed. 
However, at the end of the weight loss program, bone turnover values slowed down and 
reduced bone formation. Because of the bone marker plot pattern during this active period of 
bone growth, those results lets us hypothesis a possible effect of the WL intervention in 
addition to growth pattern. As WL induced by diet only is well known to induce bone loss 
(Zibellini et al. 2015), physical activity might induce a positive effect during the acute phase of 
weight loss (% -9.04 (4.57)) on bone turnover by inhibiting resorption. However, the osteogenic 
stimuli from the physical activity component of the intervention may have lacked similar or 
sufficient intensity of weight bearing activity between the 4 to 8 months of the intervention. 
As such markers of positive effects on bone were not maintained and would have possibly 
required a stronger mid-intervention review to elicit a more progressive, bone enhancing 
exercise regime. In adult studies, it has been well established that losing weight via caloric 
restriction alone can induce bone loss, but when weight loss is combined with weight-bearing 
exercise, BMD loss is attenuated  (Schafer 2016) (Martyn-St James et al. 2008) (Zibellini et al. 
2015). Bone loss induced by weight loss might be explained by a reduction in mechanical 
loading (Shapses et al. 2012), which stimulates sclerostin secretion by osteocytes (Turner et al. 
2009). Because sclerostin is inhibited by mechanical loading, future consideration should be 
given to the inclusion of measures of sclerostin level to refute or support this hypothesis in 
effective physical activity impact on bone.  
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When bone marker plots were normalised to NW baseline median values to perform a group 
comparisons, interesting results emerged. Despite both obese groups sharing similar P1NP and 
CTx baseline levels, the UI of the obese control group was lower than their NW peers. When 
reviewing results from the 4-month data normalised to NW baseline median values, it might 
be suggested that osteoblasts under obese conditions are less functional and produce less 
collagen. However, osteoclasts in the control group with obesity appeared to be as active as in 
the normal weight state. Because of this observation, it is speculated that the weight loss 
intervention combining nutrition and physical activity potentially inhibited osteoclast activity. 
Indeed, compared with leaner individuals, both obese groups showed lower bone formation 
activity, while similar CTx levels were observed between both control groups (NW and Ob). 
Also, adolescents enrolled in the WL intervention displayed lower circulating CTx than both 
control groups.  The results of less bone formation activity are supported by previous work in 
young adults with a history of early onset of obesity (Viljakainen et al. 2014). Specifically, the 
young adults with obesity had lower bone formation markers without any differences in the 
formation/resorption calculated index than their lean peers (Viljakainen et al. 2014). 
 
Mechanistic hypothesis 
Obesity leads to complex alterations of hormonal secretions. Selected secretions potentially 
affect bone metabolism, with stronger alterations observed during critical periods of 
developmental change such as puberty (Dimitri et al. 2012) (Douchi et al. 2000). Major 
hormonal alterations with maturation, bone and obesity have been previously described in this 
thesis (Chapter 2 - Review of literature).  
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The results demonstrated lower bone mass, potential alteration of osteoblasts activities, as 
well as an “androgen-like” bone growth adaptation in adolescents with obesity. In the absence 
of extensive additional hormonal analyses, which could have helped in elucidating bone 
responses under conditions of obesity, the following questions and hypotheses are proposed:  
 
(1) Can obesity alter osteoblastic activity?  
Hypotheses: Fewer osteoblast numbers and/or more limited activity of osteoblasts could be the 
result of diminished mesenchymal stem cells differentiation and/or diminished control of the 
disruptive hormones.  
 
This mechanistically based theory hypothesis extends previous discussions within the literature 
(Shapses et al. 2012).  
Due to a shared origin, osteocytes and adipocytes are intimately connected. Indeed, 
mesenchymal stem cells differentiate at least into osteoblasts, chondrocytes and adipocytes 
lineages (Bruder et al. 1994). The Mitogen-Activated Kinase pathway (MAPK) was suggested as 
one of the transduction signalling pathway regulating the adipogenesis and osteogenesis 
differentiation. Cross-talk in the MAPK pathway is essential as it is composed of three enzymes; 
the extracellular signal-regulated kinase (ERK), p38, and c-Jun amino N terminal kinase (JNK). 
More precisely, these three enzymes are active within MAPK pathway and are known to be 
involved in the adipogenesis/osteogenesis differentiation process (Rodríguez-Carballo et al. 
2016). The various activators to this pathway include growth factors, insulin (Boulton et al. 
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1990), inflammatory cytokines (i.e. TNF-α, IL-6) (Cuadrado et al. 2010), estrogen (Migliaccio et 
al. 1996), glucocorticoids (Lukert et al. 1990), leptin (Takahashi et al. 1997), and  1.25 vitamin 
D (Zhang et al. 2012).  
Agreement on the precise action of JNK on osteogenesis remains controversial. However, 
reports of strong evidence of the ERK and p38 enzymes promoting osteogenesis (Rodríguez-
Carballo et al. 2016). Also, it is highlighted that the p38 enzyme is involved in adipocyte 
differentiation (PPARy phosphorylation) (Engelman et al. 1999) (Cargnello et al. 2011) (Jaiswal 
et al. 2000). Overexpression of the protein kinase MKK6 may be responsible for the p38 
activation that favours adipocyte differentiation over osteogenesis (Engelman et al. 1999). 
Moreover, in rodent studies, inhibition of the p38 has been linked with decreased weight loss, 
increased fat deposits as well as increased adipocyte size (Maekawa et al. 2010). As obesity 
can disrupt hormonal factors that activate the MAPK pathways, it might affect the 
mesenchymal stem cell differentiation with an imbalance in typical osteogenesis/adipogenesis 
differentiation to the detriment of osteoblastic lineage; due to an overexpression or activity of 
the PPARy, specifically through an upregulation of adipocyte differentiation.   
 
In addition to a postulated reduced number of osteoblasts, their activity could be limited by a 
negative loop of dysregulated hormones. Under conditions of obesity, inflammatory cytokines 
(Fain 2006), insulin (Reid 2010), aromatase (Rosen et al. 2009), and leptin (Bell et al. 2006) are 
known to have higher circulating levels. However, under the same obesogenic conditions, 
circulating levels of GH/IGF1 axis, 1.25 vitamin D (Konradsen et al. 2008), SHBG (Hautanen 
2000), and adiponectin (Balistreri et al. 2010) are lower.  The relationship of the cited 
hormones with bone health has been previously demonstrated. Some hormones act in favour 
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of formation (i.e. estrogen, SHBG), others of resorption (i.e. GH/IGF1, insulin, 1.25 vitamin D, 
inflammatory cytokines) and sometimes both formation and resorption are possible (i.e. leptin, 
adiponectin); depending on whether the pathway is central or peripheral (Shapses et al. 2012) 
(Shapses et al. 2017).  
As previously stated in the review of literature, bone secreted hormones can also influence fat 
metabolism. The skeletal system is not only responsive to altered hormonal secretions but also 
may respond to other metabolic responses altered by obesity. Higher mechanical loading on 
bone induced by obesity (“static loading” due to higher fat tissue) does not appear sufficient 
to compensate hormonal effects. Mechanical loading is known to inhibit PPARy (David et al. 
2007) and to stimulate osteoblasts (Ehrlich et al. 2002). It is postulated that disruptions to 
hormonal levels directly associated by obesity have stronger negative than positive influences 
on bone formation.    
 
(2) Is the “androgen-like” bone growth adaptation a specific response to obesity? 
Hypotheses: The “androgen-like” bone growth could result from a loss of sensitivity in estrogen 
(aromatase conversion) coupled with higher androgen levels and/or a mechanical bone growth 
response to excessive body weight under conditions of obesity.  
 
 As previously stated, the following considerations are hypothetical due to the absence of 
complementary hormonal analyses that would have helped explain bone responses. However, 
the possibility that lower osteoblast activity due to mesenchymal stem cells differentiation and 
hormonal dysregulation lacks a sound rationale for the observed “androgen-like” bone growth 
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within the two groups with obesity recruited for this thesis. Thus, other potential mechanisms 
require consideration. 
 
First, during typical growth, estrogen is known to stimulate endocortical apposition and inhibit 
periosteal expansion. Also, SHBG levels, which are inversely proportional to bone growth are 
triggered by multiple stimuli including estrogen, but inhibited by testosterone and visceral fat 
accumulation (Peter et al. 2010). Interestingly, under conditions of obesity, the literature 
reports higher levels of estrogen (aromatase conversion) and lower levels of SHBG (Peter et al. 
2010).  Theoretically, as lower SHBG levels are observed in obesity (SHBG inhibits free estrogen 
action by binding it), free estrogen levels are supposed to increase; leading to positive effects 
on bone geometric and densitometric development (Wang et al. 2004). However, our results 
did not demonstrate positive bone development. Based on these observations, a potential 
importance of body fat distribution in the crosstalk between androgens and obesity might be 
postulated (Pasquali 2006). In the recruited adolescents with obesity, visceral fat represented 
47.14 (5.07) %. Similar to leptin which under obese conditions fails to return the body’s 
adiposity to a normal range (Myers et al. 2008), a “loss of sensitivity” to estrogen from 
aromatase conversion might be compromised by obesity.  On one hand, estrogen plays an 
important role in lipid homeostasis and adipose tissue (Mauvais-Jarvis 2011). On the other 
hand, estrogen deficiency or resistance, is associated with an absence of pubertal growth spurt 
(MacGillivray et al. 1998). The pubertal growth spurt had already occurred in the recruited 
adolescents so decreased growth was not apparent. However, it is known that lipid 
homeostasis and adipose tissue are altered with obesity, which may link to the hypothesis that 
bone growth can be enhanced and compensated by high levels of androgens  (Öz et al. 2000) 
(Fisher et al. 1998). Indeed elevated androgen levels are found under certain conditions (i.e. 
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central adiposity, polycystic ovary syndrome) (Pasquali 2006) (Coviello et al. 2006). This 
hypothetical explanation, reinforces the speculation of a potential “loss of sensitivity” from 
estrogen (aromatase conversion). 
 
Second, postural stability is the major component of children and adolescents development 
(Shumway-Cook et al. 1985). Growth but also obesity is connected to morphological changes 
that interfere with postural stability (Nantel et al. 2010). The negative effects of obesity on gait 
are well known and reported in the literature (Jegede et al. 2017). Excessive body weight leads 
to compensatory body movement strategies in adolescents with obesity compared with 
normal weight adolescents (Strutzenberger et al. 2011).  Compensatory movements during 
gait due to excess weight may alter the hip (Nantel et al. 2006), the knee (Gushue et al. 2005) 
and the ankle (Shultz et al. 2009) loading; instigating a reorganisation of walking patterns. 
Moreover, adolescents with obesity have higher absolute ground reaction forces with greater 
muscle activity during walking and stairs climbing (Strutzenberger et al. 2011) (Browning et al. 
2007). The observed bone growth might simply result from mechanical adaptations to excess 
weight. It could be speculated that the observed bone adaptation is a result from the TZA NOU 
exercise program as the adolescents in the intervention group had experienced increased 
activity. Higher loads generated by muscle forces have been shown to increase periosteal 
apposition and to increase cortical thickness in order to improve bending resistance (Turner et 
al. 2003).  However, the results did not support this hypothesis in the present case despite an 
increase of physical activity (sports-related experiences). Indeed, we performed a similar 
analysis among the participants from the control group in order to have an indication of the 
impact of the TZA NOU exercise program. Similar observation on bone development were 
made among the control group (i.e. physically activity less than 120 minutes per week). 
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However, as the number of participant is this group is relatively low (n=11), especially 
considering the predominance of females (n=7) we did not integrate this complementary 
analysis to the major results section of this study. 
 
Figure 24 summarise the mechanistic hypothesis of bone metabolism in adolescents with 
obesity.  
 
 
Figure 24 - Schema of mechanistic hypothesis of bone metabolism in adolescents with obesity 
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To summarise, obesity is postulated to disrupt the mesenchymal stem cell differentiation 
between osteoblasts and adipocytes via the MAPK pathway. Alternatively, the reduced number 
of osteoblasts and/or a reduction of osteoblasts’ sensitivity might explain the osteoblastic 
dysfunction. Also, a strong influence generated by an imbalance between osteoblast and 
osteoclast activity is observed in obesity states. This imbalance appears to be mediated by key 
hormones. Each, some or all of these hormones can inhibit/stimulate, down/up regulate 
osteoblast and/or osteoclasts.  There is also the possibility that the androgen-like adaptations 
in adolescents with obesity might be the results of a loss of sensitivity to estrogen, or the results 
of mechanical body adaptations strategies to adapt the skeletal system.  
 
5.3. Limitations 
There were several limitations to the implementation and assessment of the planned protocol 
within this thesis. 
i. Although the adolescents took part in a structured physical activity intervention, it has 
not been possible to individually track the volume and intensity of the intervention. 
Because of the established links between weight bearing physical activity and bone, 
access to what occurred and how the adolescents responded to this component of the 
intervention could have been helpful in explaining a dose-response effect. This would 
have been particularly interesting because all adolescents with obesity were inactive 
before enrolling the WL intervention. However, the health providers delivering the 
program also could not supply sufficient data on nutrition, which again would have 
been helpful in understanding bone responses of the adolescents with obesity who 
238 
 
were participating in the intervention. Similarly, the physical activity and nutrition data 
of the control groups used within the study were not available; again leaving some 
uncertainty around the explanation of results relating to bone. 
 
ii. Because of the “sports-related” nature of the  physical activity program individuals may 
not have been subjected to sufficient osteogenic activities than a more bone promotion 
focused program that should be possible in future reiteration of this intervention. 
Despite the initiative to repeat baseline assessments of primary and secondary 
outcomes at 4 months, these results were not used to strengthen osteogenic 
possibilities from exercise within the intervention. However, the intervention focused 
on re-introducing positive experiences in physical activity, with the practice and 
discovery of various activities, it is possible that adolescents were supported to sustain 
some form of physical activity when they returned home. 
 
iii. We were not able to assess the sustainability of this WL intervention for the whole 
group as the recruitment of the obesity center is national and participants could live 
anywhere in France, with some participants having limited possibilities to return to the 
center. However, the obesity center offered adolescents the opportunity to re-enter 
the intervention for one week, 3 months after they returned home, which would have 
provided at least some interesting follow-up data. However, time and resource 
limitations within the present thesis precluded follow-up data collection.  
 
iv. It would have be interesting to have a complete set of data on all three groups involved 
in this research. However, restricted access to adolescents with obesity suitable for the 
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control group for the whole period of the weight loss intervention (8 months) was not 
possible. Moreover, the number of participants recruited in the obese control group 
was lower than originally anticipated. Low response rates in this population presented 
a major challenge during this research. Also, the inclusion of a few males to the larger 
number of females within the two groups with obesity could be seen as confounding 
the results. However, statistical support for the inclusion of males was confirmed via 
unaltered homogeneity testing. 
 
v. The original design of this project was set in both countries. However, because of 
difficulties in recruitment in Australia, only the French-designed project have been 
performed and can be presented within this thesis. 
 
vi. Although DXA-derived techniques have already shown acceptable reliability (Gordon et 
al. 2008), the use of 2D technologies to assess bone strength and bone trabecular 
microarchitecture may also comprise a limitation. Nonetheless, the available data was 
comprehensively explored, particularly presenting data for the first time using hip 
geometry as a region of particular interest in adolescents with obesity. 
 
vii. Markers of bone turnover are not easy to interpret during growth as they reflect 
growth, remodeling as well as nutritional status (Mosca et al. 2016). However, some 
interesting responses were monitored, particularly in the first four months of the 
intervention. 
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viii. The study did not measure specific hormones known to influence osteoblast and 
osteoclasts activity such as OPG/ RANK/ RANKL, sclerostin, osteocalcin (unOC, oC, tOC) 
but also parathyroid hormone, GH/IGH1, adiponectin. 
 
ix. Also due to budgetary considerations, testosterone and SHBG hormone (Sex hormone-
binding globulin), were not measured, but these data could have provided some high 
quality information relating to the observations of androgen-like bone growth.  
 
x. Among the adolescent females, it was not possible to control for the menstrual cycle 
phases, which may have also influence bone markers.  
 
5.4. Strengths 
This study has several strength that contribute to the existing literature.  
i. The population of adolescents were maturation-matched. The absence of matched-
maturation was previously identified as problematic in the reviewed literature. In 
addition, the targeting of only adolescents rather than children and adolescents and of 
obese rather than overweight and obese individuals can also be presented as a strength 
within the existing thesis.  
 
ii. Difficulties recruiting adolescents with obesity are well known. The challenges 
encountered in recruiting adolescents with obesity in Australia were significant and this 
planned component of the research had to be abandoned. Nonetheless, in France with 
strong clinical support, a total of 42 adolescents with obesity were recruited. This 
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number is similar to one previous study on adolescents with obesity (Campos et al. 
2014) and substantially more than others (Campos et al. 2013) (Rochefort et al. 2011) 
(El-Hage et al. 2009). 
 
iii. Another strength may lie in the duration of the intervention, which importantly allowed 
time for potential bone remodeling. Additionally, within the 8-month intervention, mid-
intervention data were collected, to detect any acute changes in body composition and 
bone parameters.  Without this scheduled data collection, some key adaptations would 
have been missed. 
 
iv. Although not all three groups were involved with complete sets of data, having three 
groups enhanced investigative opportunities. Having a normal weight control group 
beyond baseline to 8 months is not typically observed in the literature.  Also, few 
studies are design to recruit an additional control group of adolescents with obesity, 
who do not receive the intervention. 
 
v. It is acknowledged that limiting bone remodeling to only one bone formation marker 
(P1NP) and one bone resorption marker (CTx) may not provide an incomplete 
description of blood-borne responses to growth and the intervention. However, data 
were used innovatively in quantitative (median values for the uncoupling index) and 
qualitative representation of the distribution and elliptical patterns of bone remodeling 
via bone marker plots.  
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vi. Finally, although the data could be seen as incomplete, few previous studies have 
addressed adolescent obesity with a prolonged intervention within a residential 
program. Nor have they explored bone responses at the critical weight-bearing site of 
the hip using the hip structural analysis. Also, longitudinal studies on bone rarely 
combine DXA derived-data with bone biomarkers of bone turnover and maturation. 
Collectively, the results advance the existing understanding on bone responses to 
obesity and weight loss in adolescents and strengthen the directions for future 
research.  
 
5.5. Further research considerations 
This thesis opens several perspectives for future research.  
First, future research designs for interventions targeting adolescents with obesity will require 
strong considerations to improve rigour in scientific investigations. For example, compliance 
can not be assumed.  Protocols for planning monitoring and assessing physical activity and 
nutrition would strongly support potential dose-responses among participants in both 
intervention and comparative groups.   
 
Second, the protocols in this thesis could be expanded to include additional bone biomarkers 
of bone activity to investigate potential mechanistic explanations for the observed results. As 
stated in the limitations, additional bone biomarkers may more comprehensively explain the 
effects of weight loss on bone health following physical activity and nutrition intervention in 
adolescents with obesity. Specifically, measurements of RANKL/RANK/OPG, osteocalcin (unOC, 
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OC, tOC) and sclerostin would provide additional information on bone remodeling activity. 
Also, the assessment of vitamin D could be of interest as vitamin D insufficiency has been linked 
with the uncarboxylated form of osteocalcin (Giudici et al. 2017). Indeed, vitamin D deficiency 
or insufficiency often occurs under obese conditions. 
 
Third, to improve the understanding of maturational status and gender specific hormones, 
additional measures of FSH/LH could be assessed. This type of information could be used to 
add quality to data collection by (1) profiling additional measures of maturation, (2) coinciding 
blood sampling within similar phases of the  menstrual cycle. Also, because of the observed 
androgen-like adaptation growth it would be of interest to measure both testosterone and the 
SHBG hormone as its secretion is influenced by physical activity (van Gemert et al. 2015). 
Indeed, it is possible  that females with obesity have a substantially higher risk of developing 
polycystic ovary syndrome (hyperandrogenism) which may potentially explain the observed 
androgen-like bone growth. Therefore, future research could include additional bone, 
maturation and sex-specific hormones to help explain dose-related responses to lifestyle 
intervention in adolescents with obesity.  
 
The thesis also generated specific research question to be address in future research (Appendix 
31).  
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5.6. Conclusion 
This thesis investigated the impact of a multidisciplinary weight loss intervention combining 
nutrition and physical activity, on the bone health of adolescents with obesity.  
The research first identified contextual information and literatures gaps through rigorously 
reviewing the literature relating to  the implication of the bone-adiposity cross-talk in 
paediatric obesity and the effects of interventions with a physical activity component on bone 
health in children and adolescents with obesity.  
 
To strengthen the understanding of adolescents with obesity bone-related parameters, using 
a longitudinal intervention design, evidence were collected across an 8-month weight loss 
program combining physical activity and nutrition in a residential program.  This study 
identified compromised BMD through whole body and regional analysis. Even when adjusted 
for body weight and fat mass, lower BMD was observed in adolescents with obesity than their 
normal weight peers.  Despite some positive regional adaptations of bone geometry associated 
with the 8-month multidisciplinary weight loss intervention, fracture risk remained high in the 
adolescents with obesity, especially at the narrow neck.  Moreover, bone accretion in 
adolescents with obesity undergoing a weight loss intervention appeared to follow androgen-
like growth adaptations. These adaptations were shown through changes in periosteal 
expansion and endocortical resorption. An acute response at the midpoint of the intervention 
favoured bone formation. Yet, bone fragility in adolescents with obesity observed via DXA was 
supported by results from (1) bone marker z-scores, (2) the uncoupling index as well as by (3) 
the graphical representation. Future investigations of links between bone and obesity during 
adolescence can be well informed by the results of this thesis.    
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Appendix 14 - Baseline, 4 months and 8 months data of the adolescents that completed the whole WL intervention  
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Appendix 15 - Baseline and 4 months data of the adolescents with obesity in the control group 
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Appendix 17 - Excel file calculation of the 4 months bone turnover normalised to NW baseline median 
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Appendix 18 - Excel file calculation of the 8 months bone turnover normalised to NW baseline median 
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Appendix 19 - Excel file calculation of baseline Ob bone turnover normalised to Ob baseline median 
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Appendix 20 - Excel file calculation of 4 months Ob bone turnover normalised to Ob baseline median 
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Appendix 21 - Excel file calculation of 8 months Ob bone turnover normalised to Ob baseline median 
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Appendix 22 - Excel file calculation of baseline Ob control bone turnover normalised to Ob control baseline median 
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Appendix 23 - Excel file calculation of 4months Ob control bone turnover normalised to Ob control baseline median 
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Appendix 24 - Excel file calculation of baseline Ob bone turnover normalised to Ob control baseline median 
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Appendix 25 - Excel file calculation of 4 months Ob bone turnover normalised to Ob control baseline median 
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Appendix 26 - Excel file calculation of 8 months Ob bone turnover normalised to Ob control baseline median 
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Appendix 27 - Bone variables of the 24 adolescents with obesity at 4 months adjusted to (A) BW changes and (B) fat mass changes 
 
A 
WB (TBLH BMD) Lumbar Spine  Hip Neck 
Ob Ob Ob Ob 
 mean 95% CI  mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 0.964 0.927 - 1.001  1.011 0.952 - 1.070  1.035 0.975 - 1.095  0.962 0.904 - 1.020  
BMC (g) 1698.66 1572.35 - 1824.97  55.89 51.17 - 60.61  34.61 32.48 - 36.73  4.81 4.43 - 5.18  
BMAD (g/cm3) 0.092 0.090 - 0.094  0.992 0.931 - 1.053        
 
 Narrow Neck Intertrochanteric Femoral Shaft 
 Ob Ob Ob 
 mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 1.043 0.954 - 1.133  1.107 1.033 - 1.182  1.532 1.458 - 1.606  
ED (cm) 3.00 2.86 - 3.13  4.74 4.56 - 4.93  1.90 1.75 - 2.04  
ACT (cm) 0.22 0.20 - 0.23  0.48 0.44 - 0.51  0.58 0.55 - 0.61  
WIDTH (cm) 3.21 3.03 - 3.40  5.72 5.55 - 5.89  3.08 2.96 - 3.20  
CSA (cm2) 3.64 3.34 - 3.93  6.03 5.59 - 6.47  4.49 4.19 - 4.79  
CSMI (cm4) 2.95 2.56 - 3.34  16.49 14.73 - 18.26  3.88 3.32 - 4.45  
Z (cm3) 1.70 1.52 - 1.87  5.21 4.75 - 5.67  2.41 2.15 - 2.67  
BR 7.88 7.16 - 8.61  6.69 6.07 - 7.32  2.76 2.52 - 3.00  
 
B 
WB (TBLH BMD) Lumbar Spine  Hip Neck 
Ob Ob Ob Ob 
 mean 95% CI  mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 0.964 0.927 - 1.001  1.011 0.953 - 1.069  1.035 0.976 - 1.094  0.962 0.904 - 1.020  
BMC (g) 1698.66 1572.39 - 1824.93  55.89 51.39 - 60.38  34.61 32.51 - 36.71  4.81 4.44 - 5.18  
BMAD (g/cm3) 0.092 0.09 - 0.09  0.992 0.93 - 1.05        
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 Narrow Neck Intertrochanteric Femoral Shaft 
 Ob Ob Ob 
 mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 1.158 1.070 - 1.245  1.107 1.034 - 1.181  1.532 1.458 - 1.606  
ED (cm) 2.85 2.73 - 2.96  4.74 4.56 - 4.93  1.90 1.75 - 2.05  
ACT (cm) 0.22 0.20 - 0.23  0.48 0.44 - 0.51  0.58 0.55 - 0.61  
WIDTH (cm) 3.36 3.23 - 3.50  5.72 5.55 - 5.89  3.08 2.96 - 3.19  
CSA (cm2) 3.64 3.34 - 3.93  6.03 5.60 - 6.46  4.49 4.19 - 4.79  
CSMI (cm4) 2.95 2.56 - 3.33  16.49 14.71 - 18.28  3.88 3.32 - 4.44  
Z (cm3) 1.70 1.52 - 1.87  5.21 4.74 - 5.67  2.41 2.15 - 2.67  
BR 7.88 7.16 - 8.61  6.69 6.08 - 7.30  2.76 2.52 - 3.00  
 
 
Ob obese intervention group, NW normal weight control group, SD standard deviation, WB whole body, TBLH total body less head, LM lean mass, 
FM fat mass, BMD bone mineral density, BMC bone mineral content, BMAD bone mineral apparent density, NN narrow neck, IT intertrochanteric, 
FS femoral shaft, ED endocortical diameter, WIDTH width, CSA cross sectional area, CSMI cross sectional moment of inertia, ACT average cortical 
thickness, Z section modulus, BR buckling ratio 
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Appendix 28 - Bone variables of the 24 adolescents with obesity at 8 months adjusted to (A) BW changes and (B) fat mass changes 
 
A 
WB (TBLH BMD) Lumbar Spine  Hip Neck 
Ob Ob Ob Ob 
 mean 95% CI  mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 0.993 0.959 - 1.027  1.038 0.980 - 1.096  1.040 0.979 - 1.100  0.962 0.905 - 1.019  
BMC (g) 1788.79 1663.45 - 1914.13  58.79 54.16 - 63.43  35.10 32.53 - 37.66  4.92 4.56 - 5.29  
BMAD (g/cm3) 0.094 0.092 - 0.096  1.038 0.980 - 1.096        
 
 Narrow Neck Intertrochanteric Femoral Shaft 
 Ob Ob Ob 
 mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 1.153 1.070 - 1.236  1.091 1.071 - 1.166  1.572 1.505 - 1.640  
ED (cm) 2.92 2.79 - 3.05  4.74 4.55 - 4.92  1.88 1.74 - 2.02  
ACT (cm) 0.23 0.21 - 0.24  0.52 0.49 - 0.55  0.65 0.61 - 0.69  
WIDTH (cm) 3.39 3.27 - 3.51  5.69 5.54 - 5.85  3.04 2.88 - 3.20  
CSA (cm2) 3.69 3.42 - 3.96  5.92 5.50 - 6.34  4.65 4.40 - 4.90  
CSMI (cm4) 3.09 2.76 - 3.42  16.10 14.43 - 17.77  3.94 3.43 - 4.45  
Z (cm3) 1.73 1.57 - 1.89  5.06 4.62 - 5.51  2.44 2.19 - 2.70  
BR 8.24 7.36 - 9.12  6.85 6.22 - 7.48  2.72 2.51 - 2.94  
 
B 
WB (TBLH BMD) Lumbar Spine  Hip Neck 
Ob Ob Ob Ob 
 mean 95% CI  mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 0.993 0.959 - 1.028  1.038 0.981 - 1.095  1.040 0.976 - 1.104  0.969 0.909 - 1.029  
BMC (g) 1788.79 1663.57 - 1914.01  58.79 54.28 - 63.31  35.10 32.45 - 37.75  4.92 4.56 - 5.28  
BMAD (g/cm3) 0.094 0.092 - 0.096  1.038 0.981 - 1.095        
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 Narrow Neck Intertrochanteric Femoral Shaft 
 Ob Ob Ob 
 mean 95% CI  mean 95% CI  mean 95% CI  
BMD (g/cm2) 1.153 1.069 - 1.237  1.091 1.015 - 1.167  1.572 1.499 - 1.646  
ED (cm) 2.92 2.78 - 3.05  4.73 4.55 - 4.92  1.88 1.74 - 2.03  
ACT (cm) 0.23 0.22 - 0.24  0.52 0.49 - 0.55  0.65 0.61 - 0.68  
WIDTH (cm) 3.39 3.27 - 3.51  5.69 5.54 - 5.85  3.04 2.88 - 3.20  
CSA (cm2) 3.69 3.41 - 3.97  5.92 5.49 - 6.34  4.65 4.38 - 4.91  
CSMI (cm4) 3.09 2.74 - 3.45  16.10 14.43 - 17.77  3.94 3.43 - 4.44  
Z (cm3) 1.73 1.56 - 1.90  5.06 4.62 - 5.51  2.44 2.19 - 2.70  
BR 8.24 7.36 - 9.12  6.85 6.20 - 7.50  2.72 2.49 - 2.95  
 
Ob obese intervention group, NW normal weight control group, SD standard deviation, WB whole body, TBLH total body less head, LM lean mass, 
FM fat mass, BMD bone mineral density, BMC bone mineral content, BMAD bone mineral apparent density, NN narrow neck, IT intertrochanteric, 
FS femoral shaft, ED endocortical diameter, WIDTH width, CSA cross sectional area, CSMI cross sectional moment of inertia, ACT average cortical 
thickness, Z section modulus, BR buckling ratio 
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Appendix 29 - Baseline bone variables of the adolescents with obesity in the control group compared with the Ob intervention group 
 
 
WB (TBLH BMD) Lumbar Spine  Hip Neck 
Ob Ob control   Ob Ob control   Ob Ob control   Ob Ob control   
mean SD mean SD  mean SD mean SD  mean SD mean SD  mean SD mean SD  
BMD (g/cm2) 0.952 0.082 0.939 0.056  1.004 0.160 0.941 0.150  1.004 0.145 1.038 0.123  0.961 0.137 0.978 0.110  
BMC (g) 1619.56 303.74 1662.27 223.40  52.64 12.19 51.23 13.05  32.03 6.04 37.31 16.81  4.76 0.91 4.88 0.66  
BMAD 
(g/cm3) 
0.092 0.004 0.088 0.004  0.950 0.198 0.91 0.15  
 
        
 
 
 Narrow Neck Intertrochanteric Femoral Shaft 
 Ob Ob control   Ob Ob control   Ob Ob control   
 mean SD mean SD  mean SD mean SD  mean SD mean SD  
BMD (g/cm2) 1.196 0.17 1.217 0.14  1.101 0.21 1.100 0.06  1.486 0.16 1.507 0.10  
ED (cm) 2.73 0.21 2.66 0.32  4.59 0.39 4.60 0.35  1.87 0.33 1.81 0.24  
ACT (cm) 0.23 0.03 0.24 0.03  0.48 0.11 0.48 0.04  0.55 0.07 0.57 0.05  
WIDTH (cm) 3.20 0.23 3.15 0.33  5.56 0.40 5.56 0.37  2.98 0.28 2.95 0.19  
CSA (cm2) 3.65 0.70 3.66 0.71  5.86 1.28 5.83 0.53  4.22 0.60 4.23 0.40  
CSMI (cm4) 3.04 1.04 2.67 0.58  15.87 4.75 14.99 2.96  3.51 1.07 4.23 0.40  
Z (cm3) 1.79 0.49 1.59 0.21  5.08 1.32 4.94 0.75  2.26 0.52 2.24 0.38  
BR 7.45 1.43 6.85 1.07  6.74 1.66 6.28 0.67  2.80 0.58 2.75 0.34  
 
* p<0.05 Ob significantly different than Ob control. 
Ob obese intervention group, NW normal weight control group, SD standard deviation, WB whole body, TBLH total body less head, LM lean mass, 
FM fat mass, BMD bone mineral density, BMC bone mineral content, BMAD bone mineral apparent density, NN narrow neck, IT intertrochanteric, 
FS femoral shaft, ED endocortical diameter, WIDTH width, CSA cross sectional area, CSMI cross sectional moment of inertia, ACT average cortical 
thickness, Z section modulus, BR buckling ratio 
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Appendix 30 - Proposed future research question 
 
The proposed research question could be addressed in future research. 
i. What is the ratio between the effects of physical activity/nutrition during the WL 
intervention on bone health? 
The assessment of the relative contribution of physical activity versus nutrition on bone health 
among adolescents enrolled in a weight loss intervention is of interest. Indeed, in the current 
thesis it was not possible to individually track the volume and intensity of the exercise 
component Moreover, nutrition intakes would need to be evaluated at the beginning of the 
WL intervention along with changes during the course of the residential program to better 
explain potential bone and appetite markers changes.  
 
ii. Does High Intensity Interval Training (HIIT) combining resistance and aerobic exercise 
plus nutrition induce WL have better protective effects on bone health among 
adolescents with obesity than traditional weight loss program? 
Continuous moderate physical activity is the traditional recommendation for weight loss 
exercise intervention (Graf 2011). Yet, it is unclear which type of exercise can provide the 
greatest health benefits, including bone parameters during a weight loss intervention. Indeed, 
systematically reviewed, the results of HIIT on fat loss have been shown to be similar to 
moderate intensity (Keating et al. 2017) (Wewege et al. 2017). However, others using HIIT have 
demonstrated better efficiency in visceral fat loss (Dutheil et al. 2013), positive effects on 
cardiovascular fitness and weight status (Jung et al. 2014) (Little et al. 2014), cardiometabolic 
markers (Bluher et al. 2017), anorexigenic effects on energy intake (Thivel et al. 2012) (Thivel 
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et al. 2012), improvement of glycaemic control and pancreatic β cell function (Madsen et al. 
2015) and inhibition of sclerostin levels (Macias et al. 2012). Although, not in populations with 
obesity, high-intensity training has been associated with an effective slowdown of bone loss 
(de Jong et al. 2004).  Also, in older overweight adults with type 2 diabetes, it has been found 
that including high intensity progressive resistance training in a weight loss intervention 
optimised the effects on body composition without having a negative effect on bone health 
(Daly et al. 2005). Based on those observations it would be of interest to observe the effects 
of HIIT on bone health. 
 
iii. Can the results of weight loss interventions (physical activity and nutrition) differentiate 
between adolescent males and females with obesity?  
Observation in young mice study showed sexual dimorphism relating to bone responses to 
exercise training (Koenen et al. 2017). Indeed, after 8 weeks of high intensity interval training 
using a treadmill, male mice increased cortical bone but lost trabecular bone while no effects 
on bone were seen in female mice. Indeed, trabecular bone and cortical bone of female mice 
did not change in response to HIIT. Moreover, in human studies gender differences were 
observed in hormone circulating levels such as leptin and osteocalcin (Abseyi et al. 2012) (Do 
Prado et al. 2009) (Garanty-Bogacka et al. 2013), which have direct or indirect effects on bone 
health. Also, there is some evidence to support higher BMD values in female than male children 
with obesity (Nagasaki et al. 2004).  
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iv. Do adolescents with metabolic syndrome respond similarly to a weight loss program 
combining physical activity and nutrition in peers who demonstrate a “healthy” 
obesity?   
A potential link between bone health and metabolic syndrome (MetS) can be speculated. In 
the last decade, the influence of MetS on bone health has been explored. However, results 
remain inconclusive. The existing literature highlights that children and adolescents with 
obesity have lower values of osteocalcin than their normal weight peers. It could be 
hypothesised that during adolescence, obesity inducing metabolic syndrome might be 
associated with bone fragility. Indeed, even if their results were inconclusive about a potential 
link between osteocalcin and MetS, some evidence using animal models have shown that the 
administration of osteocalcin can correct metabolic abnormalities (Lee et al. 2007). 
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